,sent,norm_gpt,gpt_norm_4,gpt_norm_7_old,gpt_norm_7,gpt_norm_8
0,"Franchisee agrees to return all materials and supplies identified by the Marks in full cases or  packages  to Pretzel  Time for credit and dispose of all other materials and supplies, but not equipment,  identified by the Marks within thirty (30) days after the effective  date of  termination or expiration of this Agreement.","Norm 1:
- Norm type: Commitment
- Subject: Franchisee
- Object: Pretzel Time
- Antecedent: Termination or expiration of this Agreement
- Consequent: Franchisee agrees to return all materials and supplies identified by the Marks in full cases or packages to Pretzel Time for credit and dispose of all other materials and supplies, but not equipment, identified by the Marks within thirty (30) days after the effective date of termination or expiration of this Agreement.

Norm 2:
- Norm type: Prohibition
- Subject: Franchisee
- Object: None
- Antecedent: None
- Consequent: Franchisee is prohibited from disposing of equipment identified by the Marks after the effective date of termination or expiration of this Agreement.

Note: The given sentence does not contain norms related to authorization or power.","Norm 1:
1. Norm type: Commitment
2. Subject: Franchisee
3. Object: Pretzel Time
4. Antecedent: Effective date of termination or expiration of the Agreement
5. Consequent: Return all materials and supplies identified by the Marks in full cases or packages to Pretzel Time for credit and dispose of all other materials and supplies (excluding equipment) identified by the Marks within thirty (30) days after the effective date of termination or expiration of this Agreement.

Norm 2:
1. Norm type: Prohibition
2. Subject: Franchisee
3. Object: Pretzel Time
4. Antecedent: Effective date of termination or expiration of the Agreement
5. Consequent: Not dispose of equipment identified by the Marks within thirty (30) days after the effective date of termination or expiration of this Agreement.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Franchisee
3. OBJECT: Pretzel Time
4. ANTECEDENT: Effective date of termination or expiration of the Agreement
5. CONSEQUENT: Return all materials and supplies identified by the Marks in full cases or packages to Pretzel Time for credit and dispose of all other materials and supplies (excluding equipment) identified by the Marks within thirty (30) days.

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Franchisee
3. OBJECT: Pretzel Time
4. ANTECEDENT: Effective date of termination or expiration of the Agreement
5. CONSEQUENT: Not to dispose of equipment identified by the Marks within thirty (30) days after the effective date of termination or expiration of this Agreement.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Franchisee
3. OBJECT: Pretzel Time
4. ANTECEDENT: Termination or expiration of the Agreement
5. CONSEQUENT: Return all materials and supplies identified by the Marks in full cases or packages to Pretzel Time for credit and dispose of all other materials and supplies (excluding equipment) within thirty (30) days

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Franchisee
3. OBJECT: Pretzel Time
4. ANTECEDENT: Termination or expiration of the Agreement
5. CONSEQUENT: Not dispose of equipment identified by the Marks within thirty (30) days after the effective date of termination or expiration of this Agreement.","Norm 1:
1. Norm type: Commitment
2. Subject: Franchisee
3. Object: Pretzel Time
4. Antecedent: Effective date of termination or expiration of the Agreement
5. Consequent: Return all materials and supplies identified by the Marks in full cases or packages to Pretzel Time for credit and dispose of all other materials and supplies (excluding equipment) identified by the Marks within thirty (30) days.

Norm 2:
1. Norm type: Prohibition
2. Subject: Franchisee
3. Object: Pretzel Time
4. Antecedent: Effective date of termination or expiration of the Agreement
5. Consequent: Not to dispose of equipment identified by the Marks within thirty (30) days after the effective date of termination or expiration of this Agreement."
1,"To the extent any Development owned by Life Technologies relates directly to the practice of, or constitutes an improvement to, the Assay, Life Technologies hereby grants to Biocept, during the Term of this Agreement, and, except in the case of termination of this Agreement by Life Technologies for Biocept's uncured material breach, after expiration or termination of this Agreement, a non-exclusive, worldwide, royalty-free, fully-paid license, including the right to sublicense, under Life Technologies' Intellectual Property Rights in such Developments, solely to develop, make, have made, use, sell, have sold, offer for sale, import, perform and provide the Assay.","Norm 1:
Norm type: Authorization
Subject: Life Technologies
Object: Biocept
Antecedent: N/A
Consequent: Granting a non-exclusive, worldwide, royalty-free, fully-paid license to Biocept under Life Technologies' Intellectual Property Rights in the Developments, solely to develop, make, have made, use, sell, have sold, offer for sale, import, perform and provide the Assay.

Norm 2:
Norm type: Commitment
Subject: Life Technologies
Object: N/A
Antecedent: Termination of this Agreement by Life Technologies for Biocept's uncured material breach
Consequent: The non-exclusive license granted to Biocept will not be applicable in the case of termination of this Agreement by Life Technologies for Biocept's uncured material breach.

Norm 3:
Norm type: Authorization
Subject: Life Technologies
Object: Biocept
Antecedent: N/A
Consequent: Granting a non-exclusive, worldwide, royalty-free, fully-paid license to Biocept under Life Technologies' Intellectual Property Rights in the Developments, even after the expiration or termination of this Agreement.

Norm 4:
Norm type: Commitment
Subject: Life Technologies
Object: N/A
Antecedent: N/A
Consequent: The non-exclusive license granted to Biocept will continue to be applicable even after the expiration or termination of this Agreement.

Norm 5:
Norm type: Power
Subject: Biocept
Object: N/A
Antecedent: N/A
Consequent: Biocept has the power to sublicense the granted license to third parties.","Norm 1:
1. Norm type: Authorization
2. Subject: Life Technologies
3. Object: Biocept
4. Antecedent: Development owned by Life Technologies relates directly to the practice of, or constitutes an improvement to, the Assay
5. Consequent: Biocept is granted a non-exclusive, worldwide, royalty-free, fully-paid license, including the right to sublicense, under Life Technologies' Intellectual Property Rights in such Developments, solely to develop, make, have made, use, sell, have sold, offer for sale, import, perform and provide the Assay.

Norm 2:
1. Norm type: Commitment
2. Subject: Life Technologies
3. Object: Biocept
4. Antecedent: None specified
5. Consequent: Life Technologies commits to granting Biocept the license described in Norm 1 during the Term of the Agreement, and after expiration or termination of the Agreement, except in the case of termination of this Agreement by Life Technologies for Biocept's uncured material breach.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Life Technologies
3. OBJECT: Biocept
4. ANTECEDENT: Any Development owned by Life Technologies relates directly to the practice of, or constitutes an improvement to, the Assay
5. CONSEQUENT: Life Technologies grants to Biocept a non-exclusive, worldwide, royalty-free, fully-paid license, including the right to sublicense, under Life Technologies' Intellectual Property Rights in such Developments, solely to develop, make, have made, use, sell, have sold, offer for sale, import, perform and provide the Assay.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Life Technologies
3. OBJECT: Biocept
4. ANTECEDENT: The Term of this Agreement
5. CONSEQUENT: Life Technologies commits to granting Biocept the license mentioned in NORM 1 during the Term of this Agreement.

NORM 3:
1. NORM type: COMMITMENT
2. SUBJECT: Life Technologies
3. OBJECT: Biocept
4. ANTECEDENT: Except in the case of termination of this Agreement by Life Technologies for Biocept's uncured material breach
5. CONSEQUENT: Life Technologies commits to granting Biocept the license mentioned in NORM 1 after expiration or termination of this Agreement, except in the case of termination by Life Technologies for Biocept's uncured material breach.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Life Technologies
3. OBJECT: Biocept
4. ANTECEDENT: Any Development owned by Life Technologies relates directly to the practice of, or constitutes an improvement to, the Assay
5. CONSEQUENT: Biocept is granted a non-exclusive, worldwide, royalty-free, fully-paid license, including the right to sublicense, under Life Technologies' Intellectual Property Rights in such Developments, solely to develop, make, have made, use, sell, have sold, offer for sale, import, perform and provide the Assay.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Life Technologies
3. OBJECT: Biocept
4. ANTECEDENT: During the Term of this Agreement, and, except in the case of termination of this Agreement by Life Technologies for Biocept's uncured material breach, after expiration or termination of this Agreement
5. CONSEQUENT: Life Technologies commits to granting Biocept the specified license for the stated purposes.","Norm 1:
1. Norm type: Authorization
2. Subject: Life Technologies
3. Object: Biocept
4. Antecedent: Development owned by Life Technologies relates directly to the practice of, or constitutes an improvement to, the Assay
5. Consequent: Biocept granted a non-exclusive, worldwide, royalty-free, fully-paid license to develop, make, have made, use, sell, have sold, offer for sale, import, perform, and provide the Assay.

Norm 2:
1. Norm type: Commitment
2. Subject: Life Technologies
3. Object: Biocept
4. Antecedent: Term of the Agreement
5. Consequent: Life Technologies grants Biocept the license mentioned in Norm 1 during the Term of the Agreement and after expiration or termination of the Agreement, except in the case of termination by Life Technologies for Biocept's uncured material breach."
2,"Each Party shall maintain complete, current and accurate records of all Development activities conducted by it hereunder, and all data and other information resulting from such activities, for at least [***] after the expiration or termination of this Agreement in its entirety or for such longer period as may be required by Applicable Law.","1. Norm type: Commitment
2. Subject: Each Party
3. Object: -
4. Antecedent: -
5. Consequent: Each Party shall maintain complete, current and accurate records of all Development activities conducted by it hereunder, and all data and other information resulting from such activities, for at least [***] after the expiration or termination of this Agreement in its entirety or for such longer period as may be required by Applicable Law.","Norm 1:
1. Norm type: Commitment
2. Subject: Each Party
3. Object: Applicable Law
4. Antecedent: Completion of Development activities
5. Consequent: Maintenance of complete, current, and accurate records for a specified period after the expiration or termination of the Agreement

Norm 2:
1. Norm type: Authorization
2. Subject: Each Party
3. Object: Applicable Law
4. Antecedent: Expiration or termination of the Agreement
5. Consequent: Maintenance of records for a longer period if required by Applicable Law","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Each Party
3. OBJECT: -
4. ANTECEDENT: Conducting Development activities
5. CONSEQUENT: Maintaining complete, current, and accurate records for a specified period after the expiration or termination of the Agreement

CLAUSE: Each Party commits to maintaining complete, current, and accurate records of all Development activities conducted by it hereunder, and all data and other information resulting from such activities, for at least [***] after the expiration or termination of this Agreement in its entirety or for such longer period as may be required by Applicable Law.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Each Party
3. OBJECT: Applicable Law
4. ANTECEDENT: Expiration or termination of the Agreement
5. CONSEQUENT: Maintaining records for a longer period if required by Applicable Law

CLAUSE: Each Party commits to maintaining records for a longer period if required by Applicable Law after the expiration or termination of this Agreement.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Each Party
3. OBJECT: -
4. ANTECEDENT: Development activities conducted by it hereunder
5. CONSEQUENT: maintain complete, current and accurate records of all Development activities

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Each Party
3. OBJECT: -
4. ANTECEDENT: all data and other information resulting from such activities
5. CONSEQUENT: maintain complete, current and accurate records of all data and information

NORM 3:
1. NORM type: COMMITMENT
2. SUBJECT: Each Party
3. OBJECT: -
4. ANTECEDENT: expiration or termination of this Agreement
5. CONSEQUENT: maintain records for at least [***] after expiration or termination

NORM 4:
1. NORM type: COMMITMENT
2. SUBJECT: Each Party
3. OBJECT: -
4. ANTECEDENT: expiration or termination of this Agreement
5. CONSEQUENT: maintain records for such longer period as may be required by Applicable Law.","Norm 1:
1. Norm type: Commitment
2. Subject: Each Party
3. Object: N/A
4. Antecedent: Conducting Development activities
5. Consequent: Maintaining complete, current, and accurate records for a specified period after the expiration or termination of the Agreement.

Norm 2:
1. Norm type: Authorization
2. Subject: Each Party
3. Object: N/A
4. Antecedent: Conducting Development activities
5. Consequent: Maintaining data and information resulting from activities for a specified period after the expiration or termination of the Agreement."
3,Either party may terminate this Agreement by providing [*] month's written       notice to the other.,"Norm 1:
1. Norm type: Authorization
2. Subject: Either party
3. Object: The other party
4. Antecedent: None specified
5. Consequent: Termination of the Agreement

Norm 2:
1. Norm type: Commitment
2. Subject: Either party
3. Object: The other party
4. Antecedent: None specified
5. Consequent: Providing [*] month's written notice

Norm 3:
1. Norm type: Commitment
2. Subject: The other party
3. Object: Either party
4. Antecedent: None specified
5. Consequent: Receiving [*] month's written notice

Norm 4:
1. Norm type: Prohibition
2. Subject: None specified
3. Object: None specified
4. Antecedent: None specified
5. Consequent: None specified

Norm 5:
1. Norm type: Power
2. Subject: Either party
3. Object: None specified
4. Antecedent: None specified
5. Consequent: Termination of the Agreement","Norm 1:
1. Norm type: Power
2. Subject: Either party
3. Object: The other party
4. Antecedent: Providing [*] month's written notice
5. Consequent: Termination of the Agreement

Norm 2:
1. Norm type: Commitment
2. Subject: Either party
3. Object: The other party
4. Antecedent: None
5. Consequent: Ensuring termination of the Agreement if [*] month's written notice is provided","NORM 1:
1. NORM type: POWER
2. SUBJECT: Either party
3. OBJECT: the other party
4. ANTECEDENT: [*] month's written notice is provided
5. CONSEQUENT: Agreement may be terminated

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Either party
3. OBJECT: the other party
4. ANTECEDENT: [*] month's written notice is provided
5. CONSEQUENT: Agreement will be terminated","1. NORM type: COMMITMENT
2. SUBJECT: Either party
3. OBJECT: the other party
4. ANTECEDENT: providing [*] month's written notice
5. CONSEQUENT: termination of the Agreement","1. Norm type: authorization
2. Subject: Either party
3. Object: the other party
4. Antecedent: providing [*] month's written notice
5. Consequent: termination of the Agreement"
4,"If Pfizer and Exact are unable to reach agreement on the terms of such Product rights within forty-five (45) days of the commencement of negotiations, then Exact shall be free to enter into negotiations and consummate an agreement with any Third Party regarding such OB/Gyn Commercial Rights; provided that the economic terms of such agreement shall be no more favorable to such Third Party than those last offered to Pfizer.","1. Norm type: Authorization
Subject: Exact
Object: Third Party
Antecedent: Pfizer and Exact are unable to reach agreement on the terms of such Product rights within forty-five (45) days of the commencement of negotiations
Consequent: Exact shall be free to enter into negotiations and consummate an agreement with any Third Party regarding such OB/Gyn Commercial Rights

2. Norm type: Commitment
Subject: Exact
Object: Pfizer
Antecedent: Pfizer and Exact are unable to reach agreement on the terms of such Product rights within forty-five (45) days of the commencement of negotiations
Consequent: Exact shall be free to enter into negotiations and consummate an agreement with any Third Party regarding such OB/Gyn Commercial Rights; provided that the economic terms of such agreement shall be no more favorable to such Third Party than those last offered to Pfizer.","Norm 1:
1. Norm type: Authorization
2. Subject: Exact
3. Object: Pfizer
4. Antecedent: Pfizer and Exact are unable to reach agreement on the terms of Product rights within forty-five (45) days of the commencement of negotiations
5. Consequent: Exact shall be free to enter into negotiations and consummate an agreement with any Third Party regarding OB/Gyn Commercial Rights

Norm 2:
1. Norm type: Prohibition
2. Subject: Exact
3. Object: Pfizer
4. Antecedent: Pfizer and Exact are unable to reach agreement on the terms of Product rights within forty-five (45) days of the commencement of negotiations
5. Consequent: The economic terms of the agreement with any Third Party shall not be more favorable than those last offered to Pfizer.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Pfizer
3. OBJECT: Exact
4. ANTECEDENT: Pfizer and Exact are unable to reach agreement on the terms of Product rights within forty-five (45) days of the commencement of negotiations
5. CONSEQUENT: Exact shall be free to enter into negotiations and consummate an agreement with any Third Party regarding OB/Gyn Commercial Rights

CLAUSE: ""Exact shall be free to enter into negotiations and consummate an agreement with any Third Party regarding OB/Gyn Commercial Rights""

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Pfizer
3. OBJECT: Exact
4. ANTECEDENT: Pfizer and Exact are unable to reach agreement on the terms of Product rights within forty-five (45) days of the commencement of negotiations
5. CONSEQUENT: the economic terms of the agreement with any Third Party shall not be more favorable than those last offered to Pfizer

CLAUSE: ""the economic terms of such agreement shall be no more favorable to such Third Party than those last offered to Pfizer""","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Pfizer
3. OBJECT: Exact
4. ANTECEDENT: Pfizer and Exact are unable to reach agreement on the terms of Product rights within forty-five (45) days of the commencement of negotiations
5. CONSEQUENT: Exact shall be free to enter into negotiations and consummate an agreement with any Third Party regarding OB/Gyn Commercial Rights

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Pfizer
3. OBJECT: Exact
4. ANTECEDENT: Pfizer and Exact are unable to reach agreement on the terms of Product rights within forty-five (45) days of the commencement of negotiations
5. CONSEQUENT: The economic terms of the agreement with any Third Party shall not be more favorable than those last offered to Pfizer.","Norm 1:
1. Norm type: Authorization
2. Subject: Pfizer
3. Object: Exact
4. Antecedent: Pfizer and Exact are unable to reach agreement on the terms of Product rights within forty-five (45) days of the commencement of negotiations
5. Consequent: Exact shall be free to enter into negotiations and consummate an agreement with any Third Party regarding OB/Gyn Commercial Rights

Norm 2:
1. Norm type: Prohibition
2. Subject: Exact
3. Object: Third Party
4. Antecedent: Pfizer and Exact are unable to reach agreement on the terms of Product rights within forty-five (45) days of the commencement of negotiations
5. Consequent: The economic terms of the agreement with the Third Party shall not be more favorable than those last offered to Pfizer."
5,Either Party shall be entitled forthwith to terminate this Agreement by notice to the other if:<omitted>(i) the other Party ceases or threatens to cease to carry on the whole or any material part of its business;,"1. Norm type: Authorization
Subject: Either Party
Object: the other Party
Antecedent: the other Party ceases or threatens to cease to carry on the whole or any material part of its business
Consequent: termination of the Agreement

2. Norm type: Commitment
Subject: Either Party
Object: the Agreement
Antecedent: None mentioned
Consequent: termination of the Agreement

3. Norm type: Prohibition
Subject: None mentioned
Object: None mentioned
Antecedent: None mentioned
Consequent: None mentioned

Note: The given sentence does not explicitly mention any norms related to power or prohibition.","Norm 1:
1. Norm type: Power
2. Subject: Either Party
3. Object: the other Party
4. Antecedent: the other Party ceases or threatens to cease to carry on the whole or any material part of its business
5. Consequent: termination of the Agreement

Norm 2:
1. Norm type: Commitment
2. Subject: Either Party
3. Object: the other Party
4. Antecedent: the other Party ceases or threatens to cease to carry on the whole or any material part of its business
5. Consequent: termination of the Agreement","NORM 1:
1. NORM type: POWER
2. SUBJECT: Either Party
3. OBJECT: the other Party
4. ANTECEDENT: the other Party ceases or threatens to cease to carry on the whole or any material part of its business
5. CONSEQUENT: termination of the Agreement

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Either Party
3. OBJECT: the other Party
4. ANTECEDENT: the other Party ceases or threatens to cease to carry on the whole or any material part of its business
5. CONSEQUENT: termination of the Agreement","NORM 1:
1. NORM type: POWER
2. SUBJECT: Either Party
3. OBJECT: the other Party
4. ANTECEDENT: the other Party ceases or threatens to cease to carry on the whole or any material part of its business
5. CONSEQUENT: termination of the Agreement

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Either Party
3. OBJECT: the other Party
4. ANTECEDENT: the other Party ceases or threatens to cease to carry on the whole or any material part of its business
5. CONSEQUENT: termination of the Agreement","1. Norm type: commitment
2. Subject: Either Party
3. Object: the other Party
4. Antecedent: the other Party ceases or threatens to cease to carry on the whole or any material part of its business
5. Consequent: termination of the Agreement"
6,"At the end of the sell-off period set forth in Section 12.3(c)(iii), Sanofi shall transfer to RevMed any and all inventory of SHP2 Inhibitors and Termination Products (including all research materials, final product, bulk drug substance, intermediates, work-in-process, formulation materials, reference standards, drug product clinical reserve samples, packaged retention samples, and the like) then in the possession of Sanofi, its Affiliates or Sublicensees, and continue or have continued any ongoing stability studies pertaining to any materials so transferred to RevMed for a reasonable period of time until RevMed can assume responsibility for such activities","Norm 1:
Norm type: Authorization
Subject: Sanofi
Object: RevMed
Antecedent: End of the sell-off period set forth in Section 12.3(c)(iii)
Consequent: Sanofi shall transfer any and all inventory of SHP2 Inhibitors and Termination Products to RevMed, including all research materials, final product, bulk drug substance, intermediates, work-in-process, formulation materials, reference standards, drug product clinical reserve samples, packaged retention samples, and the like. Sanofi shall also continue or have continued any ongoing stability studies pertaining to any materials transferred to RevMed for a reasonable period of time until RevMed can assume responsibility for such activities.

Norm 2:
Norm type: Commitment
Subject: Sanofi
Object: RevMed
Antecedent: None
Consequent: Sanofi commits to transferring any and all inventory of SHP2 Inhibitors and Termination Products to RevMed, including all research materials, final product, bulk drug substance, intermediates, work-in-process, formulation materials, reference standards, drug product clinical reserve samples, packaged retention samples, and the like. Sanofi also commits to continuing or having continued any ongoing stability studies pertaining to any materials transferred to RevMed for a reasonable period of time until RevMed can assume responsibility for such activities.

Norm 3:
Norm type: Authorization
Subject: Sanofi
Object: None
Antecedent: End of the sell-off period set forth in Section 12.3(c)(iii)
Consequent: Sanofi is authorized to transfer any and all inventory of SHP2 Inhibitors and Termination Products, including all research materials, final product, bulk drug substance, intermediates, work-in-process, formulation materials, reference standards, drug product clinical reserve samples, packaged retention samples, and the like, to any party.

Norm 4:
Norm type: Commitment
Subject: Sanofi
Object: None
Antecedent: None
Consequent: Sanofi commits to transferring any and all inventory of SHP2 Inhibitors and Termination Products, including all research materials, final product, bulk drug substance, intermediates, work-in-process, formulation materials, reference standards, drug product clinical reserve samples, packaged retention samples, and the like, to any party.

Norm 5:
Norm type: Commitment
Subject: Sanofi
Object: RevMed
Antecedent: None
Consequent: Sanofi commits to transferring any and all inventory of SHP2 Inhibitors and Termination Products to RevMed, including all research materials, final product, bulk drug substance, intermediates, work-in-process, formulation materials, reference standards, drug product clinical reserve samples, packaged retention samples, and the like. Sanofi also commits to continuing or having continued any ongoing stability studies pertaining to any materials transferred to RevMed for a reasonable period of time until RevMed can assume responsibility for such activities.","Norm 1:
1. Norm type: Commitment
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: End of the sell-off period set forth in Section 12.3(c)(iii)
5. Consequent: Transfer any and all inventory of SHP2 Inhibitors and Termination Products (including specified materials) to RevMed, continue or have continued any ongoing stability studies pertaining to any materials transferred to RevMed for a reasonable period of time until RevMed can assume responsibility for such activities

Norm 2:
1. Norm type: Authorization
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: End of the sell-off period set forth in Section 12.3(c)(iii)
5. Consequent: Transfer any and all inventory of SHP2 Inhibitors and Termination Products (including specified materials) to RevMed, continue or have continued any ongoing stability studies pertaining to any materials transferred to RevMed for a reasonable period of time until RevMed can assume responsibility for such activities","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: End of the sell-off period set forth in Section 12.3(c)(iii)
5. CONSEQUENT: Transfer any and all inventory of SHP2 Inhibitors and Termination Products to RevMed, including research materials, final product, bulk drug substance, intermediates, work-in-process, formulation materials, reference standards, drug product clinical reserve samples, packaged retention samples, and the like. Continue or have continued any ongoing stability studies pertaining to any materials transferred to RevMed for a reasonable period of time until RevMed can assume responsibility for such activities.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: End of the sell-off period set forth in Section 12.3(c)(iii)
5. CONSEQUENT: Assume responsibility for the ongoing stability studies pertaining to any materials transferred by Sanofi, its Affiliates, or Sublicensees for a reasonable period of time.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: End of the sell-off period set forth in Section 12.3(c)(iii)
5. CONSEQUENT: Transfer any and all inventory of SHP2 Inhibitors and Termination Products to RevMed, continue or have continued any ongoing stability studies pertaining to any materials transferred to RevMed for a reasonable period of time until RevMed can assume responsibility for such activities

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: End of the sell-off period set forth in Section 12.3(c)(iii)
5. CONSEQUENT: Transfer any and all inventory of SHP2 Inhibitors and Termination Products to RevMed, continue or have continued any ongoing stability studies pertaining to any materials transferred to RevMed for a reasonable period of time until RevMed can assume responsibility for such activities","1. Norm type: Authorization
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: End of the sell-off period set forth in Section 12.3(c)(iii)
5. Consequent: Transfer of inventory of SHP2 Inhibitors and Termination Products to RevMed and continuation of ongoing stability studies for a reasonable period of time. 

2. Norm type: Commitment
3. Subject: Sanofi
4. Antecedent: End of the sell-off period set forth in Section 12.3(c)(iii)
5. Consequent: Transfer of inventory of SHP2 Inhibitors and Termination Products to RevMed and continuation of ongoing stability studies for a reasonable period of time."
7,"Accordingly, neither this Agreement nor any part of your interest in it, nor any Interest (as defined in Paragraph 14.2) of Franchise Owner or a Principal Owner, may be transferred (see definition below) without our advance written approval if such transfer will result in the Principal Owner(s) set forth in Exhibit 4 holding less than a seventy-five percent (75%) Interest in Franchise Owner.<omitted>As used in this Agreement the term ""Transfer"" means any voluntary, involuntary, direct or indirect assignment, sale, gift, exchange, grant of a security interest, or occurrence of any other event which would or might change the ownership of any Interest, and includes, without limitation: (1) the Transfer of ownership of capital stock, partnership interest or other ownership interest (including the granting of options (such as stock options or any option which give anyone ownership rights now or in the future); (2) merger or consolidation, or issuance of additional securities representing an ownership interest in Franchise Owner; (3) sale of common stock of Franchise Owner sold pursuant to a private placement or registered public offering; (4) Transfer of an Interest in a divorce proceeding or otherwise by operation of law; or (5) Transfer of an Interest by will, declaration of or transfer in trust, or under the laws of intestate succession.","Norm 1:
Norm type: Prohibition
Subject: Franchise Owner or a Principal Owner
Object: Our (the party granting approval)
Antecedent: Transfer of interest in the Agreement
Consequent: Transfer is not allowed without advance written approval if it results in the Principal Owner(s) holding less than a seventy-five percent (75%) Interest in Franchise Owner.

Norm 2:
Norm type: Authorization
Subject: Our (the party granting approval)
Object: Franchise Owner or a Principal Owner
Antecedent: None mentioned
Consequent: Advance written approval is required for any transfer of interest in the Agreement.

Norm 3:
Norm type: Prohibition
Subject: Franchise Owner or a Principal Owner
Object: None mentioned
Antecedent: None mentioned
Consequent: Transfer of interest in the Agreement is not allowed without advance written approval.

Norm 4:
Norm type: Commitment
Subject: None mentioned
Object: None mentioned
Antecedent: None mentioned
Consequent: The term ""Transfer"" is defined as any event that changes the ownership of any Interest, including but not limited to the transfer of ownership of capital stock, partnership interest, or other ownership interest.

Norm 5:
Norm type: Commitment
Subject: None mentioned
Object: None mentioned
Antecedent: None mentioned
Consequent: The term ""Transfer"" includes various actions such as assignment, sale, gift, exchange, grant of a security interest, merger, consolidation, issuance of additional securities, sale of common stock, transfer in a divorce proceeding, transfer by will, declaration of or transfer in trust, or under the laws of intestate succession.","Norm 1:
1. Norm type: Prohibition
2. Subject: Franchise Owner or a Principal Owner
3. Object: The party requiring advance written approval
4. Antecedent: Transfer of interest resulting in Principal Owner(s) holding less than 75% interest in Franchise Owner
5. Consequent: Transfer of interest without advance written approval is prohibited

Norm 2:
1. Norm type: Authorization
2. Subject: The party requiring advance written approval
3. Object: Franchise Owner or a Principal Owner
4. Antecedent: Transfer of interest as defined in the agreement
5. Consequent: The party requiring advance written approval is authorized to approve or disapprove the transfer of interest as defined in the agreement.","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: Franchise Owner or a Principal Owner
3. OBJECT: the party seeking to transfer their interest in the Agreement
4. ANTECEDENT: Transfer of interest without advance written approval
5. CONSEQUENT: Holding less than a seventy-five percent (75%) Interest in Franchise Owner

CLAUSE: ""neither this Agreement nor any part of your interest in it, nor any Interest (as defined in Paragraph 14.2) of Franchise Owner or a Principal Owner, may be transferred without our advance written approval if such transfer will result in the Principal Owner(s) set forth in Exhibit 4 holding less than a seventy-five percent (75%) Interest in Franchise Owner.""

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: the party seeking to transfer their interest in the Agreement
3. OBJECT: Franchise Owner or a Principal Owner
4. ANTECEDENT: Transfer of interest with advance written approval
5. CONSEQUENT: Holding at least a seventy-five percent (75%) Interest in Franchise Owner

CLAUSE: ""neither this Agreement nor any part of your interest in it, nor any Interest (as defined in Paragraph 14.2) of Franchise Owner or a Principal Owner, may be transferred without our advance written approval if such transfer will result in the Principal Owner(s) set forth in Exhibit 4 holding less than a seventy-five percent (75%) Interest in Franchise Owner.""","1. NORM type: PROHIBITION
2. SUBJECT: Franchise Owner or a Principal Owner
3. OBJECT: the party with respect to whom the NORM applies
4. ANTECEDENT: Transfer of ownership resulting in Principal Owner(s) holding less than 75% Interest in Franchise Owner
5. CONSEQUENT: Transfer of ownership not allowed without advance written approval","1. Norm type: Authorization
2. Subject: Franchise Owner or a Principal Owner
3. Object: the party granting approval (not explicitly mentioned in the sentence)
4. Antecedent: Transfer of interest resulting in Principal Owner(s) holding less than 75% interest
5. Consequent: Transfer of interest requires advance written approval"
8,"Biocept grants to Life Technologies a non-exclusive option, exercisable during the two (2) year period beginning on the Effective Date, to develop plans, and negotiate with Biocept, for the co-development with Biocept of such systems for the Assay, employing or based on Biocept technologies.","1. Norm type: Authorization
Subject: Biocept
Object: Life Technologies
Antecedent: None mentioned
Consequent: Granting a non-exclusive option to Life Technologies to develop plans and negotiate with Biocept for the co-development of systems for the Assay, employing or based on Biocept technologies.

2. Norm type: Commitment
Subject: Life Technologies
Object: Biocept
Antecedent: None mentioned
Consequent: Life Technologies commits to developing plans and negotiating with Biocept for the co-development of systems for the Assay, employing or based on Biocept technologies.

3. Norm type: Commitment
Subject: Biocept
Object: None mentioned
Antecedent: None mentioned
Consequent: Biocept commits to considering the development of plans and negotiation with Life Technologies for the co-development of systems for the Assay, employing or based on Biocept technologies.

4. Norm type: Commitment
Subject: Life Technologies
Object: None mentioned
Antecedent: None mentioned
Consequent: Life Technologies commits to developing plans and negotiating with Biocept for the co-development of systems for the Assay, employing or based on Biocept technologies.

5. Norm type: Authorization
Subject: Biocept
Object: None mentioned
Antecedent: None mentioned
Consequent: Biocept grants the option to Life Technologies to develop plans and negotiate for the co-development of systems for the Assay, employing or based on Biocept technologies.","Norm 1:
1. Norm type: Authorization
2. Subject: Life Technologies
3. Object: Biocept
4. Antecedent: Exercisable during the two (2) year period beginning on the Effective Date
5. Consequent: Develop plans and negotiate with Biocept for the co-development of systems for the Assay, employing or based on Biocept technologies

Norm 2:
1. Norm type: Power
2. Subject: Life Technologies
3. Object: Biocept
4. Antecedent: Exercisable during the two (2) year period beginning on the Effective Date
5. Consequent: Life Technologies has the power to develop plans and negotiate with Biocept for the co-development of systems for the Assay, employing or based on Biocept technologies, even if it causes a change in the existing normative relationship.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Life Technologies
3. OBJECT: Biocept
4. ANTECEDENT: Exercisable during the two (2) year period beginning on the Effective Date
5. CONSEQUENT: Develop plans and negotiate with Biocept for the co-development of systems for the Assay, employing or based on Biocept technologies

NORM 2:
1. NORM type: POWER
2. SUBJECT: Life Technologies
3. OBJECT: Biocept
4. ANTECEDENT: Exercisable during the two (2) year period beginning on the Effective Date
5. CONSEQUENT: Develop plans and negotiate with Biocept for the co-development of systems for the Assay, employing or based on Biocept technologies","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Biocept
3. OBJECT: Life Technologies
4. ANTECEDENT: Exercisable during the two (2) year period beginning on the Effective Date
5. CONSEQUENT: Develop plans and negotiate with Biocept for the co-development with Biocept of systems for the Assay, employing or based on Biocept technologies

NORM 2:
1. NORM type: POWER
2. SUBJECT: Life Technologies
3. OBJECT: Biocept
4. ANTECEDENT: Exercisable during the two (2) year period beginning on the Effective Date
5. CONSEQUENT: Develop plans and negotiate with Biocept for the co-development with Biocept of systems for the Assay, employing or based on Biocept technologies","Norm 1:
1. Norm type: Authorization
2. Subject: Biocept
3. Object: Life Technologies
4. Antecedent: Exercisable during the two (2) year period beginning on the Effective Date
5. Consequent: Develop plans and negotiate with Biocept for the co-development of systems for the Assay, employing or based on Biocept technologies

Norm 2:
1. Norm type: Power
2. Subject: Life Technologies
3. Object: Biocept
4. Antecedent: Exercisable during the two (2) year period beginning on the Effective Date
5. Consequent: Develop plans and negotiate with Biocept for the co-development of systems for the Assay, employing or based on Biocept technologies"
9,"This Agreement can be terminated at any time prior to the expiry of the Term, as follows:<omitted>(c) by the Consultant electing to give the Company notice, in the event that there occurs a Change of Control (as defined below) within six (6) months of the effective date of such Change of Control, and if the Consultant so elects to terminate this Agreement, then the Consultant will be immediately entitled to a termination payment equal to CDN$750,000;","1. Norm type: Commitment
2. Subject: Consultant
3. Object: Company
4. Antecedent: Occurrence of a Change of Control within six (6) months of the effective date of such Change of Control
5. Consequent: Consultant will be immediately entitled to a termination payment equal to CDN$750,000","Norm 1:
1. Norm type: Commitment
2. Subject: Consultant
3. Object: Company
4. Antecedent: Change of Control occurs within six (6) months of the effective date
5. Consequent: Consultant is entitled to a termination payment equal to CDN$750,000

Norm 2:
1. Norm type: Authorization
2. Subject: Consultant
3. Object: Company
4. Antecedent: Change of Control occurs within six (6) months of the effective date
5. Consequent: Consultant can elect to terminate the Agreement and receive a termination payment equal to CDN$750,000","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Consultant
3. OBJECT: Company
4. ANTECEDENT: Change of Control occurs within six (6) months of the effective date
5. CONSEQUENT: Consultant is entitled to terminate the Agreement and receive a termination payment of CDN$750,000

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Consultant
3. OBJECT: Company
4. ANTECEDENT: Change of Control occurs within six (6) months of the effective date
5. CONSEQUENT: Consultant commits to giving notice to the Company and terminating the Agreement if the Consultant elects to do so.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Consultant
3. OBJECT: Company
4. ANTECEDENT: Change of Control occurring within six (6) months of the effective date
5. CONSEQUENT: Consultant entitled to termination payment equal to CDN$750,000

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Consultant
3. OBJECT: Company
4. ANTECEDENT: Change of Control occurring within six (6) months of the effective date
5. CONSEQUENT: Consultant electing to terminate the Agreement","1. Norm type: commitment
2. Subject: Consultant
3. Object: Company
4. Antecedent: Change of Control occurring within six (6) months of the effective date
5. Consequent: Consultant entitled to a termination payment equal to CDN$750,000"
10,"During the Term, Supplier will promptly notify Customer in writing if at any time a Change of Control shall occur as to Supplier, such notification to be given no later than fifteen (15) days following such Change of Control. [* * *]","1. Norm type: Commitment
Subject: Supplier
Object: Customer
Antecedent: Change of Control occurring as to Supplier
Consequent: Supplier will promptly notify Customer in writing

2. Norm type: Authorization
Subject: Supplier
Object: Supplier
Antecedent: None
Consequent: Supplier has the authority to notify Customer in writing

3. Norm type: Commitment
Subject: Supplier
Object: Customer
Antecedent: None
Consequent: Supplier will provide the notification no later than fifteen (15) days following the Change of Control

4. Norm type: Prohibition
Subject: None
Object: Supplier
Antecedent: None
Consequent: Supplier is prohibited from failing to notify Customer in writing

5. Norm type: Commitment
Subject: Customer
Object: Supplier
Antecedent: None
Consequent: Customer expects to be promptly notified in writing by Supplier","Norm 1:
1. Norm type: Commitment
2. Subject: Supplier
3. Object: Customer
4. Antecedent: Change of Control occurs as to Supplier
5. Consequent: Supplier will promptly notify Customer in writing no later than fifteen (15) days following such Change of Control

Norm 2:
1. Norm type: Power
2. Subject: Supplier
3. Object: Customer
4. Antecedent: Change of Control occurs as to Supplier
5. Consequent: Supplier has the power to notify Customer in writing no later than fifteen (15) days following such Change of Control","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Supplier
3. OBJECT: Customer
4. ANTECEDENT: Change of Control occurs as to Supplier
5. CONSEQUENT: Supplier will promptly notify Customer in writing within fifteen (15) days following such Change of Control

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Supplier
3. OBJECT: Customer
4. ANTECEDENT: Change of Control occurs as to Supplier
5. CONSEQUENT: Supplier is forbidden from failing to notify Customer in writing within fifteen (15) days following such Change of Control","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Supplier
3. OBJECT: Customer
4. ANTECEDENT: Change of Control occurs as to Supplier
5. CONSEQUENT: Supplier will promptly notify Customer in writing within fifteen (15) days following such Change of Control

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Supplier
3. OBJECT: Customer
4. ANTECEDENT: Change of Control occurs as to Supplier
5. CONSEQUENT: Supplier is forbidden from failing to notify Customer in writing within fifteen (15) days following such Change of Control","1. Norm type: commitment
2. Subject: Supplier
3. Object: Customer
4. Antecedent: Change of Control occurs as to Supplier
5. Consequent: Supplier will promptly notify Customer in writing, no later than fifteen (15) days following such Change of Control."
11,"Accordingly, either Party may terminate this Agreement or all/part of a Project for any reason and at any time upon giving the other Party sixty (60) days prior written notice.","Norm 1:
Norm type: Authorization
Subject: Either Party
Object: This Agreement or all/part of a Project
Antecedent: Any reason and at any time
Consequent: Termination of the Agreement or all/part of a Project

Norm 2:
Norm type: Commitment
Subject: Either Party
Object: the other Party
Antecedent: Sixty (60) days prior written notice
Consequent: Termination of this Agreement or all/part of a Project

Norm 3:
Norm type: Commitment
Subject: Either Party
Object: the other Party
Antecedent: None
Consequent: Giving sixty (60) days prior written notice

Norm 4:
Norm type: Prohibition
Subject: None
Object: None
Antecedent: None
Consequent: None

Norm 5:
Norm type: Prohibition
Subject: None
Object: None
Antecedent: None
Consequent: None","Norm 1:
1. Norm type: Power
2. Subject: Either Party
3. Object: The other Party
4. Antecedent: None specified
5. Consequent: Termination of the Agreement or all/part of a Project

Norm 2:
1. Norm type: Commitment
2. Subject: Either Party
3. Object: The other Party
4. Antecedent: Giving sixty (60) days prior written notice
5. Consequent: Termination of the Agreement or all/part of a Project","NORM 1:
1. NORM type: POWER
2. SUBJECT: Either Party
3. OBJECT: the other Party
4. ANTECEDENT: None specified
5. CONSEQUENT: Termination of the Agreement or all/part of a Project

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Either Party
3. OBJECT: the other Party
4. ANTECEDENT: Giving sixty (60) days prior written notice
5. CONSEQUENT: Termination of the Agreement or all/part of a Project","NORM 1:
1. NORM type: POWER
2. SUBJECT: Either Party
3. OBJECT: the other Party
4. ANTECEDENT: giving the other Party sixty (60) days prior written notice
5. CONSEQUENT: termination of the Agreement or all/part of a Project

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Either Party
3. OBJECT: the other Party
4. ANTECEDENT: giving the other Party sixty (60) days prior written notice
5. CONSEQUENT: termination of the Agreement or all/part of a Project","1. Norm type: commitment
2. Subject: either Party
3. Object: the other Party
4. Antecedent: giving sixty (60) days prior written notice
5. Consequent: termination of the Agreement or all/part of a Project"
12,"Should there be a Change of Control of either Party resulting in the control of such Party by a Third Party which  markets or sells a Competing Product in any part of the Territory, then the rights under this Agreement may not be assigned without the  express consent of the other Party which consent shall not be unreasonably withheld. ""Change of Control"" shall mean (a) the sale, lease,  exchange, license or disposition of all or substantially all of the Party's assets in one transaction or series of related transactions or (b) a  merger or consolidation with an unaffiliated Third Party as a result of which the holders of the Party's issued and outstanding voting  securities immediately before such transaction own or control less than a majority of the voting securities of the continuing or surviving  entity immediately after such transaction.","Norm 1:
Norm type: Prohibition
Subject: Either Party
Object: Third Party
Antecedent: Change of Control of either Party resulting in the control of such Party by a Third Party which markets or sells a Competing Product in any part of the Territory
Consequent: The rights under this Agreement may not be assigned without the express consent of the other Party which consent shall not be unreasonably withheld.

Norm 2:
Norm type: Authorization
Subject: Other Party
Object: Either Party
Antecedent: Change of Control of either Party resulting in the control of such Party by a Third Party which markets or sells a Competing Product in any part of the Territory
Consequent: The express consent of the other Party is required for the assignment of rights under this Agreement.

Norm 3:
Norm type: Prohibition
Subject: Third Party
Object: Either Party
Antecedent: None
Consequent: The Third Party is prohibited from assigning the rights under this Agreement without the express consent of the other Party.

Norm 4:
Norm type: Commitment
Subject: Third Party
Object: None
Antecedent: None
Consequent: The Third Party is committed to not unreasonably withhold consent for the assignment of rights under this Agreement.

Norm 5:
Norm type: Commitment
Subject: Other Party
Object: None
Antecedent: None
Consequent: The Other Party is committed to not unreasonably withhold consent for the assignment of rights under this Agreement.","Norm 1:
1. Norm type: Prohibition
2. Subject: Either Party
3. Object: Third Party
4. Antecedent: Change of Control of either Party resulting in the control of such Party by a Third Party which markets or sells a Competing Product in any part of the Territory
5. Consequent: The rights under this Agreement may not be assigned without the express consent of the other Party which consent shall not be unreasonably withheld.

Norm 2:
1. Norm type: Authorization
2. Subject: Other Party
3. Object: Either Party
4. Antecedent: Change of Control of either Party resulting in the control of such Party by a Third Party which markets or sells a Competing Product in any part of the Territory
5. Consequent: The rights under this Agreement may not be assigned without the express consent of the other Party which consent shall not be unreasonably withheld.","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: Party undergoing Change of Control
3. OBJECT: Third Party marketing or selling a Competing Product in any part of the Territory
4. ANTECEDENT: Change of Control of either Party resulting in the control of such Party by a Third Party which markets or sells a Competing Product in any part of the Territory
5. CONSEQUENT: Assignment of rights under the Agreement may not be done without the express consent of the other Party

CLAUSE: ""Should there be a Change of Control of either Party resulting in the control of such Party by a Third Party which markets or sells a Competing Product in any part of the Territory, then the rights under this Agreement may not be assigned without the express consent of the other Party which consent shall not be unreasonably withheld.""

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Party undergoing Change of Control
3. OBJECT: Third Party marketing or selling a Competing Product in any part of the Territory
4. ANTECEDENT: Change of Control of either Party resulting in the control of such Party by a Third Party which markets or sells a Competing Product in any part of the Territory
5. CONSEQUENT: Assignment of rights under the Agreement may be done with the express consent of the other Party

CLAUSE: ""Should there be a Change of Control of either Party resulting in the control of such Party by a Third Party which markets or sells a Competing Product in any part of the Territory, then the rights under this Agreement may be assigned with the express consent of the other Party which consent shall not be unreasonably withheld.""","1. NORM type: PROHIBITION
2. SUBJECT: Party undergoing a Change of Control
3. OBJECT: Third Party marketing or selling a Competing Product in any part of the Territory
4. ANTECEDENT: Change of Control of either Party resulting in the control of such Party by a Third Party which markets or sells a Competing Product in any part of the Territory
5. CONSEQUENT: Rights under the Agreement may not be assigned without the express consent of the other Party","1. Norm type: prohibition
2. Subject: Party undergoing a Change of Control
3. Object: Third Party marketing or selling a Competing Product in any part of the Territory
4. Antecedent: Change of Control of either Party resulting in the control of such Party by a Third Party which markets or sells a Competing Product in any part of the Territory
5. Consequent: Assignment of rights under the Agreement may not be done without the express consent of the other Party"
13,"""Distribution Term"" means the period commencing on the first Regulatory Approval of the Product in the Territory and continuing until [***], or if this Agreement is terminated earlier pursuant to Article 12, the effective date of such termination.<omitted>At any time following the expiration of the Distribution Term (as defined in Section 1.17), the Distributor may terminate this Agreement at will upon [***] prior written notice to Zogenix.","1. Norm type: Authorization
Subject: Distributor
Object: Zogenix
Antecedent: Expiration of the Distribution Term
Consequent: Termination of the Agreement

2. Norm type: Commitment
Subject: Distributor
Object: Zogenix
Antecedent: None
Consequent: Termination of the Agreement

3. Norm type: Commitment
Subject: Distributor
Object: Zogenix
Antecedent: None
Consequent: Providing prior written notice

4. Norm type: Commitment
Subject: Distributor
Object: Zogenix
Antecedent: None
Consequent: Termination of the Agreement at will

5. Norm type: Commitment
Subject: Distributor
Object: Zogenix
Antecedent: None
Consequent: Termination of the Agreement upon [***] prior written notice to Zogenix","Norm 1:
1. Norm type: Power
2. Subject: Distributor
3. Object: Zogenix
4. Antecedent: Expiration of the Distribution Term
5. Consequent: Distributor may terminate the Agreement at will upon [***] prior written notice to Zogenix.

Norm 2:
1. Norm type: Commitment
2. Subject: Zogenix
3. Object: Distributor
4. Antecedent: Agreement termination earlier pursuant to Article 12
5. Consequent: Distributor may terminate the Agreement at will upon [***] prior written notice to Zogenix.","NORM 1:
1. NORM type: POWER
2. SUBJECT: Distributor
3. OBJECT: Zogenix
4. ANTECEDENT: Expiration of the Distribution Term
5. CONSEQUENT: Distributor may terminate the Agreement at will upon [***] prior written notice to Zogenix

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Zogenix
3. OBJECT: Distributor
4. ANTECEDENT: Termination of the Agreement earlier pursuant to Article 12
5. CONSEQUENT: Zogenix commits to the effective date of such termination.","NORM 1:
1. NORM type: POWER
2. SUBJECT: Distributor
3. OBJECT: Zogenix
4. ANTECEDENT: Expiration of the Distribution Term
5. CONSEQUENT: Distributor may terminate the Agreement at will upon prior written notice to Zogenix

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Distributor
3. OBJECT: Zogenix
4. ANTECEDENT: None specified
5. CONSEQUENT: Distributor commits to terminating the Agreement at will upon prior written notice to Zogenix","1. Norm type: authorization
2. Subject: Distributor
3. Object: Zogenix
4. Antecedent: Expiration of the Distribution Term
5. Consequent: Termination of the Agreement at will upon [***] prior written notice"
14,"Unless this Agreement is terminated by Zogenix under Section 12.2(c), Distributor shall use Commercially Reasonable Efforts to cooperate with Zogenix and/or its designee to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination.","Norm 1:
Norm type: Commitment
Subject: Distributor
Object: Zogenix and/or its designee
Antecedent: Agreement not terminated by Zogenix under Section 12.2(c)
Consequent: Distributor shall use Commercially Reasonable Efforts to cooperate with Zogenix and/or its designee to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination.

Norm 2:
Norm type: Authorization
Subject: Zogenix
Object: Distributor
Antecedent: Agreement not terminated by Zogenix under Section 12.2(c)
Consequent: Zogenix has the authority to require Distributor to use Commercially Reasonable Efforts to cooperate with Zogenix and/or its designee to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination.

Norm 3:
Norm type: Commitment
Subject: Zogenix
Object: Distributor
Antecedent: Agreement not terminated by Zogenix under Section 12.2(c)
Consequent: Zogenix commits to working with Distributor and/or its designee to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination.

Norm 4:
Norm type: Commitment
Subject: Zogenix and/or its designee
Object: Distributor
Antecedent: Agreement not terminated by Zogenix under Section 12.2(c)
Consequent: Zogenix and/or its designee commits to working with Distributor to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination.

Norm 5:
Norm type: Commitment
Subject: Distributor
Object: Zogenix and/or its designee
Antecedent: Agreement not terminated by Zogenix under Section 12.2(c)
Consequent: Distributor commits to using Commercially Reasonable Efforts to cooperate with Zogenix and/or its designee to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination.","Norm 1:
1. Norm type: Commitment
2. Subject: Distributor
3. Object: Zogenix
4. Antecedent: Agreement not terminated by Zogenix under Section 12.2(c)
5. Consequent: Distributor shall use Commercially Reasonable Efforts to cooperate with Zogenix and/or its designee to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination.

Norm 2:
1. Norm type: Authorization
2. Subject: Zogenix
3. Object: Distributor
4. Antecedent: Agreement not terminated by Zogenix under Section 12.2(c)
5. Consequent: Zogenix and/or its designee are authorized to work with Distributor to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination.","1. NORM type: COMMITMENT
2. SUBJECT: Distributor
3. OBJECT: Zogenix and/or its designee
4. ANTECEDENT: Agreement not terminated by Zogenix under Section 12.2(c)
5. CONSEQUENT: Distributor shall use Commercially Reasonable Efforts to cooperate with Zogenix and/or its designee to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination.

2. NORM type: AUTHORIZATION
3. SUBJECT: Zogenix and/or its designee
4. ANTECEDENT: Agreement not terminated by Zogenix under Section 12.2(c)
5. CONSEQUENT: Zogenix and/or its designee are authorized to work with Distributor to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Distributor
3. OBJECT: Zogenix
4. ANTECEDENT: Agreement not terminated by Zogenix under Section 12.2(c)
5. CONSEQUENT: Distributor shall use Commercially Reasonable Efforts to cooperate with Zogenix and/or its designee to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Zogenix
3. OBJECT: Distributor
4. ANTECEDENT: Agreement not terminated by Zogenix under Section 12.2(c)
5. CONSEQUENT: Zogenix and/or its designee are authorized to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination.","Norm 1:
1. Norm type: Commitment
2. Subject: Distributor
3. Object: Zogenix
4. Antecedent: Agreement not terminated by Zogenix under Section 12.2(c)
5. Consequent: Distributor shall use Commercially Reasonable Efforts to cooperate with Zogenix and/or its designee to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination.

Norm 2:
1. Norm type: Authorization
2. Subject: Zogenix
3. Object: Distributor
4. Antecedent: Agreement not terminated by Zogenix under Section 12.2(c)
5. Consequent: Distributor shall use Commercially Reasonable Efforts to cooperate with Zogenix and/or its designee to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination."
15,"Any later proposal to complete that proposed Transfer will be deemed a new offer, giving us a new right of approval and right of first refusal effective as of the day we receive formal notice of the new (or continuing) proposal.","Norm 1:
Norm type: Authorization
Subject: Us (the party receiving the proposal)
Object: Any later proposal to complete that proposed Transfer
Antecedent: None mentioned
Consequent: The new offer will be deemed a new offer, giving us a new right of approval and right of first refusal effective as of the day we receive formal notice of the new (or continuing) proposal.

Norm 2:
Norm type: Commitment
Subject: Any later proposal to complete that proposed Transfer
Object: Us (the party receiving the proposal)
Antecedent: None mentioned
Consequent: The proposal is committed to being treated as a new offer, giving us a new right of approval and right of first refusal effective as of the day we receive formal notice of the new (or continuing) proposal.","Norm 1:
1. Norm type: Authorization
2. Subject: Party making the proposal for Transfer
3. Object: Receiving party
4. Antecedent: Any later proposal to complete the proposed Transfer
5. Consequent: Deemed a new offer, giving the receiving party a new right of approval and right of first refusal effective as of the day formal notice of the new (or continuing) proposal is received. 

Norm 2:
1. Norm type: Commitment
2. Subject: Receiving party
3. Object: Party making the proposal for Transfer
4. Antecedent: Any later proposal to complete the proposed Transfer
5. Consequent: Deemed a new offer, giving the receiving party a new right of approval and right of first refusal effective as of the day formal notice of the new (or continuing) proposal is received.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Us (the party receiving the proposal)
3. OBJECT: You (the party making the proposal)
4. ANTECEDENT: Any later proposal to complete that proposed Transfer
5. CONSEQUENT: will be deemed a new offer, giving us a new right of approval and right of first refusal effective as of the day we receive formal notice of the new (or continuing) proposal.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: You (the party making the proposal)
3. OBJECT: Us (the party receiving the proposal)
4. ANTECEDENT: Any later proposal to complete that proposed Transfer
5. CONSEQUENT: will be deemed a new offer, giving us a new right of approval and right of first refusal effective as of the day we receive formal notice of the new (or continuing) proposal.","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: Party making the later proposal
3. OBJECT: Receiving party
4. ANTECEDENT: Any later proposal to complete the proposed Transfer
5. CONSEQUENT: Receiving party having the right of approval and right of first refusal

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Receiving party
3. OBJECT: Party making the later proposal
4. ANTECEDENT: Day of receiving formal notice of the new (or continuing) proposal
5. CONSEQUENT: Receiving party ensuring the new right of approval and right of first refusal","1. Norm type: authorization, commitment
2. Subject: the party making the proposal
3. Object: the party receiving the proposal
4. Antecedent: any later proposal to complete the proposed Transfer
5. Consequent: the new offer, giving the receiving party a new right of approval and right of first refusal"
16,"Subject to the terms and conditions of this Agreement commencing as of the Effective Date and for the duration of the Term and any Transition-out Period, Ehave hereby grants to CHT a non-transferable (except as permitted under Section 20(f)), right to: (i) sub-license the use of the Ehave Companion Solution within the Field of Use in the Territory to End Users and their respective Authorized Users, including in operation or by interfacing with other software, hardware, systems, networks and services, in accordance with and subject to the provisions of CHT's Subscription Agreement; and (ii) use the Ehave Companion Solution to support its licensed End Users.","Norm 1:
Norm type: Authorization
Subject: Ehave
Object: CHT
Antecedent: Terms and conditions of this Agreement
Consequent: Ehave grants CHT a non-transferable right to sub-license the use of the Ehave Companion Solution within the Field of Use in the Territory to End Users and their respective Authorized Users, including in operation or by interfacing with other software, hardware, systems, networks, and services, in accordance with and subject to the provisions of CHT's Subscription Agreement.

Norm 2:
Norm type: Authorization
Subject: Ehave
Object: CHT
Antecedent: Terms and conditions of this Agreement
Consequent: Ehave grants CHT the right to use the Ehave Companion Solution to support its licensed End Users.

Norm 3:
Norm type: Commitment
Subject: CHT
Object: N/A
Antecedent: N/A
Consequent: CHT commits to sub-license the use of the Ehave Companion Solution within the Field of Use in the Territory to End Users and their respective Authorized Users, including in operation or by interfacing with other software, hardware, systems, networks, and services, in accordance with and subject to the provisions of CHT's Subscription Agreement.

Norm 4:
Norm type: Commitment
Subject: CHT
Object: N/A
Antecedent: N/A
Consequent: CHT commits to using the Ehave Companion Solution to support its licensed End Users.

Norm 5:
Norm type: Prohibition
Subject: N/A
Object: N/A
Antecedent: Section 20(f)
Consequent: The right to transfer the non-transferable right granted to CHT is prohibited, except as permitted under Section 20(f).","Norm 1:
1. Norm type: Authorization
2. Subject: Ehave
3. Object: CHT
4. Antecedent: Subject to the terms and conditions of this Agreement commencing as of the Effective Date and for the duration of the Term and any Transition-out Period
5. Consequent: Ehave grants CHT a non-transferable right to sub-license the use of the Ehave Companion Solution within the Field of Use in the Territory to End Users and their respective Authorized Users, including in operation or by interfacing with other software, hardware, systems, networks, and services, in accordance with and subject to the provisions of CHT's Subscription Agreement.

Norm 2:
1. Norm type: Authorization
2. Subject: Ehave
3. Object: CHT
4. Antecedent: Subject to the terms and conditions of this Agreement commencing as of the Effective Date and for the duration of the Term and any Transition-out Period
5. Consequent: Ehave grants CHT a non-transferable right to use the Ehave Companion Solution to support its licensed End Users.","1. NORM type: AUTHORIZATION
2. SUBJECT: Ehave
3. OBJECT: CHT
4. ANTECEDENT: Subject to the terms and conditions of this Agreement commencing as of the Effective Date and for the duration of the Term and any Transition-out Period
5. CONSEQUENT: grants to CHT a non-transferable (except as permitted under Section 20(f)), right to sub-license the use of the Ehave Companion Solution within the Field of Use in the Territory to End Users and their respective Authorized Users, including in operation or by interfacing with other software, hardware, systems, networks and services, in accordance with and subject to the provisions of CHT's Subscription Agreement

2. NORM type: AUTHORIZATION
3. SUBJECT: CHT
4. OBJECT: Ehave
5. ANTECEDENT: Subject to the terms and conditions of this Agreement commencing as of the Effective Date and for the duration of the Term and any Transition-out Period
6. CONSEQUENT: use the Ehave Companion Solution to support its licensed End Users.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Ehave
3. OBJECT: CHT
4. ANTECEDENT: Subject to the terms and conditions of this Agreement commencing as of the Effective Date and for the duration of the Term and any Transition-out Period
5. CONSEQUENT: grants to CHT a non-transferable right to sub-license the use of the Ehave Companion Solution within the Field of Use in the Territory to End Users and their respective Authorized Users, including in operation or by interfacing with other software, hardware, systems, networks and services, in accordance with and subject to the provisions of CHT's Subscription Agreement

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Ehave
3. OBJECT: CHT
4. ANTECEDENT: Subject to the terms and conditions of this Agreement commencing as of the Effective Date and for the duration of the Term and any Transition-out Period
5. CONSEQUENT: grants to CHT a non-transferable right to use the Ehave Companion Solution to support its licensed End Users.","Norm 1:
1. Norm type: Authorization
2. Subject: Ehave
3. Object: CHT
4. Antecedent: Subject to the terms and conditions of this Agreement commencing as of the Effective Date and for the duration of the Term and any Transition-out Period
5. Consequent: Ehave grants CHT a non-transferable right to sub-license the use of the Ehave Companion Solution within the Field of Use in the Territory to End Users and their respective Authorized Users.

Norm 2:
1. Norm type: Authorization
2. Subject: Ehave
3. Object: CHT
4. Antecedent: Subject to the terms and conditions of this Agreement commencing as of the Effective Date and for the duration of the Term and any Transition-out Period
5. Consequent: Ehave grants CHT the right to use the Ehave Companion Solution to support its licensed End Users."
17,"If ENERGOUS is acquired by a third party, ENERGOUS' acquirer will have the right, for a period of [***] following closing of such acquisition, to terminate this Agreement upon written notice to DIALOG.","1. Norm type: Authorization
Subject: ENERGOUS' acquirer
Object: DIALOG
Antecedent: ENERGOUS being acquired by a third party
Consequent: The right to terminate the Agreement upon written notice to DIALOG

2. Norm type: Commitment
Subject: ENERGOUS' acquirer
Object: N/A
Antecedent: N/A
Consequent: The commitment to terminate the Agreement upon written notice to DIALOG if ENERGOUS is acquired by a third party

3. Norm type: Power
Subject: ENERGOUS' acquirer
Object: N/A
Antecedent: N/A
Consequent: The power to terminate the Agreement upon written notice to DIALOG for a period of [***] following the closing of the acquisition of ENERGOUS by a third party

Note: The antecedent and consequent for the power norm type are not explicitly mentioned in the sentence, but can be inferred from the context.

4. Norm type: Commitment
Subject: DIALOG
Object: N/A
Antecedent: N/A
Consequent: The commitment to abide by the termination of the Agreement upon written notice from ENERGOUS' acquirer if ENERGOUS is acquired by a third party

5. Norm type: Commitment
Subject: DIALOG
Object: ENERGOUS' acquirer
Antecedent: ENERGOUS being acquired by a third party
Consequent: The commitment to accept the termination of the Agreement upon written notice from ENERGOUS' acquirer for a period of [***] following the closing of the acquisition","Norm 1:
1. Norm type: Power
2. Subject: ENERGOUS' acquirer
3. Object: DIALOG
4. Antecedent: ENERGOUS is acquired by a third party
5. Consequent: ENERGOUS' acquirer will have the right to terminate the Agreement upon written notice to DIALOG.

Norm 2:
1. Norm type: Commitment
2. Subject: DIALOG
3. Object: ENERGOUS' acquirer
4. Antecedent: ENERGOUS is acquired by a third party
5. Consequent: DIALOG agrees to allow ENERGOUS' acquirer to terminate the Agreement upon written notice.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: ENERGOUS' acquirer
3. OBJECT: DIALOG
4. ANTECEDENT: ENERGOUS is acquired by a third party
5. CONSEQUENT: ENERGOUS' acquirer will have the right to terminate the Agreement upon written notice to DIALOG.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: ENERGOUS' acquirer
3. OBJECT: DIALOG
4. ANTECEDENT: ENERGOUS is acquired by a third party
5. CONSEQUENT: ENERGOUS' acquirer commits to terminate the Agreement upon written notice to DIALOG.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: DIALOG
3. OBJECT: ENERGOUS' acquirer
4. ANTECEDENT: ENERGOUS is acquired by a third party
5. CONSEQUENT: ENERGOUS' acquirer will have the right to terminate the Agreement

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: ENERGOUS' acquirer
3. OBJECT: DIALOG
4. ANTECEDENT: ENERGOUS is acquired by a third party
5. CONSEQUENT: ENERGOUS' acquirer will terminate the Agreement upon written notice to DIALOG.","Norm 1:
1. Norm type: Authorization
2. Subject: ENERGOUS' acquirer
3. Object: DIALOG
4. Antecedent: ENERGOUS is acquired by a third party
5. Consequent: ENERGOUS' acquirer will have the right to terminate the Agreement upon written notice to DIALOG.

Norm 2:
1. Norm type: Commitment
2. Subject: DIALOG
3. Object: ENERGOUS' acquirer
4. Antecedent: ENERGOUS is acquired by a third party
5. Consequent: DIALOG will abide by the termination of the Agreement by ENERGOUS' acquirer upon receiving written notice."
18,"Sanofi may terminate this Agreement (A) in its entirety by providing [***] written notice of termination to RevMed or (B) on a country-by-country or Product-by-Product basis by providing [***] written notice of termination to RevMed; provided that if Sanofi desires to terminate this Agreement under this Section 12.2(a)(i)B only with respect to the U.S. (for all Products or one or more Products), Sanofi shall provide [***] written notice of termination to RevMed.","Norm 1:
Norm type: Authorization
Subject: Sanofi
Object: RevMed
Antecedent: None mentioned
Consequent: Termination of the Agreement in its entirety

Norm 2:
Norm type: Authorization
Subject: Sanofi
Object: RevMed
Antecedent: None mentioned
Consequent: Termination of the Agreement on a country-by-country or Product-by-Product basis

Norm 3:
Norm type: Authorization
Subject: Sanofi
Object: RevMed
Antecedent: Sanofi desires to terminate this Agreement under this Section 12.2(a)(i)B only with respect to the U.S. (for all Products or one or more Products)
Consequent: Termination of the Agreement with respect to the U.S. (for all Products or one or more Products)

Note: The clause does not explicitly mention the consequence of Norm 3, but it implies the termination of the Agreement with respect to the U.S. (for all Products or one or more Products).

Please note that the extraction of norms and associated clauses may vary depending on the interpretation of the sentence and the context of the contract.","Norm 1:
1. Norm type: Power
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: Sanofi desires to terminate the Agreement on a country-by-country or Product-by-Product basis
5. Consequent: Sanofi can terminate the Agreement by providing written notice of termination to RevMed

Norm 2:
1. Norm type: Commitment
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: Sanofi desires to terminate the Agreement under Section 12.2(a)(i)B only with respect to the U.S. (for all Products or one or more Products)
5. Consequent: Sanofi shall provide written notice of termination to RevMed.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: Sanofi desires to terminate the Agreement
5. CONSEQUENT: Sanofi shall provide [***] written notice of termination to RevMed

CLAUSE: Sanofi commits to providing [***] written notice of termination to RevMed if Sanofi desires to terminate the Agreement.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: Sanofi desires to terminate the Agreement under Section 12.2(a)(i)B only with respect to the U.S.
5. CONSEQUENT: RevMed shall receive [***] written notice of termination from Sanofi

CLAUSE: Sanofi authorizes RevMed to receive [***] written notice of termination if Sanofi desires to terminate the Agreement under Section 12.2(a)(i)B only with respect to the U.S.","1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: Sanofi desires to terminate the Agreement
5. CONSEQUENT: Sanofi must provide written notice of termination to RevMed

1. NORM type: POWER
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: Sanofi desires to terminate the Agreement only with respect to the U.S.
5. CONSEQUENT: Sanofi shall provide written notice of termination to RevMed.","1. Norm type: 
- Authorization
- Power
- Commitment

2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: Providing written notice of termination
5. Consequent: Termination of the Agreement"
19,"Upon the Effective Date, Harpoon hereby grants to AbbVie the exclusive right, but not the obligation, to obtain the licenses set forth in Section 5.1.3 (the ""License Option"").","1. Norm type: Authorization
Subject: Harpoon
Object: AbbVie
Antecedent: Effective Date
Consequent: Granting exclusive right to AbbVie to obtain licenses

2. Norm type: Power
Subject: Harpoon
Object: AbbVie
Antecedent: Effective Date
Consequent: Empowering AbbVie with the exclusive right to obtain licenses

3. Norm type: Commitment
Subject: Harpoon
Object: AbbVie
Antecedent: Effective Date
Consequent: Committing to granting the exclusive right to AbbVie to obtain licenses

4. Norm type: Commitment
Subject: AbbVie
Object: Harpoon
Antecedent: Effective Date
Consequent: Committing to exercise the exclusive right to obtain licenses

5. Norm type: Prohibition
Subject: Harpoon
Object: AbbVie
Antecedent: None
Consequent: Prohibiting AbbVie from being obligated to obtain the licenses","Norm 1:
1. Norm type: Authorization
2. Subject: Harpoon
3. Object: AbbVie
4. Antecedent: Effective Date
5. Consequent: AbbVie has the exclusive right to obtain the licenses set forth in Section 5.1.3

Norm 2:
1. Norm type: Power
2. Subject: AbbVie
3. Object: Harpoon
4. Antecedent: Effective Date
5. Consequent: AbbVie has the exclusive right to obtain the licenses set forth in Section 5.1.3, even if it causes a change in the existing normative relationship.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Harpoon
3. OBJECT: AbbVie
4. ANTECEDENT: Effective Date
5. CONSEQUENT: AbbVie has the exclusive right to obtain the licenses set forth in Section 5.1.3

NORM 2:
1. NORM type: POWER
2. SUBJECT: Harpoon
3. OBJECT: AbbVie
4. ANTECEDENT: Effective Date
5. CONSEQUENT: AbbVie has the exclusive right to obtain the licenses set forth in Section 5.1.3, even if it causes a change in existing norms.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Harpoon
3. OBJECT: AbbVie
4. ANTECEDENT: Effective Date
5. CONSEQUENT: AbbVie has the exclusive right to obtain the licenses set forth in Section 5.1.3

NORM 2:
1. NORM type: POWER
2. SUBJECT: Harpoon
3. OBJECT: AbbVie
4. ANTECEDENT: Effective Date
5. CONSEQUENT: AbbVie has the exclusive right to obtain the licenses set forth in Section 5.1.3, even if it causes a change in existing norms.","Norm 1:
1. Norm type: Authorization
2. Subject: Harpoon
3. Object: AbbVie
4. Antecedent: Effective Date
5. Consequent: AbbVie has the exclusive right to obtain the licenses set forth in Section 5.1.3

Norm 2:
1. Norm type: Power
2. Subject: Harpoon
3. Object: AbbVie
4. Antecedent: Effective Date
5. Consequent: AbbVie has the exclusive right to obtain the licenses set forth in Section 5.1.3, causing a change in the existing norms."
20,"Upon the expiration of the Term or termination of this Supply Agreement, in its entirety or with respect to one or more Products, this Supply Agreement shall, except as otherwise provided in this Section 10.3 or Section 10.5, be of no further force or effect; provided, however, that (a) in the event this Supply Agreement is terminated by SutroVax pursuant to Section 10.2.3 and there are outstanding Work Orders or other purchase orders accepted by Sutro that would not be fulfilled as a result of such termination, SutroVax shall reimburse Sutro for all supplies and materials purchased by Sutro and time incurred by Sutro personnel (to the extent incurred solely for manufacture of Product for SutroVax) for the manufacture, or preparation for the manufacture, of Products for any Work Orders placed by SutroVax and any other purchase orders accepted by Sutro prior to such expiration or termination, in each case to the extent Sutro cannot otherwise reasonably mitigate such the costs and expenses of such supplies, materials and time (e.g., by use of resulting supplies, materials and work-in-progress Product for other purposes); provided that to the extent SutroVax pays for any supplies or materials, upon SutroVax's request Sutro shall promptly transfer and deliver such supplies and materials to SutroVax; and (b) if this Supply Agreement is terminated with respect to one or more Products, but not all Products, then this Supply Agreement shall continue in full force and effect with respect to the applicable Product(s) for which it is not terminated.","Norm 1:
Norm type: Prohibition
Subject: N/A
Object: N/A
Antecedent: N/A
Consequent: Upon the expiration of the Term or termination of this Supply Agreement, in its entirety or with respect to one or more Products, this Supply Agreement shall be of no further force or effect.

Norm 2:
Norm type: Commitment
Subject: SutroVax
Object: Sutro
Antecedent: Termination of this Supply Agreement by SutroVax pursuant to Section 10.2.3
Consequent: SutroVax shall reimburse Sutro for all supplies and materials purchased by Sutro and time incurred by Sutro personnel (to the extent incurred solely for manufacture of Product for SutroVax) for the manufacture, or preparation for the manufacture, of Products for any Work Orders placed by SutroVax and any other purchase orders accepted by Sutro prior to such expiration or termination, in each case to the extent Sutro cannot otherwise reasonably mitigate such the costs and expenses of such supplies, materials, and time.

Norm 3:
Norm type: Authorization
Subject: Sutro
Object: SutroVax
Antecedent: N/A
Consequent: Sutro shall promptly transfer and deliver supplies and materials to SutroVax upon SutroVax's request, if SutroVax pays for any supplies or materials.

Norm 4:
Norm type: Commitment
Subject: N/A
Object: N/A
Antecedent: Termination of this Supply Agreement with respect to one or more Products, but not all Products
Consequent: This Supply Agreement shall continue in full force and effect with respect to the applicable Product(s) for which it is not terminated.

Norm 5:
Norm type: Prohibition
Subject: N/A
Object: N/A
Antecedent: N/A
Consequent: N/A","Norm 1:
1. Norm type: Commitment
2. Subject: SutroVax
3. Object: Sutro
4. Antecedent: Termination of the Supply Agreement by SutroVax pursuant to Section 10.2.3
5. Consequent: Reimbursement of Sutro for supplies, materials, and time incurred for the manufacture of Products for any outstanding Work Orders or purchase orders accepted by Sutro prior to termination.

Clause: SutroVax shall reimburse Sutro for all supplies and materials purchased by Sutro and time incurred by Sutro personnel for the manufacture of Products for any Work Orders placed by SutroVax and any other purchase orders accepted by Sutro prior to termination, to the extent Sutro cannot otherwise reasonably mitigate such costs and expenses.

Norm 2:
1. Norm type: Commitment
2. Subject: Sutro
3. Object: SutroVax
4. Antecedent: Termination of the Supply Agreement with respect to one or more Products
5. Consequent: Continuation of the Supply Agreement in full force and effect with respect to the applicable Product(s) for which it is not terminated.

Clause: If the Supply Agreement is terminated with respect to one or more Products, but not all Products, then the Supply Agreement shall continue in full force and effect with respect to the applicable Product(s) for which it is not terminated.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: SutroVax
3. OBJECT: Sutro
4. ANTECEDENT: Termination of the Supply Agreement by SutroVax pursuant to Section 10.2.3
5. CONSEQUENT: SutroVax shall reimburse Sutro for all supplies and materials purchased by Sutro and time incurred by Sutro personnel for the manufacture of Products for any Work Orders placed by SutroVax and any other purchase orders accepted by Sutro prior to termination.

CLAUSE: SutroVax commits to reimbursing Sutro for supplies, materials, and time incurred in the manufacture of Products if the Supply Agreement is terminated by SutroVax pursuant to Section 10.2.3.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Sutro
3. OBJECT: SutroVax
4. ANTECEDENT: SutroVax's request for transfer and delivery of supplies and materials
5. CONSEQUENT: Sutro shall promptly transfer and deliver supplies and materials to SutroVax upon request.

CLAUSE: Sutro is authorized to transfer and deliver supplies and materials to SutroVax upon SutroVax's request.

NORM 3:
1. NORM type: POWER
2. SUBJECT: Sutro
3. OBJECT: SutroVax
4. ANTECEDENT: Termination of the Supply Agreement with respect to one or more Products
5. CONSEQUENT: The Supply Agreement shall continue in full force and effect with respect to the applicable Product(s) for which it is not terminated.

CLAUSE: Sutro has the power to continue the Supply Agreement with respect to specific Products even if the agreement is terminated for other Products.","1. NORM type: COMMITMENT
2. SUBJECT: SutroVax
3. OBJECT: Sutro
4. ANTECEDENT: Termination of the Supply Agreement by SutroVax pursuant to Section 10.2.3
5. CONSEQUENT: Reimbursement of supplies, materials, and time incurred by Sutro for the manufacture of Products for SutroVax if Work Orders or purchase orders accepted by Sutro cannot be fulfilled. 

2. NORM type: AUTHORIZATION
3. SUBJECT: Sutro
4. ANTECEDENT: Termination of the Supply Agreement with respect to one or more Products
5. CONSEQUENT: Continuation of the Supply Agreement in full force and effect with respect to the applicable Product(s) for which it is not terminated.","1. Norm type: commitment
2. Subject: SutroVax
3. Object: Sutro
4. Antecedent: Termination of the Supply Agreement by SutroVax pursuant to Section 10.2.3
5. Consequent: Reimbursement of supplies, materials, and time incurred by Sutro for the manufacture of Products for SutroVax

2. Norm type: commitment
2. Subject: SutroVax
3. Object: Sutro
4. Antecedent: Termination of the Supply Agreement with respect to one or more Products
5. Consequent: Continuation of the Supply Agreement in full force and effect with respect to the applicable Product(s) for which it is not terminated."
21,"Notwithstanding anything contained herein to the contrary, in the event that EKR is entitled to exercise its right to terminate this Agreement pursuant to Section 16.1(a), in addition to the right to terminate as provided therein and any other remedies EKR  may have hereunder, PPI shall assist EKR in the transfer of the manufacture of the Products, including the Specifications from PPI to EKR  or EKR's designee.","1. Norm type: Authorization
Subject: PPI
Object: EKR
Antecedent: EKR being entitled to exercise its right to terminate the Agreement pursuant to Section 16.1(a)
Consequent: PPI shall assist EKR in the transfer of the manufacture of the Products, including the Specifications from PPI to EKR or EKR's designee.

2. Norm type: Commitment
Subject: EKR
Object: PPI
Antecedent: None specified
Consequent: EKR shall have the right to terminate the Agreement pursuant to Section 16.1(a) and any other remedies EKR may have hereunder.

3. Norm type: Commitment
Subject: PPI
Object: EKR
Antecedent: None specified
Consequent: PPI shall assist EKR in the transfer of the manufacture of the Products, including the Specifications from PPI to EKR or EKR's designee.

Note: The sentence does not contain any clauses that can be categorized as 'power' or 'prohibition' norms.","Norm 1:
1. Norm type: Commitment
2. Subject: PPI
3. Object: EKR
4. Antecedent: EKR is entitled to exercise its right to terminate the Agreement pursuant to Section 16.1(a)
5. Consequent: PPI shall assist EKR in the transfer of the manufacture of the Products, including the Specifications from PPI to EKR or EKR's designee.

Norm 2:
1. Norm type: Authorization
2. Subject: EKR
3. Object: PPI
4. Antecedent: EKR is entitled to exercise its right to terminate the Agreement pursuant to Section 16.1(a)
5. Consequent: EKR has the right to request assistance from PPI in the transfer of the manufacture of the Products, including the Specifications from PPI to EKR or EKR's designee.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: PPI
3. OBJECT: EKR
4. ANTECEDENT: EKR is entitled to exercise its right to terminate the Agreement pursuant to Section 16.1(a)
5. CONSEQUENT: PPI shall assist EKR in the transfer of the manufacture of the Products, including the Specifications from PPI to EKR or EKR's designee.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: EKR
3. OBJECT: PPI
4. ANTECEDENT: EKR is entitled to exercise its right to terminate the Agreement pursuant to Section 16.1(a)
5. CONSEQUENT: EKR is authorized to receive assistance from PPI in the transfer of the manufacture of the Products, including the Specifications from PPI to EKR or EKR's designee.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: PPI
3. OBJECT: EKR
4. ANTECEDENT: EKR is entitled to exercise its right to terminate the Agreement pursuant to Section 16.1(a)
5. CONSEQUENT: PPI shall assist EKR in the transfer of the manufacture of the Products, including the Specifications from PPI to EKR or EKR's designee.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: EKR
3. OBJECT: PPI
4. ANTECEDENT: EKR is entitled to exercise its right to terminate the Agreement pursuant to Section 16.1(a)
5. CONSEQUENT: EKR is authorized to receive assistance from PPI in the transfer of the manufacture of the Products, including the Specifications from PPI to EKR or EKR's designee.","Norm 1:
1. Norm type: Commitment
2. Subject: PPI
3. Object: EKR
4. Antecedent: EKR is entitled to exercise its right to terminate the Agreement pursuant to Section 16.1(a)
5. Consequent: PPI shall assist EKR in the transfer of the manufacture of the Products, including the Specifications from PPI to EKR or EKR's designee.

Norm 2:
1. Norm type: Authorization
2. Subject: EKR
3. Object: PPI
4. Antecedent: EKR is entitled to exercise its right to terminate the Agreement pursuant to Section 16.1(a)
5. Consequent: EKR can request assistance from PPI in the transfer of the manufacture of the Products, including the Specifications from PPI to EKR or EKR's designee."
22,"This Agreement may be terminated at any time prior to the Effective Time by Parent, in its sole and absolute discretion, without the approval or consent of<omitted>any other Person, including SpinCo.","Norm 1:
1. Norm type: Authorization
2. Subject: Parent
3. Object: None specified
4. Antecedent: None specified
5. Consequent: Termination of the Agreement

Norm 2:
1. Norm type: Power
2. Subject: Parent
3. Object: None specified
4. Antecedent: None specified
5. Consequent: Parent has the sole and absolute discretion to terminate the Agreement

Norm 3:
1. Norm type: Prohibition
2. Subject: Parent
3. Object: SpinCo
4. Antecedent: None specified
5. Consequent: Parent does not require the approval or consent of SpinCo or any other person to terminate the Agreement

Note: The sentence does not explicitly mention any commitment norm.","Norm 1:
1. Norm type: Power
2. Subject: Parent
3. Object: SpinCo
4. Antecedent: Prior to the Effective Time
5. Consequent: Termination of the Agreement

Norm 2:
1. Norm type: Prohibition
2. Subject: SpinCo
3. Object: Parent
4. Antecedent: Prior to the Effective Time
5. Consequent: Approval or consent for termination of the Agreement","NORM 1:
1. NORM type: POWER
2. SUBJECT: Parent
3. OBJECT: SpinCo
4. ANTECEDENT: Agreement may be terminated at any time prior to the Effective Time
5. CONSEQUENT: Termination of the Agreement

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Parent
3. OBJECT: any other Person, including SpinCo
4. ANTECEDENT: Agreement may be terminated at any time prior to the Effective Time
5. CONSEQUENT: Approval or consent is not required for termination of the Agreement","NORM 1:
1. NORM type: POWER
2. SUBJECT: Parent
3. OBJECT: SpinCo
4. ANTECEDENT: Agreement may be terminated at any time prior to the Effective Time
5. CONSEQUENT: Termination of the Agreement

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Parent
3. OBJECT: SpinCo
4. ANTECEDENT: Agreement may be terminated at any time prior to the Effective Time
5. CONSEQUENT: Approval or consent of any other Person, including SpinCo, is not required.","Norm 1:
1. Norm type: Power
2. Subject: Parent
3. Object: SpinCo
4. Antecedent: Agreement may be terminated at any time prior to the Effective Time
5. Consequent: Termination of the Agreement

Norm 2:
1. Norm type: Authorization
2. Subject: SpinCo
3. Object: Parent
4. Antecedent: Agreement may be terminated at any time prior to the Effective Time
5. Consequent: Termination of the Agreement"
23,"If Franchisee desires to assign his rights under the Franchise to a new franchisee,  Franchisee  (Assignor of the  Franchise),  agrees to pay to Pretzel Time a transfer  fee equal to the  greater of SIX  THOUSAND  TWO  HUNDRED  FIFTY DOLLARS  ($6,250.00) or the then current  transfer fee being paid by franchisees upon the assignment, gift, bequeath or transfer of ownership of the Franchise to cover administrative costs and expenses.","1. Norm type: Authorization
Subject: Franchisee (Assignor of the Franchise)
Object: Pretzel Time
Antecedent: Franchisee desires to assign his rights under the Franchise to a new franchisee
Consequent: Franchisee agrees to pay a transfer fee equal to the greater of $6,250.00 or the then current transfer fee being paid by franchisees upon the assignment, gift, bequeath or transfer of ownership of the Franchise to cover administrative costs and expenses.

2. Norm type: Commitment
Subject: Franchisee (Assignor of the Franchise)
Object: Pretzel Time
Antecedent: Franchisee desires to assign his rights under the Franchise to a new franchisee
Consequent: Franchisee commits to paying a transfer fee equal to the greater of $6,250.00 or the then current transfer fee being paid by franchisees upon the assignment, gift, bequeath or transfer of ownership of the Franchise to cover administrative costs and expenses.","Norm 1:
1. Norm type: Commitment
2. Subject: Franchisee (Assignor of the Franchise)
3. Object: Pretzel Time
4. Antecedent: Franchisee desires to assign his rights under the Franchise to a new franchisee
5. Consequent: Franchisee agrees to pay to Pretzel Time a transfer fee equal to the greater of SIX THOUSAND TWO HUNDRED FIFTY DOLLARS ($6,250.00) or the then current transfer fee being paid by franchisees upon the assignment, gift, bequeath, or transfer of ownership of the Franchise to cover administrative costs and expenses.

Norm 2:
1. Norm type: Authorization
2. Subject: Franchisee (Assignor of the Franchise)
3. Object: Pretzel Time
4. Antecedent: Franchisee desires to assign his rights under the Franchise to a new franchisee
5. Consequent: Franchisee agrees to pay to Pretzel Time a transfer fee equal to the greater of SIX THOUSAND TWO HUNDRED FIFTY DOLLARS ($6,250.00) or the then current transfer fee being paid by franchisees upon the assignment, gift, bequeath, or transfer of ownership of the Franchise to cover administrative costs and expenses.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Franchisee (Assignor of the Franchise)
3. OBJECT: Pretzel Time
4. ANTECEDENT: Franchisee desires to assign his rights under the Franchise to a new franchisee
5. CONSEQUENT: Franchisee agrees to pay to Pretzel Time a transfer fee equal to the greater of SIX THOUSAND TWO HUNDRED FIFTY DOLLARS ($6,250.00) or the then current transfer fee being paid by franchisees upon the assignment, gift, bequeath or transfer of ownership of the Franchise to cover administrative costs and expenses.

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Franchisee (Assignor of the Franchise)
3. OBJECT: Pretzel Time
4. ANTECEDENT: Franchisee desires to assign his rights under the Franchise to a new franchisee
5. CONSEQUENT: Franchisee is forbidden from assigning his rights under the Franchise to a new franchisee without paying the transfer fee to Pretzel Time.","1. NORM type: COMMITMENT
2. SUBJECT: Franchisee (Assignor of the Franchise)
3. OBJECT: Pretzel Time
4. ANTECEDENT: Franchisee desires to assign his rights under the Franchise to a new franchisee
5. CONSEQUENT: Franchisee agrees to pay to Pretzel Time a transfer fee equal to the greater of $6,250.00 or the then current transfer fee being paid by franchisees upon the assignment, gift, bequeath, or transfer of ownership of the Franchise to cover administrative costs and expenses.","Norm 1:
1. Norm type: Commitment
2. Subject: Franchisee
3. Object: Pretzel Time
4. Antecedent: Franchisee desires to assign his rights under the Franchise to a new franchisee
5. Consequent: Franchisee agrees to pay a transfer fee equal to the greater of $6,250.00 or the then current transfer fee being paid by franchisees upon the assignment, gift, bequeath, or transfer of ownership of the Franchise to cover administrative costs and expenses.

Norm 2:
1. Norm type: Authorization
2. Subject: Pretzel Time
3. Object: Franchisee
4. Antecedent: Franchisee desires to assign his rights under the Franchise to a new franchisee
5. Consequent: Franchisee is authorized to assign his rights under the Franchise to a new franchisee."
24,"In the event of expiration or termination of this Agreement, an Order or of Maintenance Services under this Agreement, Supplier agrees that upon the request of Bank of America, Supplier will, at no additional cost to Bank of America and through the period of paid up Maintenance Services, continue uninterrupted operations, conclude and cooperate with Bank of America in the transition of the business at Bank of America's direction and in a manner that causes no material disruption to Bank of America business and operations.","Norm 1:
Norm type: Commitment
Subject: Supplier
Object: Bank of America
Antecedent: Expiration or termination of this Agreement, an Order or of Maintenance Services under this Agreement
Consequent: Supplier agrees to continue uninterrupted operations, conclude and cooperate with Bank of America in the transition of the business at Bank of America's direction and in a manner that causes no material disruption to Bank of America business and operations.

Norm 2:
Norm type: Commitment
Subject: Supplier
Object: Bank of America
Antecedent: Expiration or termination of this Agreement, an Order or of Maintenance Services under this Agreement
Consequent: Supplier agrees to provide the requested services at no additional cost to Bank of America through the period of paid up Maintenance Services.

Norm 3:
Norm type: Commitment
Subject: Supplier
Object: Bank of America
Antecedent: Expiration or termination of this Agreement, an Order or of Maintenance Services under this Agreement
Consequent: Supplier agrees to cooperate with Bank of America in the transition of the business at Bank of America's direction.

Norm 4:
Norm type: Commitment
Subject: Supplier
Object: Bank of America
Antecedent: Expiration or termination of this Agreement, an Order or of Maintenance Services under this Agreement
Consequent: Supplier agrees to conclude the business operations.

Norm 5:
Norm type: Commitment
Subject: Supplier
Object: Bank of America
Antecedent: Expiration or termination of this Agreement, an Order or of Maintenance Services under this Agreement
Consequent: Supplier agrees to cause no material disruption to Bank of America business and operations during the transition.","Norm 1:
1. Norm type: Commitment
2. Subject: Supplier
3. Object: Bank of America
4. Antecedent: Expiration or termination of the Agreement, an Order, or Maintenance Services under the Agreement
5. Consequent: Supplier agrees to continue uninterrupted operations, conclude, and cooperate with Bank of America in the transition of the business at Bank of America's direction and in a manner that causes no material disruption to Bank of America business and operations.

Norm 2:
1. Norm type: Authorization
2. Subject: Bank of America
3. Object: Supplier
4. Antecedent: Expiration or termination of the Agreement, an Order, or Maintenance Services under the Agreement
5. Consequent: Bank of America can request Supplier to continue uninterrupted operations, conclude, and cooperate in the transition of the business at Bank of America's direction and in a manner that causes no material disruption to Bank of America business and operations.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Supplier
3. OBJECT: Bank of America
4. ANTECEDENT: Expiration or termination of the Agreement, an Order, or Maintenance Services under the Agreement
5. CONSEQUENT: Supplier agrees to continue uninterrupted operations, conclude, and cooperate with Bank of America in the transition of the business at Bank of America's direction and in a manner that causes no material disruption to Bank of America business and operations.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Bank of America
3. OBJECT: Supplier
4. ANTECEDENT: Expiration or termination of the Agreement, an Order, or Maintenance Services under the Agreement
5. CONSEQUENT: Bank of America can request Supplier to continue uninterrupted operations, conclude, and cooperate in the transition of the business at Bank of America's direction and in a manner that causes no material disruption to Bank of America business and operations.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Supplier
3. OBJECT: Bank of America
4. ANTECEDENT: Expiration or termination of the Agreement, an Order, or Maintenance Services under the Agreement
5. CONSEQUENT: Supplier agrees to continue uninterrupted operations, conclude, and cooperate with Bank of America in the transition of the business at Bank of America's direction and in a manner that causes no material disruption to Bank of America business and operations.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Bank of America
3. OBJECT: Supplier
4. ANTECEDENT: Expiration or termination of the Agreement, an Order, or Maintenance Services under the Agreement
5. CONSEQUENT: Bank of America can request Supplier to continue uninterrupted operations, conclude, and cooperate in the transition of the business at Bank of America's direction and in a manner that causes no material disruption to Bank of America business and operations.","Norm 1:
1. Norm type: Commitment
2. Subject: Supplier
3. Object: Bank of America
4. Antecedent: Expiration or termination of the Agreement, an Order, or Maintenance Services under the Agreement
5. Consequent: Supplier will continue uninterrupted operations, conclude, and cooperate with Bank of America in the transition of the business at Bank of America's direction and in a manner that causes no material disruption to Bank of America business and operations.

Norm 2:
1. Norm type: Authorization
2. Subject: Bank of America
3. Object: Supplier
4. Antecedent: Expiration or termination of the Agreement, an Order, or Maintenance Services under the Agreement
5. Consequent: Supplier will continue uninterrupted operations, conclude, and cooperate with Bank of America in the transition of the business at Bank of America's direction and in a manner that causes no material disruption to Bank of America business and operations."
25,Any material change in the terms of the offer from a third-party after we have elected not to purchase the seller's interest will constitute a new offer subject to the same right of first refusal as the third party's initial offer.,"Norm 1:
Norm type: Prohibition
Subject: We (the party receiving the offer)
Object: Third-party
Antecedent: Material change in the terms of the offer from a third-party
Consequent: Constitutes a new offer subject to the same right of first refusal as the third party's initial offer.

Norm 2:
Norm type: Commitment
Subject: We (the party receiving the offer)
Object: Seller's interest
Antecedent: Election not to purchase the seller's interest
Consequent: Constitutes a new offer subject to the same right of first refusal as the third party's initial offer.","Norm 1:
1. Norm type: Authorization
2. Subject: We (the party receiving the offer)
3. Object: Third-party
4. Antecedent: Any material change in the terms of the offer from a third-party after we have elected not to purchase the seller's interest
5. Consequent: Constitutes a new offer subject to the same right of first refusal as the third party's initial offer

Norm 2:
1. Norm type: Commitment
2. Subject: Third-party
3. Object: We (the party receiving the offer)
4. Antecedent: Any material change in the terms of the offer from a third-party after we have elected not to purchase the seller's interest
5. Consequent: Constitutes a new offer subject to the same right of first refusal as the third party's initial offer","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: Third-party
3. OBJECT: Seller
4. ANTECEDENT: Any material change in the terms of the offer from a third-party after we have elected not to purchase the seller's interest
5. CONSEQUENT: Constitutes a new offer subject to the same right of first refusal as the third party's initial offer

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Third-party
3. OBJECT: Seller
4. ANTECEDENT: Any material change in the terms of the offer from a third-party after we have elected not to purchase the seller's interest
5. CONSEQUENT: To ensure that it constitutes a new offer subject to the same right of first refusal as the third party's initial offer","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: Third-party
3. OBJECT: Seller
4. ANTECEDENT: Any material change in the terms of the offer from a third-party after we have elected not to purchase the seller's interest
5. CONSEQUENT: Constitutes a new offer subject to the same right of first refusal as the third party's initial offer

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Third-party
3. OBJECT: Seller
4. ANTECEDENT: Any material change in the terms of the offer from a third-party after we have elected not to purchase the seller's interest
5. CONSEQUENT: To ensure that the new offer constitutes a new offer subject to the same right of first refusal as the third party's initial offer.","Norm 1:
1. Norm type: Prohibition
2. Subject: Third-party
3. Object: Seller
4. Antecedent: Any material change in the terms of the offer from a third-party after we have elected not to purchase the seller's interest
5. Consequent: Will constitute a new offer subject to the same right of first refusal as the third party's initial offer

Norm 2:
1. Norm type: Commitment
2. Subject: Seller
3. Object: Third-party
4. Antecedent: Any material change in the terms of the offer from a third-party after we have elected not to purchase the seller's interest
5. Consequent: Will constitute a new offer subject to the same right of first refusal as the third party's initial offer"
26,"Following the License Option Exercise Closing Date, if [***] owned or controlled by a Third Party in a particular country or jurisdiction is necessary to Exploit a Licensed Compound or Licensed Product, AbbVie shall have the first right, but not the obligation, to negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right.","1. Norm type: Authorization
Subject: AbbVie
Object: Third Party
Antecedent: [***] owned or controlled by a Third Party in a particular country or jurisdiction is necessary to Exploit a Licensed Compound or Licensed Product
Consequent: AbbVie shall have the first right, but not the obligation, to negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right.

2. Norm type: Commitment
Subject: AbbVie
Object: Third Party
Antecedent: [***] owned or controlled by a Third Party in a particular country or jurisdiction is necessary to Exploit a Licensed Compound or Licensed Product
Consequent: AbbVie shall have the first right, but not the obligation, to negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right.

3. Norm type: Power
Subject: AbbVie
Object: None
Antecedent: None
Consequent: AbbVie shall have the first right, but not the obligation, to negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right.

4. Norm type: Authorization
Subject: AbbVie
Object: Third Party
Antecedent: [***] owned or controlled by a Third Party in a particular country or jurisdiction is necessary to Exploit a Licensed Compound or Licensed Product
Consequent: AbbVie shall have the first right, but not the obligation, to negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right.

5. Norm type: Commitment
Subject: AbbVie
Object: Third Party
Antecedent: [***] owned or controlled by a Third Party in a particular country or jurisdiction is necessary to Exploit a Licensed Compound or Licensed Product
Consequent: AbbVie shall have the first right, but not the obligation, to negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right.","Norm 1:
1. Norm type: Authorization
2. Subject: AbbVie
3. Object: Third Party
4. Antecedent: Ownership or control of a Patent or intellectual property right by a Third Party in a particular country or jurisdiction is necessary to Exploit a Licensed Compound or Licensed Product
5. Consequent: AbbVie shall have the first right to negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right.

Norm 2:
1. Norm type: Power
2. Subject: AbbVie
3. Object: Third Party
4. Antecedent: Ownership or control of a Patent or intellectual property right by a Third Party in a particular country or jurisdiction is necessary to Exploit a Licensed Compound or Licensed Product
5. Consequent: AbbVie has the power to negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right, even if it causes a change in the existing normative relationship.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: AbbVie
3. OBJECT: Third Party
4. ANTECEDENT: [***] owned or controlled by a Third Party in a particular country or jurisdiction is necessary to Exploit a Licensed Compound or Licensed Product
5. CONSEQUENT: AbbVie shall have the first right to negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right.

NORM 2:
1. NORM type: POWER
2. SUBJECT: AbbVie
3. OBJECT: Third Party
4. ANTECEDENT: [***] owned or controlled by a Third Party in a particular country or jurisdiction is necessary to Exploit a Licensed Compound or Licensed Product
5. CONSEQUENT: AbbVie has the power to negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right, even if it causes a change in existing norms.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: AbbVie
3. OBJECT: Third Party
4. ANTECEDENT: [***] owned or controlled by a Third Party in a particular country or jurisdiction is necessary to Exploit a Licensed Compound or Licensed Product
5. CONSEQUENT: AbbVie shall have the first right, but not the obligation, to negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right.

NORM 2:
1. NORM type: POWER
2. SUBJECT: AbbVie
3. OBJECT: Third Party
4. ANTECEDENT: [***] owned or controlled by a Third Party in a particular country or jurisdiction is necessary to Exploit a Licensed Compound or Licensed Product
5. CONSEQUENT: AbbVie can negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right, even if it causes a change in existing norms.","Norm 1:
1. Norm type: Authorization
2. Subject: AbbVie
3. Object: Third Party
4. Antecedent: [***] owned or controlled by a Third Party in a particular country or jurisdiction is necessary to Exploit a Licensed Compound or Licensed Product
5. Consequent: AbbVie shall have the first right, but not the obligation, to negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right.

Norm 2:
1. Norm type: Power
2. Subject: AbbVie
3. Object: Third Party
4. Antecedent: [***] owned or controlled by a Third Party in a particular country or jurisdiction is necessary to Exploit a Licensed Compound or Licensed Product
5. Consequent: AbbVie can negotiate and enter into an agreement with a Third Party in order to obtain a license or right under such Patent or intellectual property right."
27,"Notwithstanding Section 7.1 above, this Agreement may be terminated upon the occurrence of any of the following events:<omitted>(d) By either party hereto upon sixty (60) days prior written notice to the other party hereto;","1. Norm type: Commitment
Subject: Either party hereto
Object: The other party hereto
Antecedent: Sixty (60) days prior written notice
Consequent: Termination of the Agreement

2. Norm type: Authorization
Subject: Either party hereto
Object: The other party hereto
Antecedent: None
Consequent: Termination of the Agreement

3. Norm type: Power
Subject: Either party hereto
Object: None
Antecedent: None
Consequent: Termination of the Agreement

4. Norm type: Commitment
Subject: Either party hereto
Object: The other party hereto
Antecedent: None
Consequent: Termination of the Agreement

5. Norm type: Commitment
Subject: Either party hereto
Object: The other party hereto
Antecedent: None
Consequent: Termination of the Agreement","Norm 1:
1. Norm type: Power
2. Subject: Either party
3. Object: The other party
4. Antecedent: Occurrence of any of the events listed in the contract
5. Consequent: Termination of the Agreement
6. Clause: ""By either party hereto upon sixty (60) days prior written notice to the other party hereto""","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: either party
3. OBJECT: the other party
4. ANTECEDENT: occurrence of any of the following events
5. CONSEQUENT: termination of the Agreement

CLAUSE 1: By either party hereto upon sixty (60) days prior written notice to the other party hereto","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: either party
3. OBJECT: the other party
4. ANTECEDENT: occurrence of any of the events listed in Section 7.1
5. CONSEQUENT: termination of the Agreement

NORM 2:
1. NORM type: POWER
2. SUBJECT: either party
3. OBJECT: the other party
4. ANTECEDENT: sixty (60) days prior written notice
5. CONSEQUENT: termination of the Agreement","Norm 1:
1. Norm type: commitment
2. Subject: either party
3. Object: the other party
4. Antecedent: sixty (60) days prior written notice
5. Consequent: termination of the Agreement

Norm 2:
1. Norm type: authorization
2. Subject: either party
3. Object: the other party
4. Antecedent: occurrence of any of the following events
5. Consequent: termination of the Agreement"
28,"On expiration or the effective date of termination of this Agreement, if earlier:<omitted>e) Supplier shall promptly cooperate with Customer to transfer and transition supply of the Products to a Third Party supplier. Upon Customer's request, Supplier shall cooperate with Customer in the transfer of technology and know-how necessary to Manufacture Products to such Third Party supplier, including providing Customer and the Third Party supplier with reasonable access to the Facilities and consulting services related to Manufacturing of the Product. Supplier shall conduct such activities at Customer's expense paid in advance.","1. Norm type: Commitment
Subject: Supplier
Object: Customer
Antecedent: Expiration or effective date of termination of the Agreement
Consequent: Supplier shall promptly cooperate with Customer to transfer and transition supply of the Products to a Third Party supplier. Upon Customer's request, Supplier shall cooperate with Customer in the transfer of technology and know-how necessary to Manufacture Products to such Third Party supplier, including providing Customer and the Third Party supplier with reasonable access to the Facilities and consulting services related to Manufacturing of the Product. Supplier shall conduct such activities at Customer's expense paid in advance.","Norm 1:
1. Norm type: Commitment
2. Subject: Supplier
3. Object: Customer
4. Antecedent: Expiration or effective date of termination of the Agreement
5. Consequent: Supplier shall promptly cooperate with Customer to transfer and transition supply of the Products to a Third Party supplier. Upon Customer's request, Supplier shall cooperate with Customer in the transfer of technology and know-how necessary to Manufacture Products to such Third Party supplier, including providing Customer and the Third Party supplier with reasonable access to the Facilities and consulting services related to Manufacturing of the Product. Supplier shall conduct such activities at Customer's expense paid in advance.

Norm 2:
1. Norm type: Commitment
2. Subject: Customer
3. Object: Supplier
4. Antecedent: Expiration or effective date of termination of the Agreement
5. Consequent: Customer shall request Supplier to cooperate in the transfer of technology and know-how necessary to Manufacture Products to a Third Party supplier, including providing Supplier and the Third Party supplier with reasonable access to the Facilities and consulting services related to Manufacturing of the Product. Customer shall pay for such activities in advance.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Supplier
3. OBJECT: Customer
4. ANTECEDENT: On expiration or the effective date of termination of this Agreement
5. CONSEQUENT: Supplier shall promptly cooperate with Customer to transfer and transition supply of the Products to a Third Party supplier. Upon Customer's request, Supplier shall cooperate with Customer in the transfer of technology and know-how necessary to Manufacture Products to such Third Party supplier, including providing Customer and the Third Party supplier with reasonable access to the Facilities and consulting services related to Manufacturing of the Product. Supplier shall conduct such activities at Customer's expense paid in advance.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Supplier
3. OBJECT: Customer
4. ANTECEDENT: On expiration or the effective date of termination of this Agreement
5. CONSEQUENT: Supplier shall promptly cooperate with Customer to transfer and transition supply of the Products to a Third Party supplier. Upon Customer's request, Supplier shall cooperate with Customer in the transfer of technology and know-how necessary to Manufacture Products to such Third Party supplier, including providing Customer and the Third Party supplier with reasonable access to the Facilities and consulting services related to Manufacturing of the Product. Supplier shall conduct such activities at Customer's expense paid in advance.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Supplier
3. OBJECT: Customer
4. ANTECEDENT: Expiration or effective date of termination of the Agreement
5. CONSEQUENT: Supplier shall promptly cooperate with Customer to transfer and transition supply of the Products to a Third Party supplier.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Supplier
3. OBJECT: Customer
4. ANTECEDENT: Expiration or effective date of termination of the Agreement
5. CONSEQUENT: Supplier shall cooperate with Customer in the transfer of technology and know-how necessary to Manufacture Products to such Third Party supplier, including providing Customer and the Third Party supplier with reasonable access to the Facilities and consulting services related to Manufacturing of the Product. Supplier shall conduct such activities at Customer's expense paid in advance.","1. Norm type: commitment
2. Subject: Supplier
3. Object: Customer
4. Antecedent: On expiration or the effective date of termination of this Agreement
5. Consequent: Supplier shall promptly cooperate with Customer to transfer and transition supply of the Products to a Third Party supplier.

1. Norm type: commitment
2. Subject: Supplier
3. Object: Customer
4. Antecedent: On expiration or the effective date of termination of this Agreement
5. Consequent: Upon Customer's request, Supplier shall cooperate with Customer in the transfer of technology and know-how necessary to Manufacture Products to such Third Party supplier, including providing Customer and the Third Party supplier with reasonable access to the Facilities and consulting services related to Manufacturing of the Product. Supplier shall conduct such activities at Customer's expense paid in advance."
29,"Unless this Agreement is terminated by Zogenix under Section 12.2(c), at the written request of Zogenix, Distributor shall assign to Zogenix any Product-specific Third Party agreements, to the furthest extent possible, provided that such assignment is permitted under the Product-specific agreement or is otherwise agreed by the applicable Third Party.","1. Norm type: Authorization
Subject: Distributor
Object: Zogenix
Antecedent: Agreement not terminated by Zogenix under Section 12.2(c)
Consequent: Distributor shall assign any Product-specific Third Party agreements to Zogenix, to the furthest extent possible, if permitted under the Product-specific agreement or agreed by the applicable Third Party.

2. Norm type: Commitment
Subject: Zogenix
Object: Distributor
Antecedent: N/A
Consequent: Zogenix has the written request authority to request Distributor to assign any Product-specific Third Party agreements to Zogenix, to the furthest extent possible, if permitted under the Product-specific agreement or agreed by the applicable Third Party.

3. Norm type: Prohibition
Subject: N/A
Object: Distributor
Antecedent: N/A
Consequent: Distributor is prohibited from assigning any Product-specific Third Party agreements to Zogenix if such assignment is not permitted under the Product-specific agreement or not agreed by the applicable Third Party.

Note: The given sentence does not contain any clauses related to the norm types 'power' or 'prohibition.'","Norm 1:
1. Norm type: Commitment
2. Subject: Distributor
3. Object: Zogenix
4. Antecedent: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
5. Consequent: Distributor shall assign to Zogenix any Product-specific Third Party agreements, to the furthest extent possible, provided that such assignment is permitted under the Product-specific agreement or is otherwise agreed by the applicable Third Party.

Norm 2:
1. Norm type: Authorization
2. Subject: Zogenix
3. Object: Distributor
4. Antecedent: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
5. Consequent: Distributor shall assign to Zogenix any Product-specific Third Party agreements, to the furthest extent possible, provided that such assignment is permitted under the Product-specific agreement or is otherwise agreed by the applicable Third Party.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Distributor
3. OBJECT: Zogenix
4. ANTECEDENT: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
5. CONSEQUENT: Distributor shall assign to Zogenix any Product-specific Third Party agreements, to the furthest extent possible, provided that such assignment is permitted under the Product-specific agreement or is otherwise agreed by the applicable Third Party.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Zogenix
3. OBJECT: Distributor
4. ANTECEDENT: At the written request of Zogenix
5. CONSEQUENT: Distributor shall assign to Zogenix any Product-specific Third Party agreements, to the furthest extent possible, provided that such assignment is permitted under the Product-specific agreement or is otherwise agreed by the applicable Third Party.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Distributor
3. OBJECT: Zogenix
4. ANTECEDENT: Agreement not terminated by Zogenix under Section 12.2(c)
5. CONSEQUENT: Distributor shall assign Product-specific Third Party agreements to Zogenix

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Distributor
3. OBJECT: Zogenix
4. ANTECEDENT: Agreement not terminated by Zogenix under Section 12.2(c)
5. CONSEQUENT: Distributor can assign Product-specific Third Party agreements to Zogenix if permitted under the Product-specific agreement or agreed by the applicable Third Party.","Norm 1:
1. Norm type: Commitment
2. Subject: Distributor
3. Object: Zogenix
4. Antecedent: Agreement not terminated by Zogenix under Section 12.2(c)
5. Consequent: Distributor shall assign Product-specific Third Party agreements to Zogenix

Norm 2:
1. Norm type: Authorization
2. Subject: Distributor
3. Object: Zogenix
4. Antecedent: Agreement not terminated by Zogenix under Section 12.2(c)
5. Consequent: Distributor shall assign Product-specific Third Party agreements to Zogenix, provided such assignment is permitted under the Product-specific agreement or agreed by the applicable Third Party."
30,A Change of Control shall be deemed an assignment for purposes of this Agreement.,"Norm 1:
- Norm type: Authorization
- Subject: Change of Control
- Object: Parties involved in the Agreement
- Antecedent: N/A
- Consequent: Change of Control shall be deemed an assignment for purposes of this Agreement.

Norm 2:
- Norm type: Commitment
- Subject: Parties involved in the Agreement
- Object: N/A
- Antecedent: N/A
- Consequent: Parties involved in the Agreement commit to treating a Change of Control as an assignment for purposes of this Agreement.

Note: In this sentence, there is only one norm identified, which can be interpreted as both an authorization and a commitment norm.","Norm 1:
1. Norm type: Prohibition
2. Subject: Parties involved in the contract
3. Object: Parties involved in the contract
4. Antecedent: Change of Control
5. Consequent: Deemed an assignment for purposes of this Agreement

Norm 2:
1. Norm type: Commitment
2. Subject: Parties involved in the contract
3. Object: Parties involved in the contract
4. Antecedent: Change of Control
5. Consequent: Ensuring that it is deemed an assignment for purposes of this Agreement","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: The party undergoing a Change of Control
3. OBJECT: The other party involved in the Agreement
4. ANTECEDENT: Change of Control
5. CONSEQUENT: Deemed as an assignment for purposes of the Agreement

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: The party undergoing a Change of Control
3. OBJECT: The other party involved in the Agreement
4. ANTECEDENT: Change of Control
5. CONSEQUENT: Ensuring that the Change of Control is not considered an assignment for purposes of the Agreement","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: Change of Control
3. OBJECT: parties involved in the Agreement
4. ANTECEDENT: Change of Control
5. CONSEQUENT: assignment for purposes of the Agreement

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: parties involved in the Agreement
3. OBJECT: Change of Control
4. ANTECEDENT: Change of Control
5. CONSEQUENT: assignment for purposes of the Agreement","1. Norm type: prohibition
2. Subject: Change of Control
3. Object: parties involved in the Agreement
4. Antecedent: Change of Control
5. Consequent: assignment for purposes of the Agreement"
31,"Upon the termination of this Agreement, Operator shall cooperate in the transition of operations to Owner or a successor operator and upon  Owner's request, will promptly deliver all books and records and other property (including, without limitation, intellectual property) of Owner to  Owner or the successor operator, as applicable.","Norm 1:
Norm type: Commitment
Subject: Operator
Object: Owner or a successor operator
Antecedent: Termination of this Agreement
Consequent: Cooperation in the transition of operations to Owner or a successor operator

Norm 2:
Norm type: Commitment
Subject: Operator
Object: Owner
Antecedent: Owner's request
Consequent: Prompt delivery of all books and records and other property (including, without limitation, intellectual property) of Owner to Owner

Norm 3:
Norm type: Commitment
Subject: Operator
Object: Successor operator
Antecedent: Owner's request
Consequent: Prompt delivery of all books and records and other property (including, without limitation, intellectual property) of Owner to the successor operator

Norm 4:
Norm type: Authorization
Subject: Owner
Object: Operator
Antecedent: Termination of this Agreement
Consequent: Requesting the prompt delivery of all books and records and other property (including, without limitation, intellectual property) of Owner

Norm 5:
Norm type: Authorization
Subject: Owner
Object: Successor operator
Antecedent: Termination of this Agreement
Consequent: Requesting the prompt delivery of all books and records and other property (including, without limitation, intellectual property) of Owner to the successor operator","Norm 1:
1. Norm type: Commitment
2. Subject: Operator
3. Object: Owner or successor operator
4. Antecedent: Termination of the Agreement
5. Consequent: Cooperation in the transition of operations, delivery of books, records, and other property to Owner or successor operator

Norm 2:
1. Norm type: Authorization
2. Subject: Owner
3. Object: Operator
4. Antecedent: Request from Owner
5. Consequent: Prompt delivery of books, records, and other property (including intellectual property) to Owner or successor operator","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Operator
3. OBJECT: Owner
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Cooperation in the transition of operations to Owner or a successor operator

CLAUSE: ""Upon the termination of this Agreement, Operator shall cooperate in the transition of operations to Owner or a successor operator.""

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Operator
3. OBJECT: Owner
4. ANTECEDENT: Owner's request
5. CONSEQUENT: Prompt delivery of all books and records and other property (including, without limitation, intellectual property) of Owner to Owner or the successor operator

CLAUSE: ""Upon Owner's request, Operator will promptly deliver all books and records and other property (including, without limitation, intellectual property) of Owner to Owner or the successor operator.""","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Operator
3. OBJECT: Owner
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Cooperation in the transition of operations to Owner or a successor operator

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Operator
3. OBJECT: Owner
4. ANTECEDENT: Owner's request
5. CONSEQUENT: Prompt delivery of all books and records and other property (including, without limitation, intellectual property) of Owner to Owner or the successor operator","Norm 1:
1. Norm type: Commitment
2. Subject: Operator
3. Object: Owner
4. Antecedent: Termination of the Agreement
5. Consequent: Cooperation in the transition of operations to Owner or a successor operator

Norm 2:
1. Norm type: Authorization
2. Subject: Operator
3. Object: Owner
4. Antecedent: Owner's request
5. Consequent: Prompt delivery of all books and records and other property (including, without limitation, intellectual property) of Owner to Owner or the successor operator"
32,"If AbbVie terminates this Agreement with respect to a country or other jurisdiction, or in its entirety pursuant to Section 12.3, AbbVie shall have the right for at least [***] and no more than [***], which period shall be determined by Harpoon in its sole discretion, after the effective date of such termination with respect to such country or other jurisdiction to sell or otherwise dispose of all Licensed Compound or Licensed Product then in its inventory and any in-progress inventory, in each case that is intended for sale or disposition in such country or other jurisdiction, as though this Agreement had not terminated with respect to such country or other jurisdiction, and such sale or disposition shall not constitute infringement of Harpoon's or its Affiliates' Patent or other intellectual property or other proprietary rights.","Norm 1:
Norm type: Authorization
Subject: AbbVie
Object: Harpoon
Antecedent: Termination of the Agreement with respect to a country or other jurisdiction, or in its entirety pursuant to Section 12.3
Consequent: AbbVie has the right to sell or dispose of all Licensed Compound or Licensed Product in its inventory and any in-progress inventory intended for sale or disposition in the terminated country or jurisdiction, without infringing Harpoon's or its Affiliates' Patent or other intellectual property or other proprietary rights.

Norm 2:
Norm type: Commitment
Subject: AbbVie
Object: Harpoon
Antecedent: Termination of the Agreement with respect to a country or other jurisdiction, or in its entirety pursuant to Section 12.3
Consequent: AbbVie is committed to selling or disposing of all Licensed Compound or Licensed Product in its inventory and any in-progress inventory intended for sale or disposition in the terminated country or jurisdiction, as though the Agreement had not terminated with respect to such country or other jurisdiction.

Norm 3:
Norm type: Commitment
Subject: Harpoon
Object: AbbVie
Antecedent: Termination of the Agreement with respect to a country or other jurisdiction, or in its entirety pursuant to Section 12.3
Consequent: Harpoon is committed to allowing AbbVie the period of at least [***] and no more than [***], as determined by Harpoon in its sole discretion, after the effective date of termination to sell or dispose of all Licensed Compound or Licensed Product in its inventory and any in-progress inventory intended for sale or disposition in the terminated country or jurisdiction, as though the Agreement had not terminated with respect to such country or other jurisdiction.

Norm 4:
Norm type: Prohibition
Subject: None
Object: None
Antecedent: None
Consequent: The sale or disposition of all Licensed Compound or Licensed Product in AbbVie's inventory and any in-progress inventory intended for sale or disposition in the terminated country or jurisdiction shall not constitute infringement of Harpoon's or its Affiliates' Patent or other intellectual property or other proprietary rights.

Note: The given sentence does not contain a norm that fits the norm type 'power.'","Norm 1:
1. Norm type: Authorization
2. Subject: AbbVie
3. Object: Harpoon
4. Antecedent: Termination of the Agreement with respect to a country or other jurisdiction, or in its entirety pursuant to Section 12.3
5. Consequent: AbbVie shall have the right for at least [***] and no more than [***], which period shall be determined by Harpoon in its sole discretion, after the effective date of such termination with respect to such country or other jurisdiction to sell or otherwise dispose of all Licensed Compound or Licensed Product then in its inventory and any in-progress inventory, in each case that is intended for sale or disposition in such country or other jurisdiction, as though this Agreement had not terminated with respect to such country or other jurisdiction, and such sale or disposition shall not constitute infringement of Harpoon's or its Affiliates' Patent or other intellectual property or other proprietary rights.

Norm 2:
1. Norm type: Commitment
2. Subject: Harpoon
3. Object: AbbVie
4. Antecedent: Termination of the Agreement with respect to a country or other jurisdiction, or in its entirety pursuant to Section 12.3
5. Consequent: Allowing AbbVie to sell or dispose of all Licensed Compound or Licensed Product then in its inventory and any in-progress inventory intended for sale or disposition in such country or other jurisdiction, as though the Agreement had not terminated with respect to such country or other jurisdiction.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: AbbVie
3. OBJECT: Harpoon
4. ANTECEDENT: Termination of the Agreement with respect to a country or other jurisdiction, or in its entirety pursuant to Section 12.3
5. CONSEQUENT: AbbVie shall have the right for at least [***] and no more than [***], which period shall be determined by Harpoon in its sole discretion, after the effective date of such termination with respect to such country or other jurisdiction to sell or otherwise dispose of all Licensed Compound or Licensed Product then in its inventory and any in-progress inventory, in each case that is intended for sale or disposition in such country or other jurisdiction, as though this Agreement had not terminated with respect to such country or other jurisdiction, and such sale or disposition shall not constitute infringement of Harpoon's or its Affiliates' Patent or other intellectual property or other proprietary rights.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Harpoon
3. OBJECT: AbbVie
4. ANTECEDENT: Termination of the Agreement with respect to a country or other jurisdiction, or in its entirety pursuant to Section 12.3
5. CONSEQUENT: Harpoon shall allow AbbVie the right to sell or otherwise dispose of all Licensed Compound or Licensed Product then in its inventory and any in-progress inventory, in each case that is intended for sale or disposition in such country or other jurisdiction, as though this Agreement had not terminated with respect to such country or other jurisdiction, and such sale or disposition shall not constitute infringement of Harpoon's or its Affiliates' Patent or other intellectual property or other proprietary rights.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: AbbVie
3. OBJECT: Harpoon
4. ANTECEDENT: Termination of the Agreement with respect to a country or other jurisdiction, or in its entirety pursuant to Section 12.3
5. CONSEQUENT: AbbVie shall have the right for at least [***] and no more than [***], which period shall be determined by Harpoon in its sole discretion, after the effective date of such termination with respect to such country or other jurisdiction to sell or otherwise dispose of all Licensed Compound or Licensed Product then in its inventory and any in-progress inventory, in each case that is intended for sale or disposition in such country or other jurisdiction, as though this Agreement had not terminated with respect to such country or other jurisdiction, and such sale or disposition shall not constitute infringement of Harpoon's or its Affiliates' Patent or other intellectual property or other proprietary rights.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Harpoon
3. OBJECT: AbbVie
4. ANTECEDENT: Termination of the Agreement with respect to a country or other jurisdiction, or in its entirety pursuant to Section 12.3
5. CONSEQUENT: Harpoon shall allow AbbVie to sell or otherwise dispose of all Licensed Compound or Licensed Product then in its inventory and any in-progress inventory, in each case that is intended for sale or disposition in such country or other jurisdiction, as though this Agreement had not terminated with respect to such country or other jurisdiction, and such sale or disposition shall not constitute infringement of Harpoon's or its Affiliates' Patent or other intellectual property or other proprietary rights.","1. Norm type: authorization
2. Subject: AbbVie
3. Object: Harpoon
4. Antecedent: Termination of the Agreement with respect to a country or other jurisdiction, or in its entirety pursuant to Section 12.3
5. Consequent: AbbVie has the right to sell or dispose of Licensed Compound or Licensed Product in its inventory intended for sale or disposition in the terminated country or jurisdiction without infringing on Harpoon's or its Affiliates' Patent or other intellectual property rights. 

2. Norm type: commitment
2. Subject: Harpoon
3. Object: AbbVie
4. Antecedent: Termination of the Agreement with respect to a country or other jurisdiction, or in its entirety pursuant to Section 12.3
5. Consequent: Harpoon shall allow AbbVie a period of at least [***] and no more than [***], determined by Harpoon in its sole discretion, to sell or dispose of Licensed Compound or Licensed Product in its inventory intended for sale or disposition in the terminated country or jurisdiction."
33,"In the event the closing of the purchase does not occur within said ninety (90) day period because Franchisee fails to act diligently in connection therewith,  the purchase price shall be reduced by ten percent (10%).","1. Norm type: Commitment
Subject: Franchisee
Object: Not specified
Antecedent: Failure to act diligently in connection with the closing of the purchase within the ninety (90) day period
Consequent: The purchase price shall be reduced by ten percent (10%)

2. Norm type: Prohibition
Subject: Not specified
Object: Not specified
Antecedent: Not specified
Consequent: Not applicable

Note: The given sentence does not explicitly mention any authorization or power norms.","Norm 1:
1. Norm type: Commitment
2. Subject: Franchisee
3. Object: Other party (not explicitly mentioned in the sentence)
4. Antecedent: Closing of the purchase does not occur within the ninety (90) day period
5. Consequent: Purchase price shall be reduced by ten percent (10%)

Norm 2:
1. Norm type: Prohibition
2. Subject: Franchisee
3. Object: Other party (not explicitly mentioned in the sentence)
4. Antecedent: Failure to act diligently in connection with the closing of the purchase
5. Consequent: Purchase price shall be reduced by ten percent (10%)","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Franchisee
3. OBJECT: Not specified
4. ANTECEDENT: Closing of the purchase does not occur within ninety (90) day period
5. CONSEQUENT: Purchase price shall be reduced by ten percent (10%)

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Franchisee
3. OBJECT: Not specified
4. ANTECEDENT: Franchisee fails to act diligently in connection with the purchase
5. CONSEQUENT: Purchase price shall be reduced by ten percent (10%)","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: Franchisee
3. OBJECT: Not specified
4. ANTECEDENT: Closing of the purchase does not occur within ninety (90) day period
5. CONSEQUENT: Purchase price shall be reduced by ten percent (10%)

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Franchisee
3. OBJECT: Not specified
4. ANTECEDENT: Franchisee fails to act diligently in connection with the purchase
5. CONSEQUENT: Purchase price shall be reduced by ten percent (10%)","Norm 1:
1. Norm type: Commitment
2. Subject: Franchisee
3. Object: Not specified
4. Antecedent: Closing of the purchase does not occur within ninety (90) day period
5. Consequent: Purchase price shall be reduced by ten percent (10%)

Norm 2:
1. Norm type: Prohibition
2. Subject: Franchisee
3. Object: Not specified
4. Antecedent: Franchisee fails to act diligently in connection with the closing of the purchase
5. Consequent: Purchase price shall be reduced by ten percent (10%)"
34,"Unless this Agreement is terminated by Zogenix under Section 12.2(c), at Zogenix's option, which shall be exercised by written notice to Distributor, to the extent permitted under Applicable Laws, Distributor shall assign or cause to be assigned to Zogenix or its designee (or to the extent not so assignable, Distributor shall take all reasonable actions to make available to Zogenix or its designee the benefits of), at Zogenix's cost, all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory.","1. Norm type: Authorization
Subject: Distributor
Object: Zogenix or its designee
Antecedent: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
Consequent: Distributor shall assign or cause to be assigned to Zogenix or its designee (or to the extent not so assignable, Distributor shall take all reasonable actions to make available to Zogenix or its designee the benefits of), at Zogenix's cost, all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory.

2. Norm type: Commitment
Subject: Distributor
Object: Zogenix or its designee
Antecedent: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
Consequent: Distributor shall assign or cause to be assigned to Zogenix or its designee (or to the extent not so assignable, Distributor shall take all reasonable actions to make available to Zogenix or its designee the benefits of), at Zogenix's cost, all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory.

3. Norm type: Commitment
Subject: Zogenix
Object: Distributor
Antecedent: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
Consequent: Distributor shall assign or cause to be assigned to Zogenix or its designee (or to the extent not so assignable, Distributor shall take all reasonable actions to make available to Zogenix or its designee the benefits of), at Zogenix's cost, all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory.

4. Norm type: Commitment
Subject: Distributor
Object: Zogenix or its designee
Antecedent: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
Consequent: Distributor shall take all reasonable actions to make available to Zogenix or its designee the benefits of, at Zogenix's cost, all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory.

5. Norm type: Commitment
Subject: Distributor
Object: Zogenix or its designee
Antecedent: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
Consequent: Distributor shall take all reasonable actions to make available to Zogenix or its designee the benefits of, at Zogenix's cost, all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory.","Norm 1:
1. Norm type: Commitment
2. Subject: Distributor
3. Object: Zogenix
4. Antecedent: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
5. Consequent: Distributor shall assign or cause to be assigned to Zogenix or its designee (or to the extent not so assignable, Distributor shall take all reasonable actions to make available to Zogenix or its designee the benefits of), at Zogenix's cost, all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory.

Norm 2:
1. Norm type: Power
2. Subject: Zogenix
3. Object: Distributor
4. Antecedent: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
5. Consequent: Zogenix, at its option, which shall be exercised by written notice to Distributor, to the extent permitted under Applicable Laws, shall have the power to require Distributor to assign or cause to be assigned all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Distributor
3. OBJECT: Zogenix
4. ANTECEDENT: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
5. CONSEQUENT: Distributor shall assign or cause to be assigned to Zogenix or its designee (or to the extent not so assignable, Distributor shall take all reasonable actions to make available to Zogenix or its designee the benefits of), at Zogenix's cost, all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Zogenix
3. OBJECT: Distributor
4. ANTECEDENT: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
5. CONSEQUENT: Zogenix, at its option, which shall be exercised by written notice to Distributor, to the extent permitted under Applicable Laws, shall assign or cause to be assigned to Distributor all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Distributor
3. OBJECT: Zogenix
4. ANTECEDENT: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
5. CONSEQUENT: Distributor shall assign or cause to be assigned to Zogenix or its designee (or to the extent not so assignable, Distributor shall take all reasonable actions to make available to Zogenix or its designee the benefits of), at Zogenix's cost, all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Zogenix
3. OBJECT: Distributor
4. ANTECEDENT: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
5. CONSEQUENT: Distributor shall assign or cause to be assigned to Zogenix or its designee (or to the extent not so assignable, Distributor shall take all reasonable actions to make available to Zogenix or its designee the benefits of), at Zogenix's cost, all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory.","1. Norm type: commitment
2. Subject: Distributor
3. Object: Zogenix
4. Antecedent: Unless this Agreement is terminated by Zogenix under Section 12.2(c)
5. Consequent: Distributor shall assign or cause to be assigned to Zogenix or its designee all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory."
35,"Without limiting the provisions of Section 11, commencing on the delivery of any notice of termination of this Agreement, and continuing through the effective date of termination and for a period of sixty (60) Business Days thereafter (the ""Transition-out Period""), Ehave will, to the extent requested by CHT, provide to CHT (or at CHT's request to CHT's End User) such reasonable cooperation, assistance and services to facilitate the orderly wind down, transition and migration and transfer of the End User Data from Ehave to CHT (the ""Transition-out Services"").","Norm 1:
Norm type: Commitment
Subject: Ehave
Object: CHT
Antecedent: Delivery of any notice of termination of this Agreement
Consequent: Ehave will provide reasonable cooperation, assistance, and services to facilitate the orderly wind down, transition, and migration and transfer of the End User Data from Ehave to CHT during the Transition-out Period.

Norm 2:
Norm type: Authorization
Subject: Ehave
Object: CHT
Antecedent: Request from CHT
Consequent: Ehave will provide reasonable cooperation, assistance, and services to facilitate the orderly wind down, transition, and migration and transfer of the End User Data from Ehave to CHT (or at CHT's request to CHT's End User) during the Transition-out Period.

Norm 3:
Norm type: Commitment
Subject: Ehave
Object: CHT's End User
Antecedent: Request from CHT
Consequent: Ehave will provide reasonable cooperation, assistance, and services to facilitate the orderly wind down, transition, and migration and transfer of the End User Data from Ehave to CHT's End User during the Transition-out Period.

Norm 4:
Norm type: Commitment
Subject: Ehave
Object: CHT
Antecedent: Request from CHT
Consequent: Ehave will provide reasonable cooperation, assistance, and services to facilitate the orderly wind down, transition, and migration and transfer of the End User Data from Ehave to CHT during the Transition-out Period.

Norm 5:
Norm type: Commitment
Subject: Ehave
Object: CHT
Antecedent: Request from CHT
Consequent: Ehave will provide Transition-out Services to facilitate the orderly wind down, transition, and migration and transfer of the End User Data from Ehave to CHT during the Transition-out Period.","Norm 1:
1. Norm type: Commitment
2. Subject: Ehave
3. Object: CHT
4. Antecedent: Delivery of any notice of termination of the Agreement
5. Consequent: Ehave will provide reasonable cooperation, assistance, and services to facilitate the orderly wind down, transition, migration, and transfer of End User Data from Ehave to CHT during the Transition-out Period.

Norm 2:
1. Norm type: Authorization
2. Subject: Ehave
3. Object: CHT
4. Antecedent: Request by CHT
5. Consequent: Ehave will provide Transition-out Services to CHT or CHT's End User as requested by CHT.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Ehave
3. OBJECT: CHT
4. ANTECEDENT: Delivery of any notice of termination of the Agreement
5. CONSEQUENT: Providing reasonable cooperation, assistance, and services to facilitate the orderly wind down, transition, migration, and transfer of End User Data from Ehave to CHT during the Transition-out Period

CLAUSE: Ehave commits to providing Transition-out Services to CHT upon the delivery of any notice of termination of the Agreement.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: CHT
3. OBJECT: Ehave
4. ANTECEDENT: Request by CHT
5. CONSEQUENT: Receiving reasonable cooperation, assistance, and services from Ehave to facilitate the orderly wind down, transition, migration, and transfer of the End User Data during the Transition-out Period

CLAUSE: CHT authorizes Ehave to provide Transition-out Services upon request to facilitate the orderly wind down, transition, migration, and transfer of the End User Data.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Ehave
3. OBJECT: CHT
4. ANTECEDENT: delivery of any notice of termination of the Agreement
5. CONSEQUENT: provide reasonable cooperation, assistance, and services to facilitate the orderly wind down, transition, and migration of End User Data from Ehave to CHT during the Transition-out Period

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Ehave
3. OBJECT: CHT
4. ANTECEDENT: request from CHT
5. CONSEQUENT: provide Transition-out Services to CHT or CHT's End User as requested by CHT during the Transition-out Period","1. Norm type: commitment
2. Subject: Ehave
3. Object: CHT
4. Antecedent: delivery of any notice of termination of the Agreement
5. Consequent: provide reasonable cooperation, assistance, and services to facilitate the orderly wind down, transition, and migration of End User Data from Ehave to CHT. 

2. Norm type: authorization
3. Subject: CHT
4. Antecedent: request for cooperation, assistance, and services from Ehave
5. Consequent: receive reasonable cooperation, assistance, and services from Ehave for the transition-out period."
36,"We may terminate your right to provide products and services to a Major Account customer at any time by giving you at least 30 days' prior written notice, and you may terminate your right to provide products and services to a Major Account at any time by giving us at least 30 days' prior written notice.","1. Norm type: Authorization
Subject: We
Object: You
Antecedent: None mentioned
Consequent: Termination of your right to provide products and services to a Major Account customer

2. Norm type: Authorization
Subject: You
Object: Us
Antecedent: None mentioned
Consequent: Termination of your right to provide products and services to a Major Account

3. Norm type: Commitment
Subject: We
Object: You
Antecedent: None mentioned
Consequent: Providing at least 30 days' prior written notice for termination

4. Norm type: Commitment
Subject: You
Object: Us
Antecedent: None mentioned
Consequent: Providing at least 30 days' prior written notice for termination

Note: In this sentence, there are no norms of 'power' or 'prohibition' type.","Norm 1:
1. Norm type: Power
2. Subject: We (the party terminating the right)
3. Object: You (the party whose right is being terminated)
4. Antecedent: None specified
5. Consequent: Termination of the right to provide products and services to a Major Account customer

Norm 2:
1. Norm type: Power
2. Subject: You (the party terminating the right)
3. Object: Us (the party whose right is being terminated)
4. Antecedent: None specified
5. Consequent: Termination of the right to provide products and services to a Major Account

Clause:
- Both parties have the power to terminate the right to provide products and services to a Major Account customer by giving at least 30 days' prior written notice.","NORM 1:
1. NORM type: POWER
2. SUBJECT: We
3. OBJECT: You
4. ANTECEDENT: None specified
5. CONSEQUENT: Terminate your right to provide products and services to a Major Account customer at any time by giving you at least 30 days' prior written notice.

CLAUSE: We have the power to terminate your right to provide products and services to a Major Account customer by giving you at least 30 days' prior written notice.

NORM 2:
1. NORM type: POWER
2. SUBJECT: You
3. OBJECT: Us
4. ANTECEDENT: None specified
5. CONSEQUENT: Terminate your right to provide products and services to a Major Account at any time by giving us at least 30 days' prior written notice.

CLAUSE: You have the power to terminate your right to provide products and services to a Major Account by giving us at least 30 days' prior written notice.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: We
3. OBJECT: You
4. ANTECEDENT: Termination of the right to provide products and services to a Major Account customer
5. CONSEQUENT: Giving at least 30 days' prior written notice

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: You
3. OBJECT: Us
4. ANTECEDENT: Termination of the right to provide products and services to a Major Account
5. CONSEQUENT: Giving at least 30 days' prior written notice","Norm 1:
1. Norm type: Authorization
2. Subject: We
3. Object: You
4. Antecedent: Giving at least 30 days' prior written notice
5. Consequent: Terminating your right to provide products and services to a Major Account customer

Norm 2:
1. Norm type: Authorization
2. Subject: You
3. Object: Us
4. Antecedent: Giving at least 30 days' prior written notice
5. Consequent: Terminating your right to provide products and services to a Major Account"
37,"AbbVie may terminate this Agreement in its entirety, or on a country or other jurisdiction -by-country or other jurisdiction basis, for any or no reason, upon ninety (90) days' prior written notice to Harpoon.","1. Norm type: Authorization
Subject: AbbVie
Object: This Agreement
Antecedent: None specified
Consequent: Termination of the Agreement

2. Norm type: Commitment
Subject: AbbVie
Object: Harpoon
Antecedent: None specified
Consequent: Providing ninety (90) days' prior written notice

3. Norm type: Prohibition
Subject: None specified
Object: AbbVie
Antecedent: None specified
Consequent: Not terminating the Agreement without providing ninety (90) days' prior written notice to Harpoon

Note: The sentence does not contain any clauses related to 'power' norm type.","Norm 1:
1. Norm type: Power
2. Subject: AbbVie
3. Object: Harpoon
4. Antecedent: None specified
5. Consequent: Termination of the Agreement

Norm 2:
1. Norm type: Commitment
2. Subject: AbbVie
3. Object: Harpoon
4. Antecedent: None specified
5. Consequent: Providing ninety (90) days' prior written notice before termination of the Agreement","NORM 1:
1. NORM type: POWER
2. SUBJECT: AbbVie
3. OBJECT: Harpoon
4. ANTECEDENT: None specified
5. CONSEQUENT: Termination of the Agreement

CLAUSE: AbbVie has the power to terminate the Agreement with Harpoon for any reason upon ninety (90) days' prior written notice.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: AbbVie
3. OBJECT: Harpoon
4. ANTECEDENT: None specified
5. CONSEQUENT: Termination of the Agreement

CLAUSE: AbbVie commits to providing ninety (90) days' prior written notice to Harpoon before terminating the Agreement.","NORM 1:
1. NORM type: POWER
2. SUBJECT: AbbVie
3. OBJECT: Harpoon
4. ANTECEDENT: AbbVie may terminate this Agreement in its entirety, or on a country or other jurisdiction-by-country or other jurisdiction basis
5. CONSEQUENT: Termination of the Agreement

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: AbbVie
3. OBJECT: Harpoon
4. ANTECEDENT: AbbVie providing ninety (90) days' prior written notice
5. CONSEQUENT: Termination of the Agreement","Norm 1:
1. Norm type: Power
2. Subject: AbbVie
3. Object: Harpoon
4. Antecedent: None specified
5. Consequent: Termination of the Agreement

Norm 2:
1. Norm type: Commitment
2. Subject: AbbVie
3. Object: Harpoon
4. Antecedent: AbbVie providing ninety (90) days' prior written notice
5. Consequent: Termination of the Agreement"
38,"Notwithstanding anything else in this Agreement, in the event of termination under this Paragraph 12.04 ExxonMobil may terminate any licenses granted to FCE under this Agreement that would otherwise survive termination, taking into account the circumstances surrounding the Change in Control.","Norm 1:
Norm type: Authorization
Subject: ExxonMobil
Object: FCE
Antecedent: Termination under Paragraph 12.04
Consequent: Termination of licenses granted to FCE under the Agreement that would otherwise survive termination

Norm 2:
Norm type: Commitment
Subject: ExxonMobil
Object: FCE
Antecedent: Change in Control
Consequent: Taking into account the circumstances surrounding the Change in Control

Note: The sentence does not contain any clauses related to power or prohibition norms.","Norm 1:
1. Norm type: Power
2. Subject: ExxonMobil
3. Object: FCE
4. Antecedent: Termination under Paragraph 12.04
5. Consequent: Termination of any licenses granted to FCE under the Agreement that would otherwise survive termination

Norm 2:
1. Norm type: Commitment
2. Subject: ExxonMobil
3. Object: FCE
4. Antecedent: Change in Control
5. Consequent: Termination of licenses granted to FCE under the Agreement, considering the circumstances surrounding the Change in Control.","NORM 1:
1. NORM type: POWER
2. SUBJECT: ExxonMobil
3. OBJECT: FCE
4. ANTECEDENT: Termination under Paragraph 12.04
5. CONSEQUENT: Termination of any licenses granted to FCE under the Agreement that would otherwise survive termination

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: FCE
3. OBJECT: ExxonMobil
4. ANTECEDENT: Change in Control
5. CONSEQUENT: Termination of any licenses granted to FCE under the Agreement that would otherwise survive termination","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: ExxonMobil
3. OBJECT: FCE
4. ANTECEDENT: Termination under Paragraph 12.04
5. CONSEQUENT: Termination of any licenses granted to FCE under the Agreement

NORM 2:
1. NORM type: POWER
2. SUBJECT: ExxonMobil
3. OBJECT: FCE
4. ANTECEDENT: Change in Control
5. CONSEQUENT: Termination of any licenses granted to FCE under the Agreement","Norm 1:
1. Norm type: Authorization
2. Subject: ExxonMobil
3. Object: FCE
4. Antecedent: Termination under Paragraph 12.04
5. Consequent: Termination of any licenses granted to FCE under the Agreement that would otherwise survive termination

Norm 2:
1. Norm type: Commitment
2. Subject: ExxonMobil
3. Object: FCE
4. Antecedent: Change in Control
5. Consequent: Termination of any licenses granted to FCE under the Agreement that would otherwise survive termination"
39,"If AbbVie [***] and does not subsequently exercise the License Option, then AbbVie shall [***].","Norm 1:
1. Norm type: Commitment
2. Subject: AbbVie
3. Object: N/A
4. Antecedent: AbbVie does not exercise the License Option
5. Consequent: AbbVie shall [***]

Norm 2:
1. Norm type: Authorization
2. Subject: AbbVie
3. Object: N/A
4. Antecedent: N/A
5. Consequent: AbbVie has the authority to exercise the License Option

Norm 3:
1. Norm type: Prohibition
2. Subject: N/A
3. Object: N/A
4. Antecedent: N/A
5. Consequent: N/A

Norm 4:
1. Norm type: Commitment
2. Subject: AbbVie
3. Object: N/A
4. Antecedent: N/A
5. Consequent: AbbVie shall [***]

Norm 5:
1. Norm type: Prohibition
2. Subject: N/A
3. Object: N/A
4. Antecedent: N/A
5. Consequent: N/A","Norm 1:
1. Norm type: Commitment
2. Subject: AbbVie
3. Object: [***]
4. Antecedent: AbbVie [***] and does not subsequently exercise the License Option
5. Consequent: AbbVie shall [***]

Norm 2:
1. Norm type: Power
2. Subject: AbbVie
3. Object: [***]
4. Antecedent: AbbVie [***] and does not subsequently exercise the License Option
5. Consequent: AbbVie shall [***]","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: AbbVie
3. OBJECT: [***]
4. ANTECEDENT: AbbVie [***]
5. CONSEQUENT: exercise the License Option

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: AbbVie
3. OBJECT: [***]
4. ANTECEDENT: AbbVie [***]
5. CONSEQUENT: [***]","1. NORM type: COMMITMENT
2. SUBJECT: AbbVie
3. OBJECT: License Option
4. ANTECEDENT: AbbVie receives the License Option
5. CONSEQUENT: AbbVie shall [***]","1. Norm type: commitment
2. Subject: AbbVie
3. Object: License Option
4. Antecedent: AbbVie [***] and does not subsequently exercise the License Option
5. Consequent: AbbVie shall [***]"
40,"In the event that this Agreement is terminated by PPI in accordance with Section 16.1 or EKR in accordance with Section 16.3(b), EKR and its Affiliates, sub-distributors and sub-licensees shall be entitled to continue to sell<omitted>existing stocks of the Product in the Territory for so long as PPI deems necessary to ensure that sale of the Product is not disrupted  provided that EKR and its Affiliates shall cease such sale immediately upon notification from PPI and in any event EKR shall not so sell for  a period of longer than three (3) months following the date of termination. Immediately upon notification from PPI, such post termination  sales shall cease.","Norm 1:
Norm type: Authorization
Subject: EKR and its Affiliates, sub-distributors and sub-licensees
Object: Existing stocks of the Product
Antecedent: Termination of the Agreement by PPI in accordance with Section 16.1 or EKR in accordance with Section 16.3(b)
Consequent: EKR and its Affiliates, sub-distributors and sub-licensees shall be entitled to continue to sell existing stocks of the Product in the Territory for so long as PPI deems necessary to ensure that sale of the Product is not disrupted.

Norm 2:
Norm type: Commitment
Subject: EKR and its Affiliates
Object: Sale of the Product
Antecedent: Termination of the Agreement by PPI in accordance with Section 16.1 or EKR in accordance with Section 16.3(b)
Consequent: EKR and its Affiliates shall cease such sale immediately upon notification from PPI and in any event EKR shall not so sell for a period of longer than three (3) months following the date of termination.

Norm 3:
Norm type: Prohibition
Subject: EKR and its Affiliates
Object: Sale of the Product
Antecedent: Notification from PPI
Consequent: Such post-termination sales shall cease immediately upon notification from PPI.","Norm 1:
1. Norm type: Commitment
2. Subject: EKR and its Affiliates, sub-distributors, and sub-licensees
3. Object: PPI
4. Antecedent: Termination of the Agreement by PPI in accordance with Section 16.1 or EKR in accordance with Section 16.3(b)
5. Consequent: Entitled to continue to sell existing stocks of the Product in the Territory for a period deemed necessary by PPI to ensure that sale of the Product is not disrupted

Clause: EKR and its Affiliates, sub-distributors, and sub-licensees commit to continuing to sell existing stocks of the Product in the Territory for a period deemed necessary by PPI to ensure that sale of the Product is not disrupted.

Norm 2:
1. Norm type: Prohibition
2. Subject: EKR and its Affiliates
3. Object: PPI
4. Antecedent: Notification from PPI
5. Consequent: Cease sale of the Product immediately and not sell for a period longer than three (3) months following the date of termination

Clause: EKR and its Affiliates are prohibited from selling the Product upon notification from PPI and must cease such sale immediately. Additionally, they are prohibited from selling the Product for a period longer than three (3) months following the date of termination.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: EKR and its Affiliates, sub-distributors, and sub-licensees
3. OBJECT: PPI
4. ANTECEDENT: Agreement termination by PPI in accordance with Section 16.1 or EKR in accordance with Section 16.3(b)
5. CONSEQUENT: Entitled to continue selling existing stocks of the Product in the Territory for a period deemed necessary by PPI to ensure the sale of the Product is not disrupted

CLAUSE: EKR and its Affiliates, sub-distributors, and sub-licensees are authorized to continue selling existing stocks of the Product in the Territory for a period deemed necessary by PPI to ensure the sale of the Product is not disrupted.

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: EKR and its Affiliates
3. OBJECT: PPI
4. ANTECEDENT: Notification from PPI
5. CONSEQUENT: Cease post-termination sales immediately and not sell for a period longer than three (3) months following the date of termination

CLAUSE: EKR and its Affiliates shall cease post-termination sales immediately upon notification from PPI and shall not sell for a period longer than three (3) months following the date of termination.","1. NORM type: AUTHORIZATION
2. SUBJECT: EKR and its Affiliates, sub-distributors, and sub-licensees
3. OBJECT: PPI
4. ANTECEDENT: Agreement termination by PPI in accordance with Section 16.1 or EKR in accordance with Section 16.3(b)
5. CONSEQUENT: Entitled to continue selling existing stocks of the Product in the Territory for a period deemed necessary by PPI to ensure the sale of the Product is not disrupted

6. NORM type: PROHIBITION
7. SUBJECT: EKR and its Affiliates
8. OBJECT: PPI
9. ANTECEDENT: Notification from PPI
10. CONSEQUENT: Cease sale of the Product immediately upon notification from PPI and not sell for a period longer than three (3) months following the date of termination.","1. Norm type: authorization, commitment
2. Subject: EKR and its Affiliates, sub-distributors, and sub-licensees
3. Object: PPI
4. Antecedent: Agreement termination by PPI in accordance with Section 16.1 or EKR in accordance with Section 16.3(b)
5. Consequent: Entitled to continue to sell existing stocks of the Product in the Territory for a specified period of time, but must cease immediately upon notification from PPI and not sell for longer than three (3) months following the date of termination."
41,"If RevMed wishes to exercise its one-time Co-Promotion Option, it shall so notify Sanofi in writing at least [***] prior to the anticipated launch of such Product in the Co-Promotion Territory.","Norm 1:
1. Norm type: Authorization
2. Subject: RevMed
3. Object: Sanofi
4. Antecedent: RevMed wishing to exercise its one-time Co-Promotion Option
5. Consequent: RevMed shall notify Sanofi in writing at least [***] prior to the anticipated launch of such Product in the Co-Promotion Territory.

Norm 2:
1. Norm type: Commitment
2. Subject: RevMed
3. Object: N/A
4. Antecedent: N/A
5. Consequent: RevMed commits to notifying Sanofi in writing at least [***] prior to the anticipated launch of such Product in the Co-Promotion Territory if it wishes to exercise its one-time Co-Promotion Option.

Norm 3:
1. Norm type: Commitment
2. Subject: Sanofi
3. Object: N/A
4. Antecedent: N/A
5. Consequent: Sanofi expects to be notified in writing by RevMed at least [***] prior to the anticipated launch of such Product in the Co-Promotion Territory if RevMed wishes to exercise its one-time Co-Promotion Option.

Norm 4:
1. Norm type: Prohibition
2. Subject: N/A
3. Object: N/A
4. Antecedent: N/A
5. Consequent: No notification from RevMed in writing at least [***] prior to the anticipated launch of such Product in the Co-Promotion Territory means RevMed cannot exercise its one-time Co-Promotion Option.

Note: The [***] represents a placeholder for a specific time period that is not mentioned in the given sentence.","Norm 1:
1. Norm type: Authorization
2. Subject: RevMed
3. Object: Sanofi
4. Antecedent: RevMed wishes to exercise its one-time Co-Promotion Option
5. Consequent: RevMed shall notify Sanofi in writing at least [***] prior to the anticipated launch of such Product in the Co-Promotion Territory.

Norm 2:
1. Norm type: Commitment
2. Subject: RevMed
3. Object: Sanofi
4. Antecedent: RevMed exercises its one-time Co-Promotion Option
5. Consequent: RevMed shall notify Sanofi in writing at least [***] prior to the anticipated launch of such Product in the Co-Promotion Territory.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: RevMed wishes to exercise its one-time Co-Promotion Option
5. CONSEQUENT: RevMed shall notify Sanofi in writing at least [***] prior to the anticipated launch of such Product in the Co-Promotion Territory.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: RevMed wishes to exercise its one-time Co-Promotion Option
5. CONSEQUENT: Sanofi shall allow RevMed to exercise the Co-Promotion Option if notified in writing at least [***] prior to the anticipated launch of such Product in the Co-Promotion Territory.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: RevMed wishes to exercise its one-time Co-Promotion Option
5. CONSEQUENT: RevMed shall notify Sanofi in writing at least [***] prior to the anticipated launch of such Product in the Co-Promotion Territory.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: RevMed notifies Sanofi in writing at least [***] prior to the anticipated launch of such Product in the Co-Promotion Territory
5. CONSEQUENT: Sanofi shall allow RevMed to exercise its one-time Co-Promotion Option.","1. Norm type: Authorization
2. Subject: RevMed
3. Object: Sanofi
4. Antecedent: RevMed wishes to exercise its one-time Co-Promotion Option
5. Consequent: RevMed shall notify Sanofi in writing at least [***] prior to the anticipated launch of such Product in the Co-Promotion Territory."
42,"The Owners may not enter into any shareholders' agreement, management agreement, voting trust or other arrangement that gives a third party the power to direct and control your affairs without our prior written consent.","Norm 1:
- Norm type: Prohibition
- Subject: The Owners
- Object: Third party
- Antecedent: N/A
- Consequent: The Owners may not enter into any shareholders' agreement, management agreement, voting trust or other arrangement that gives a third party the power to direct and control your affairs without our prior written consent.

Norm 2:
- Norm type: Authorization
- Subject: The Owners
- Object: N/A
- Antecedent: N/A
- Consequent: The Owners have the authority to enter into any shareholders' agreement, management agreement, voting trust or other arrangement that gives a third party the power to direct and control your affairs with our prior written consent.

Norm 3:
- Norm type: Commitment
- Subject: The party giving the consent (not specified in the sentence)
- Object: The Owners
- Antecedent: N/A
- Consequent: The party giving the consent commits to providing prior written consent for the Owners to enter into any shareholders' agreement, management agreement, voting trust or other arrangement that gives a third party the power to direct and control their affairs.

Norm 4:
- Norm type: Prohibition
- Subject: The party giving the consent (not specified in the sentence)
- Object: N/A
- Antecedent: N/A
- Consequent: The party giving the consent prohibits the Owners from entering into any shareholders' agreement, management agreement, voting trust or other arrangement that gives a third party the power to direct and control their affairs without prior written consent.

Norm 5:
- Norm type: Prohibition
- Subject: The party giving the consent (not specified in the sentence)
- Object: The Owners
- Antecedent: N/A
- Consequent: The party giving the consent prohibits the Owners from entering into any shareholders' agreement, management agreement, voting trust or other arrangement that gives a third party the power to direct and control their affairs without prior written consent.","Norm 1:
1. Norm type: Prohibition
2. Subject: The Owners
3. Object: Third party
4. Antecedent: Entering into any shareholders' agreement, management agreement, voting trust, or other arrangement
5. Consequent: Giving the third party the power to direct and control the Owners' affairs

Norm 2:
1. Norm type: Power
2. Subject: Third party
3. Object: The Owners
4. Antecedent: The Owners entering into any shareholders' agreement, management agreement, voting trust, or other arrangement
5. Consequent: Directing and controlling the Owners' affairs

Norm 3:
1. Norm type: Authorization
2. Subject: The Owners
3. Object: The other party (not specified in the sentence)
4. Antecedent: The Owners obtaining prior written consent
5. Consequent: Entering into any shareholders' agreement, management agreement, voting trust, or other arrangement","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: The Owners
3. OBJECT: Third party
4. ANTECEDENT: The Owners entering into any shareholders' agreement, management agreement, voting trust, or other arrangement
5. CONSEQUENT: Giving the third party the power to direct and control the affairs of the Owners

NORM 2:
1. NORM type: POWER
2. SUBJECT: Third party
3. OBJECT: The Owners
4. ANTECEDENT: The Owners entering into any shareholders' agreement, management agreement, voting trust, or other arrangement
5. CONSEQUENT: Directing and controlling the affairs of the Owners

CLAUSES:
- The Owners may not enter into any shareholders' agreement, management agreement, voting trust, or other arrangement
- That gives a third party the power to direct and control your affairs
- Without our prior written consent.","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: The Owners
3. OBJECT: Third party
4. ANTECEDENT: The Owners entering into any shareholders' agreement, management agreement, voting trust, or other arrangement
5. CONSEQUENT: Third party having the power to direct and control the affairs without prior written consent

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Third party
3. OBJECT: The Owners
4. ANTECEDENT: The Owners obtaining prior written consent
5. CONSEQUENT: Third party having the power to direct and control the affairs","Norm 1:
1. Norm type: Prohibition
2. Subject: The Owners
3. Object: Third party
4. Antecedent: Entering into any shareholders' agreement, management agreement, voting trust, or other arrangement
5. Consequent: Giving the third party the power to direct and control the affairs of the party

Norm 2:
1. Norm type: Authorization
2. Subject: Third party
3. Object: The Owners
4. Antecedent: Obtaining prior written consent
5. Consequent: Directing and controlling the affairs of the party"
43,"Upon the termination of this Agreement for any reason, subject to and without limiting the provisions of Section 12: (i) the Parties shall implement the Transition-Out Services pursuant to Section 10(f); (ii) at the end of the Transition-out Period (or earlier upon CHT's request) Ehave shall terminate and invalidate any Authentication IDs associated with CHT and any of its End Users; (iii) Ehave shall, but not earlier than twenty (20) Business Days after the later of termination or expiration of this Agreement or the Transition-out Period, destroy any copies of the End User Data contained in the Ehave Companion Solution and certify in writing to CHT that it has done so; (iv) CHT shall pay to Ehave the full amount of all Royalties payable hereunder as of the date of termination, if any, whether already invoiced or not (including any amounts due as late payment charges), and any other monies owing to Ehave hereunder; and (v) each Party will return to the other Party, or at the other Party's written request, destroy, in a secure manner all Confidential Information of the other Party which is then in its possession or control and certify in writing that it has done so.","Norm 1:
Norm type: Commitment
Subject: Parties
Object: Transition-Out Services
Antecedent: Termination of this Agreement for any reason
Consequent: Implementation of Transition-Out Services pursuant to Section 10(f)

Norm 2:
Norm type: Prohibition
Subject: Ehave
Object: Authentication IDs associated with CHT and any of its End Users
Antecedent: End of the Transition-out Period or CHT's request
Consequent: Termination and invalidation of any Authentication IDs associated with CHT and any of its End Users

Norm 3:
Norm type: Commitment
Subject: Ehave
Object: End User Data contained in the Ehave Companion Solution
Antecedent: Later of termination or expiration of this Agreement or the Transition-out Period (not earlier than twenty (20) Business Days)
Consequent: Destruction of any copies of the End User Data contained in the Ehave Companion Solution and certification in writing to CHT

Norm 4:
Norm type: Commitment
Subject: CHT
Object: Ehave
Antecedent: Termination of this Agreement
Consequent: Payment of the full amount of all Royalties payable hereunder as of the date of termination, if any, whether already invoiced or not (including any amounts due as late payment charges), and any other monies owing to Ehave hereunder

Norm 5:
Norm type: Commitment
Subject: Each Party
Object: Other Party
Antecedent: None
Consequent: Return or destruction, in a secure manner, of all Confidential Information of the other Party which is then in its possession or control and certification in writing that it has done so.","1. Norm type: Commitment
   Subject: Ehave
   Object: CHT
   Antecedent: Termination of the Agreement for any reason
   Consequent: Implementation of Transition-Out Services, termination of Authentication IDs, destruction of End User Data, payment of Royalties, return or destruction of Confidential Information

2. Norm type: Authorization
   Subject: Ehave
   Object: CHT
   Antecedent: End of the Transition-out Period or CHT's request
   Consequent: Termination and invalidation of Authentication IDs associated with CHT and its End Users

3. Norm type: Commitment
   Subject: Ehave
   Object: CHT
   Antecedent: Twenty (20) Business Days after termination or expiration of the Agreement or the Transition-out Period
   Consequent: Destruction of copies of End User Data contained in the Ehave Companion Solution and certification of destruction to CHT

4. Norm type: Commitment
   Subject: CHT
   Object: Ehave
   Antecedent: Termination of the Agreement
   Consequent: Payment of all Royalties payable, including late payment charges, and any other monies owing to Ehave

5. Norm type: Commitment
   Subject: Both Parties
   Object: Each other
   Antecedent: Termination of the Agreement
   Consequent: Return or destruction of all Confidential Information of the other Party in a secure manner and certification of destruction","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Parties
3. OBJECT: Transition-Out Services
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Implementation of Transition-Out Services

CLAUSE: ""the Parties shall implement the Transition-Out Services pursuant to Section 10(f)""

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Ehave
3. OBJECT: Authentication IDs associated with CHT and its End Users
4. ANTECEDENT: End of Transition-out Period or CHT's request
5. CONSEQUENT: Terminate and invalidate any Authentication IDs associated with CHT and its End Users

CLAUSE: ""Ehave shall terminate and invalidate any Authentication IDs associated with CHT and any of its End Users""

NORM 3:
1. NORM type: COMMITMENT
2. SUBJECT: Ehave
3. OBJECT: End User Data contained in the Ehave Companion Solution
4. ANTECEDENT: Twenty (20) Business Days after termination or expiration of the Agreement or Transition-out Period
5. CONSEQUENT: Destroy any copies of the End User Data and certify in writing to CHT

CLAUSE: ""Ehave shall, but not earlier than twenty (20) Business Days after the later of termination or expiration of this Agreement or the Transition-out Period, destroy any copies of the End User Data contained in the Ehave Companion Solution and certify in writing to CHT that it has done so""

NORM 4:
1. NORM type: COMMITMENT
2. SUBJECT: CHT
3. OBJECT: Ehave
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Pay all Royalties payable and any other monies owing to Ehave

CLAUSE: ""CHT shall pay to Ehave the full amount of all Royalties payable hereunder as of the date of termination, if any, whether already invoiced or not (including any amounts due as late payment charges), and any other monies owing to Ehave hereunder""

NORM 5:
1. NORM type: COMMITMENT
2. SUBJECT: Each Party
3. OBJECT: Other Party
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Return or destroy all Confidential Information of the other Party in a secure manner and certify in writing

CLAUSE: ""each Party will return to the other Party, or at the other Party's written request, destroy, in a secure manner all Confidential Information of the other Party which is then in its possession or control and certify in writing that it has done so""","1. NORM type: 
- COMMITMENT: Ehave commits to implementing Transition-Out Services and destroying End User Data.
- PROHIBITION: Ehave is prohibited from retaining any copies of End User Data.
- COMMITMENT: CHT commits to paying all Royalties and other monies owing to Ehave.
- PROHIBITION: Each Party is prohibited from retaining or using the other Party's Confidential Information.

2. SUBJECT:
- Ehave
- Ehave
- CHT
- Each Party

3. OBJECT:
- Parties
- Ehave
- Ehave
- Each Party

4. ANTECEDENT:
- Termination of the Agreement
- End of the Transition-out Period
- Twenty (20) Business Days after termination or expiration of the Agreement or Transition-out Period
- Possession or control of Confidential Information

5. CONSEQUENT:
- Implementation of Transition-Out Services and termination of Authentication IDs
- Termination and invalidation of Authentication IDs
- Destruction of End User Data
- Payment of all Royalties and other monies owing
- Return or destruction of Confidential Information","1. Norm type: commitment
   Subject: Parties
   Object: Transition-Out Services
   Antecedent: Termination of the Agreement
   Consequent: Implementation of Transition-Out Services

2. Norm type: prohibition
   Subject: Ehave
   Object: CHT and its End Users
   Antecedent: Termination of the Agreement or Transition-out Period
   Consequent: Termination and invalidation of Authentication IDs associated with CHT and its End Users

3. Norm type: commitment
   Subject: Ehave
   Object: CHT
   Antecedent: Termination or expiration of the Agreement or Transition-out Period
   Consequent: Destruction of copies of End User Data and certification to CHT

4. Norm type: commitment
   Subject: CHT
   Object: Ehave
   Antecedent: Termination of the Agreement
   Consequent: Payment of all Royalties and other monies owing to Ehave

5. Norm type: commitment
   Subject: Each Party
   Object: Other Party
   Antecedent: Termination of the Agreement
   Consequent: Return or destruction of Confidential Information and certification of the same"
44,"In the case of a termination of this Agreement, Sanofi (with respect to the Termination Products in the Licensed Territory), shall be entitled, for a period of [***] after termination, to (i) complete Manufacture of work-in-progress, and (ii) continue conducting Commercialization activities being conducted by Sanofi hereunder as of such termination (if applicable, with respect to the terminated country(ies)), to the extent related to Termination Product in Sanofi's inventory as of such termination (or added to such inventory as a result of the completion described in clause (i)), provided that Sanofi fulfills its payment obligations under this Agreement in connection with such inventory sell-off, provided further that the payment of royalties to RevMed and the sharing of Net Profits and Net Losses under the Profit/Loss Share Agreement shall continue to apply during the sell-off period.","Norm 1:
Norm type: Authorization
Subject: Sanofi
Object: Termination Products in the Licensed Territory
Antecedent: Termination of this Agreement
Consequent: Sanofi shall be entitled to complete Manufacture of work-in-progress and continue conducting Commercialization activities related to Termination Product in Sanofi's inventory as of termination.

Norm 2:
Norm type: Commitment
Subject: Sanofi
Object: RevMed
Antecedent: None mentioned
Consequent: Sanofi shall fulfill its payment obligations under this Agreement in connection with the inventory sell-off.

Norm 3:
Norm type: Commitment
Subject: Sanofi
Object: None mentioned
Antecedent: None mentioned
Consequent: Sanofi shall continue to pay royalties to RevMed during the sell-off period.

Norm 4:
Norm type: Commitment
Subject: Sanofi
Object: None mentioned
Antecedent: None mentioned
Consequent: Sanofi shall continue to share Net Profits and Net Losses under the Profit/Loss Share Agreement during the sell-off period.

Norm 5:
Norm type: Commitment
Subject: None mentioned
Object: None mentioned
Antecedent: None mentioned
Consequent: The sharing of Net Profits and Net Losses under the Profit/Loss Share Agreement shall continue to apply during the sell-off period.","Norm 1:
1. Norm type: Commitment
2. Subject: Sanofi
3. Object: Termination Products in the Licensed Territory
4. Antecedent: Termination of the Agreement
5. Consequent: Sanofi shall be entitled, for a period of [***] after termination, to (i) complete Manufacture of work-in-progress, and (ii) continue conducting Commercialization activities being conducted by Sanofi hereunder as of such termination (if applicable, with respect to the terminated country(ies)), to the extent related to Termination Product in Sanofi's inventory as of such termination (or added to such inventory as a result of the completion described in clause (i)), provided that Sanofi fulfills its payment obligations under this Agreement in connection with such inventory sell-off, provided further that the payment of royalties to RevMed and the sharing of Net Profits and Net Losses under the Profit/Loss Share Agreement shall continue to apply during the sell-off period.

Norm 2:
1. Norm type: Authorization
2. Subject: Sanofi
3. Object: Termination Products in the Licensed Territory
4. Antecedent: Termination of the Agreement
5. Consequent: Sanofi shall be entitled, for a period of [***] after termination, to (i) complete Manufacture of work-in-progress, and (ii) continue conducting Commercialization activities being conducted by Sanofi hereunder as of such termination (if applicable, with respect to the terminated country(ies)), to the extent related to Termination Product in Sanofi's inventory as of such termination (or added to such inventory as a result of the completion described in clause (i)), provided that Sanofi fulfills its payment obligations under this Agreement in connection with such inventory sell-off, provided further that the payment of royalties to RevMed and the sharing of Net Profits and Net Losses under the Profit/Loss Share Agreement shall continue to apply during the sell-off period.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Sanofi
3. OBJECT: Termination Products in the Licensed Territory
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Sanofi shall be entitled to complete Manufacture of work-in-progress and continue conducting Commercialization activities related to Termination Product in Sanofi's inventory as of termination.

CLAUSE: Sanofi is authorized to complete Manufacture of work-in-progress and continue conducting Commercialization activities related to Termination Product in Sanofi's inventory as of termination.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: Payment obligations under the Agreement
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Sanofi shall fulfill its payment obligations under the Agreement in connection with the inventory sell-off.

CLAUSE: Sanofi commits to fulfilling its payment obligations under the Agreement in connection with the inventory sell-off.

NORM 3:
1. NORM type: AUTHORIZATION
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Payment of royalties to RevMed and sharing of Net Profits and Net Losses under the Profit/Loss Share Agreement shall continue during the sell-off period.

CLAUSE: Sanofi is authorized to continue the payment of royalties to RevMed and sharing of Net Profits and Net Losses under the Profit/Loss Share Agreement during the sell-off period.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Sanofi
3. OBJECT: Termination Products in the Licensed Territory
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Sanofi shall be entitled to complete Manufacture of work-in-progress and continue conducting Commercialization activities related to Termination Product in Sanofi's inventory after termination.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Sanofi shall fulfill its payment obligations under the Agreement in connection with the inventory sell-off, including the payment of royalties to RevMed and sharing of Net Profits and Net Losses under the Profit/Loss Share Agreement.","1. Norm type: authorization
2. Subject: Sanofi
3. Object: Termination Products in the Licensed Territory
4. Antecedent: Termination of the Agreement
5. Consequent: Sanofi shall be entitled to complete Manufacture of work-in-progress and continue conducting Commercialization activities related to Termination Product in Sanofi's inventory as of termination."
45,"This Agreement can be terminated at any time prior to the expiry of the Term, as follows: (a) by the Consultant electing to give the Company not less than 3 months prior notice of such termination;

(b) by the Company electing to give the Consultant 3 months prior notice of such termination along with a termination payment equal to the annual Consulting Fee;","1. Norm type: Authorization
Subject: Consultant
Object: Company
Antecedent: None mentioned
Consequent: Termination of the Agreement

2. Norm type: Commitment
Subject: Consultant
Object: Company
Antecedent: None mentioned
Consequent: Giving the Company not less than 3 months prior notice of termination

3. Norm type: Authorization
Subject: Company
Object: Consultant
Antecedent: None mentioned
Consequent: Termination of the Agreement

4. Norm type: Commitment
Subject: Company
Object: Consultant
Antecedent: None mentioned
Consequent: Giving the Consultant 3 months prior notice of termination along with a termination payment equal to the annual Consulting Fee

Note: The sentence does not contain any norms of 'power' or 'prohibition' type.","Norm 1:
1. Norm type: Power
2. Subject: Company
3. Object: Consultant
4. Antecedent: Termination of the Agreement at any time prior to the expiry of the Term
5. Consequent: Company has the power to terminate the Agreement by giving the Consultant 3 months prior notice along with a termination payment equal to the annual Consulting Fee.

Norm 2:
1. Norm type: Commitment
2. Subject: Consultant
3. Object: Company
4. Antecedent: Termination of the Agreement at any time prior to the expiry of the Term
5. Consequent: Consultant commits to terminate the Agreement by giving the Company not less than 3 months prior notice of such termination.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Consultant
3. OBJECT: Company
4. ANTECEDENT: Consultant electing to give the Company not less than 3 months prior notice of termination
5. CONSEQUENT: Agreement termination

CLAUSE: The Consultant commits to giving the Company not less than 3 months prior notice of termination.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Company
3. OBJECT: Consultant
4. ANTECEDENT: Company electing to give the Consultant 3 months prior notice of termination along with a termination payment equal to the annual Consulting Fee
5. CONSEQUENT: Agreement termination along with a termination payment

CLAUSE: The Company commits to giving the Consultant 3 months prior notice of termination along with a termination payment equal to the annual Consulting Fee.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Consultant
3. OBJECT: Company
4. ANTECEDENT: Consultant electing to give the Company not less than 3 months prior notice of termination
5. CONSEQUENT: Agreement termination

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Company
3. OBJECT: Consultant
4. ANTECEDENT: Company electing to give the Consultant 3 months prior notice of termination along with a termination payment equal to the annual Consulting Fee
5. CONSEQUENT: Agreement termination","Norm 1:
1. Norm type: commitment
2. Subject: Consultant
3. Object: Company
4. Antecedent: Consultant electing to give the Company not less than 3 months prior notice of termination
5. Consequent: Agreement termination

Norm 2:
1. Norm type: commitment
2. Subject: Company
3. Object: Consultant
4. Antecedent: Company electing to give the Consultant 3 months prior notice of termination along with a termination payment equal to the annual Consulting Fee
5. Consequent: Agreement termination"
46,"This Agreement may be terminated subject to the following clauses:<omitted>Subject to Section 1.6, by Vendor (or successor to Vendor), upon written notice to Distributor of a change of control of Vendor and the election by Vendor (or successor to Vendor) to terminate this Agreement, where a ""change of control"" shall mean a change in ownership of the Vendor such that an unaffiliated third party acquires a majority of the voting power of Vendor;","Norm 1:
Norm type: Authorization
Subject: Vendor (or successor to Vendor)
Object: Distributor
Antecedent: Change of control of Vendor and the election by Vendor (or successor to Vendor) to terminate this Agreement
Consequent: Termination of this Agreement

Norm 2:
Norm type: Commitment
Subject: Vendor (or successor to Vendor)
Object: Distributor
Antecedent: Change of control of Vendor
Consequent: Termination of this Agreement

Norm 3:
Norm type: Commitment
Subject: Vendor (or successor to Vendor)
Object: Distributor
Antecedent: Election by Vendor (or successor to Vendor) to terminate this Agreement
Consequent: Termination of this Agreement

Norm 4:
Norm type: Commitment
Subject: Vendor (or successor to Vendor)
Object: Distributor
Antecedent: Change in ownership of the Vendor such that an unaffiliated third party acquires a majority of the voting power of Vendor
Consequent: Change of control of Vendor

Norm 5:
Norm type: Prohibition
Subject: Unaffiliated third party
Object: Vendor
Antecedent: Change in ownership of the Vendor such that an unaffiliated third party acquires a majority of the voting power of Vendor
Consequent: None specified in the given sentence","Norm 1:
1. Norm type: Commitment
2. Subject: Vendor (or successor to Vendor)
3. Object: Distributor
4. Antecedent: Change of control of Vendor
5. Consequent: Termination of the Agreement

Norm 2:
1. Norm type: Authorization
2. Subject: Vendor (or successor to Vendor)
3. Object: Vendor
4. Antecedent: Change of control of Vendor
5. Consequent: Termination of the Agreement

Norm 3:
1. Norm type: Power
2. Subject: Vendor (or successor to Vendor)
3. Object: Vendor
4. Antecedent: Change of control of Vendor
5. Consequent: Termination of the Agreement","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Vendor (or successor to Vendor)
3. OBJECT: Distributor
4. ANTECEDENT: Change of control of Vendor
5. CONSEQUENT: Termination of the Agreement

CLAUSE: Vendor (or successor to Vendor) commits to Distributor to terminate the Agreement upon written notice of a change of control of Vendor.

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Vendor (or successor to Vendor)
3. OBJECT: Distributor
4. ANTECEDENT: Change of control of Vendor
5. CONSEQUENT: Termination of the Agreement

CLAUSE: Vendor (or successor to Vendor) is forbidden by Distributor from bringing about the termination of the Agreement in the absence of a change of control of Vendor.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Vendor (or successor to Vendor)
3. OBJECT: Distributor
4. ANTECEDENT: Change of control of Vendor
5. CONSEQUENT: Termination of the Agreement

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Vendor (or successor to Vendor)
3. OBJECT: Vendor
4. ANTECEDENT: Change of control of Vendor
5. CONSEQUENT: Termination of the Agreement","1. Norm type: commitment
2. Subject: Vendor (or successor to Vendor)
3. Object: Distributor
4. Antecedent: change of control of Vendor
5. Consequent: termination of the Agreement

2. Norm type: authorization
3. Subject: Vendor (or successor to Vendor)
4. Antecedent: change of control of Vendor
5. Consequent: termination of the Agreement"
47,"The Monthly Compensation shall be paid for the remaining monthly periods remaining in the Term, as if the termination of this Agreement had not occurred, or twenty four (24) calendar months, which ever period is less, where payment shall be made no later than thirty (30) calendar days after the end of the relevant monthly period.","1. Norm type: Commitment
   Subject: The party making the commitment - The party responsible for paying the Monthly Compensation
   Object: The party affected by the outcome - The party entitled to receive the Monthly Compensation
   Antecedent: None specified
   Consequent: The Monthly Compensation shall be paid for the remaining monthly periods remaining in the Term, as if the termination of this Agreement had not occurred, or twenty four (24) calendar months, whichever period is less.

2. Norm type: Commitment
   Subject: The party making the commitment - The party responsible for paying the Monthly Compensation
   Object: The party affected by the outcome - The party entitled to receive the Monthly Compensation
   Antecedent: None specified
   Consequent: Payment shall be made no later than thirty (30) calendar days after the end of the relevant monthly period.","Norm 1:
1. Norm type: Commitment
2. Subject: The party responsible for making the Monthly Compensation payment
3. Object: The party entitled to receive the Monthly Compensation
4. Antecedent: The termination of the Agreement
5. Consequent: Payment of the Monthly Compensation for the remaining monthly periods in the Term, as if the termination had not occurred, or for twenty-four (24) calendar months, whichever is less, with payment to be made no later than thirty (30) calendar days after the end of the relevant monthly period.

Norm 2:
1. Norm type: Authorization
2. Subject: The party responsible for making the Monthly Compensation payment
3. Object: The party entitled to receive the Monthly Compensation
4. Antecedent: The termination of the Agreement
5. Consequent: Payment of the Monthly Compensation for the remaining monthly periods in the Term, as if the termination had not occurred, or for twenty-four (24) calendar months, whichever is less, with payment to be made no later than thirty (30) calendar days after the end of the relevant monthly period.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Party responsible for paying the Monthly Compensation
3. OBJECT: Party entitled to receive the Monthly Compensation
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Monthly Compensation shall be paid for the remaining monthly periods remaining in the Term, as if the termination of the Agreement had not occurred, or twenty four (24) calendar months, whichever period is less

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Party responsible for paying the Monthly Compensation
3. OBJECT: Party entitled to receive the Monthly Compensation
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Payment shall be made no later than thirty (30) calendar days after the end of the relevant monthly period.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Party responsible for paying the Monthly Compensation
3. OBJECT: Party entitled to receive the Monthly Compensation
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Monthly Compensation shall be paid for the remaining monthly periods remaining in the Term, as if the termination of the Agreement had not occurred, or twenty four (24) calendar months, whichever period is less.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Party responsible for paying the Monthly Compensation
3. OBJECT: Party entitled to receive the Monthly Compensation
4. ANTECEDENT: End of the relevant monthly period
5. CONSEQUENT: Payment shall be made no later than thirty (30) calendar days after the end of the relevant monthly period.","Norm 1:
1. Norm type: Commitment
2. Subject: Party responsible for paying the Monthly Compensation
3. Object: Party entitled to receive the Monthly Compensation
4. Antecedent: Termination of the Agreement
5. Consequent: Monthly Compensation shall be paid for the remaining monthly periods remaining in the Term, as if the termination of the Agreement had not occurred, or for twenty-four (24) calendar months, whichever period is less.

Norm 2:
1. Norm type: Commitment
2. Subject: Party responsible for paying the Monthly Compensation
3. Object: Party entitled to receive the Monthly Compensation
4. Antecedent: End of the relevant monthly period
5. Consequent: Payment shall be made no later than thirty (30) calendar days after the end of the relevant monthly period."
48,"At any time after July 1, 2015, PPI shall have the right, exercisable upon sixty (60) days prior written notice to EKR, to terminate the Lease Term and repurchase the Transferred Equipment from EKR, subject to payment by PPI to EKR within five (5) days of such  notice of any principal paid by EKR under the Promissory Note, which if exercised shall result in the termination of the Step-in Right  set forth in Section 17.5.","1. Norm type: Authorization
Subject: PPI
Object: EKR
Antecedent: None mentioned
Consequent: PPI has the right to terminate the Lease Term and repurchase the Transferred Equipment from EKR, subject to payment by PPI to EKR within five (5) days of such notice of any principal paid by EKR under the Promissory Note.

2. Norm type: Commitment
Subject: PPI
Object: None mentioned
Antecedent: None mentioned
Consequent: PPI commits to terminating the Step-in Right set forth in Section 17.5 if the right to terminate the Lease Term and repurchase the Transferred Equipment is exercised.

3. Norm type: Commitment
Subject: EKR
Object: None mentioned
Antecedent: None mentioned
Consequent: EKR commits to allowing PPI to terminate the Lease Term and repurchase the Transferred Equipment upon receiving the required payment within five (5) days of notice.

4. Norm type: Commitment
Subject: PPI
Object: None mentioned
Antecedent: None mentioned
Consequent: PPI commits to making the required payment to EKR within five (5) days of notice.

5. Norm type: Authorization
Subject: EKR
Object: None mentioned
Antecedent: None mentioned
Consequent: EKR has the right to exercise the Step-in Right set forth in Section 17.5 unless PPI exercises its right to terminate the Lease Term and repurchase the Transferred Equipment.","Norm 1:
1. Norm type: Power
2. Subject: PPI
3. Object: EKR
4. Antecedent: After July 1, 2015
5. Consequent: PPI shall have the right to terminate the Lease Term and repurchase the Transferred Equipment from EKR

Clause: PPI shall have the right, exercisable upon sixty (60) days prior written notice to EKR, to terminate the Lease Term and repurchase the Transferred Equipment from EKR.

Norm 2:
1. Norm type: Commitment
2. Subject: PPI
3. Object: EKR
4. Antecedent: Exercise of the power to terminate the Lease Term and repurchase the Transferred Equipment
5. Consequent: Payment by PPI to EKR within five (5) days of such notice of any principal paid by EKR under the Promissory Note

Clause: Subject to payment by PPI to EKR within five (5) days of such notice of any principal paid by EKR under the Promissory Note.

Norm 3:
1. Norm type: Power
2. Subject: PPI
3. Object: EKR
4. Antecedent: Exercise of the power to terminate the Lease Term and repurchase the Transferred Equipment
5. Consequent: Termination of the Step-in Right set forth in Section 17.5

Clause: If exercised, shall result in the termination of the Step-in Right set forth in Section 17.5.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: PPI
3. OBJECT: EKR
4. ANTECEDENT: At any time after July 1, 2015
5. CONSEQUENT: PPI shall have the right to terminate the Lease Term and repurchase the Transferred Equipment from EKR

CLAUSE: PPI shall have the right, exercisable upon sixty (60) days prior written notice to EKR, to terminate the Lease Term and repurchase the Transferred Equipment from EKR, subject to payment by PPI to EKR within five (5) days of such notice of any principal paid by EKR under the Promissory Note.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: PPI
3. OBJECT: EKR
4. ANTECEDENT: If exercised
5. CONSEQUENT: Termination of the Step-in Right set forth in Section 17.5

CLAUSE: If exercised, PPI commits to terminate the Step-in Right set forth in Section 17.5.","1. NORM type: POWER
2. SUBJECT: PPI
3. OBJECT: EKR
4. ANTECEDENT: Exercisable upon sixty (60) days prior written notice to EKR
5. CONSEQUENT: Termination of the Lease Term and repurchase of the Transferred Equipment from EKR, subject to payment by PPI within five (5) days of such notice of any principal paid by EKR under the Promissory Note.","Norm 1:
1. Norm type: Authorization
2. Subject: PPI
3. Object: EKR
4. Antecedent: Exercisable upon sixty (60) days prior written notice to EKR
5. Consequent: Terminate the Lease Term and repurchase the Transferred Equipment from EKR

Norm 2:
1. Norm type: Commitment
2. Subject: PPI
3. Object: EKR
4. Antecedent: Payment by PPI to EKR within five (5) days of such notice of any principal paid by EKR under the Promissory Note
5. Consequent: Termination of the Step-in Right set forth in Section 17.5."
49,"In such event, the provisions of this Agreement that survive during the Wind Down Period will continue to survive for the remainder of the period of time that DIALOG is authorized to Sell Licensed Products to any customer in accordance with the foregoing sentence.","Norm 1:
1. Norm type: Authorization
2. Subject: DIALOG
3. Object: Any customer
4. Antecedent: The Wind Down Period
5. Consequent: The provisions of this Agreement that survive during the Wind Down Period will continue to survive for the remainder of the period of time that DIALOG is authorized to Sell Licensed Products to any customer.

Norm 2:
1. Norm type: Commitment
2. Subject: DIALOG
3. Object: Any customer
4. Antecedent: None mentioned explicitly
5. Consequent: DIALOG is committed to selling Licensed Products to any customer during the authorized period of time.

Norm 3:
1. Norm type: Authorization
2. Subject: DIALOG
3. Object: None mentioned explicitly
4. Antecedent: None mentioned explicitly
5. Consequent: DIALOG is authorized to Sell Licensed Products to any customer in accordance with the foregoing sentence.

Norm 4:
1. Norm type: Commitment
2. Subject: None mentioned explicitly
3. Object: The provisions of this Agreement
4. Antecedent: The Wind Down Period
5. Consequent: The provisions of this Agreement that survive during the Wind Down Period will continue to survive.

Norm 5:
1. Norm type: Commitment
2. Subject: None mentioned explicitly
3. Object: The provisions of this Agreement
4. Antecedent: None mentioned explicitly
5. Consequent: The provisions of this Agreement that survive during the Wind Down Period will continue to survive for the remainder of the period of time that DIALOG is authorized to Sell Licensed Products to any customer.","Norm 1:
1. Norm type: Authorization
2. Subject: DIALOG
3. Object: Creditor (party benefiting from the norm)
4. Antecedent: Wind Down Period
5. Consequent: Provisions of the Agreement surviving during the Wind Down Period will continue to survive for the remainder of the period of time that DIALOG is authorized to Sell Licensed Products to any customer in accordance with the foregoing sentence.

Norm 2:
1. Norm type: Commitment
2. Subject: DIALOG
3. Object: Creditor (party benefiting from the norm)
4. Antecedent: Provisions of the Agreement surviving during the Wind Down Period
5. Consequent: Will continue to survive for the remainder of the period of time that DIALOG is authorized to Sell Licensed Products to any customer in accordance with the foregoing sentence.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: DIALOG
3. OBJECT: Sell Licensed Products
4. ANTECEDENT: DIALOG is authorized to Sell Licensed Products to any customer
5. CONSEQUENT: Provisions of the Agreement that survive during the Wind Down Period will continue to survive for the remainder of the period of time

NORM 2:
1. NORM type: POWER
2. SUBJECT: DIALOG
3. OBJECT: N/A
4. ANTECEDENT: DIALOG is authorized to Sell Licensed Products to any customer
5. CONSEQUENT: Provisions of the Agreement that survive during the Wind Down Period will continue to survive for the remainder of the period of time","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: DIALOG
3. OBJECT: Sell Licensed Products
4. ANTECEDENT: DIALOG is authorized to Sell Licensed Products to any customer
5. CONSEQUENT: Provisions of the Agreement that survive during the Wind Down Period will continue to survive for the remainder of the period of time

NORM 2:
1. NORM type: POWER
2. SUBJECT: DIALOG
3. OBJECT: N/A
4. ANTECEDENT: DIALOG is authorized to Sell Licensed Products to any customer
5. CONSEQUENT: DIALOG is empowered to continue the provisions of the Agreement that survive during the Wind Down Period for the remainder of the period of time, even if it causes a change in existing NORMS.","1. Norm type: authorization
2. Subject: DIALOG
3. Object: Sell Licensed Products
4. Antecedent: DIALOG is authorized to Sell Licensed Products to any customer
5. Consequent: the provisions of the Agreement that survive during the Wind Down Period will continue to survive for the remainder of the period of time that DIALOG is authorized to Sell Licensed Products"
50,"Subject to the terms and conditions of this Agreement, RevMed hereby grants to Sanofi an exclusive option, under the Patent Rights and Know-How claiming or embodied in the [***].","Norm 1:
1. Norm type: Authorization
2. Subject: RevMed
3. Object: Sanofi
4. Antecedent: Terms and conditions of this Agreement
5. Consequent: Granting an exclusive option to Sanofi under the Patent Rights and Know-How claiming or embodied in the [***].

Norm 2:
1. Norm type: Commitment
2. Subject: RevMed
3. Object: N/A
4. Antecedent: N/A
5. Consequent: RevMed commits to granting an exclusive option to Sanofi under the Patent Rights and Know-How claiming or embodied in the [***].

Norm 3:
1. Norm type: Commitment
2. Subject: Sanofi
3. Object: N/A
4. Antecedent: N/A
5. Consequent: Sanofi commits to exercising the exclusive option granted by RevMed under the Patent Rights and Know-How claiming or embodied in the [***].

Norm 4:
1. Norm type: Authorization
2. Subject: Sanofi
3. Object: N/A
4. Antecedent: N/A
5. Consequent: Sanofi is authorized to exercise the exclusive option granted by RevMed under the Patent Rights and Know-How claiming or embodied in the [***].

Norm 5:
1. Norm type: Authorization
2. Subject: Sanofi
3. Object: N/A
4. Antecedent: N/A
5. Consequent: Sanofi is authorized to use the Patent Rights and Know-How claiming or embodied in the [***] for the exclusive option granted by RevMed.","Norm 1:
1. Norm type: Authorization
2. Subject: RevMed
3. Object: Sanofi
4. Antecedent: Subject to the terms and conditions of this Agreement
5. Consequent: RevMed hereby grants to Sanofi an exclusive option, under the Patent Rights and Know-How claiming or embodied in the [***].

Norm 2:
1. Norm type: Commitment
2. Subject: RevMed
3. Object: Sanofi
4. Antecedent: Subject to the terms and conditions of this Agreement
5. Consequent: RevMed commits to granting Sanofi an exclusive option under the Patent Rights and Know-How claiming or embodied in the [***].","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: Subject to the terms and conditions of this Agreement
5. CONSEQUENT: grants to Sanofi an exclusive option

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: Subject to the terms and conditions of this Agreement
5. CONSEQUENT: under the Patent Rights and Know-How claiming or embodied in the [***]","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: Subject to the terms and conditions of this Agreement
5. CONSEQUENT: grants to Sanofi an exclusive option under the Patent Rights and Know-How claiming or embodied in the [***]

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: Subject to the terms and conditions of this Agreement
5. CONSEQUENT: to ensure the exclusive option granted to Sanofi under the Patent Rights and Know-How claiming or embodied in the [***]","Norm 1:
1. Norm type: Authorization
2. Subject: RevMed
3. Object: Sanofi
4. Antecedent: Subject to the terms and conditions of this Agreement
5. Consequent: RevMed hereby grants to Sanofi an exclusive option, under the Patent Rights and Know-How claiming or embodied in the [***].

Norm 2:
1. Norm type: Power
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: Subject to the terms and conditions of this Agreement
5. Consequent: Sanofi has the exclusive option under the Patent Rights and Know-How claiming or embodied in the [***]."
51,"If the proposed Transfer includes assets not related to the operation of the Franchise, we may purchase only the assets related to the operation of the Franchise or may also purchase the other assets","Norm 1:
Norm type: Authorization
Subject: We
Object: -
Antecedent: The proposed Transfer includes assets not related to the operation of the Franchise
Consequent: We may purchase only the assets related to the operation of the Franchise or may also purchase the other assets.

Norm 2:
Norm type: Commitment
Subject: We
Object: -
Antecedent: -
Consequent: We commit to purchasing only the assets related to the operation of the Franchise or may also purchase the other assets.

Norm 3:
Norm type: Commitment
Subject: -
Object: -
Antecedent: The proposed Transfer includes assets not related to the operation of the Franchise
Consequent: The party proposing the Transfer commits to selling only the assets related to the operation of the Franchise or may also sell the other assets.

Norm 4:
Norm type: Prohibition
Subject: -
Object: -
Antecedent: -
Consequent: The party proposing the Transfer is prohibited from selling assets not related to the operation of the Franchise.

Norm 5:
Norm type: Authorization
Subject: -
Object: -
Antecedent: The proposed Transfer includes assets not related to the operation of the Franchise
Consequent: The party proposing the Transfer is authorized to sell assets related to the operation of the Franchise or may also sell the other assets.","Norm 1:
1. Norm type: Authorization
2. Subject: We
3. Object: The party proposing the Transfer
4. Antecedent: The proposed Transfer includes assets not related to the operation of the Franchise
5. Consequent: We may purchase only the assets related to the operation of the Franchise or may also purchase the other assets

Norm 2:
1. Norm type: Power
2. Subject: The party proposing the Transfer
3. Object: We
4. Antecedent: The proposed Transfer includes assets not related to the operation of the Franchise
5. Consequent: We may purchase only the assets related to the operation of the Franchise or may also purchase the other assets","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: The party proposing the Transfer
3. OBJECT: The other party (may refer to the Franchise owner)
4. ANTECEDENT: The proposed Transfer includes assets not related to the operation of the Franchise
5. CONSEQUENT: The other party may purchase only the assets related to the operation of the Franchise or may also purchase the other assets

NORM 2:
1. NORM type: POWER
2. SUBJECT: The other party (may refer to the Franchise owner)
3. OBJECT: The party proposing the Transfer
4. ANTECEDENT: The proposed Transfer includes assets not related to the operation of the Franchise
5. CONSEQUENT: The other party may purchase only the assets related to the operation of the Franchise or may also purchase the other assets","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: The party proposing the Transfer
3. OBJECT: The party considering the purchase of assets
4. ANTECEDENT: The proposed Transfer includes assets not related to the operation of the Franchise
5. CONSEQUENT: The party considering the purchase may purchase only the assets related to the operation of the Franchise or may also purchase the other assets

NORM 2:
1. NORM type: POWER
2. SUBJECT: The party considering the purchase of assets
3. OBJECT: The party proposing the Transfer
4. ANTECEDENT: The proposed Transfer includes assets not related to the operation of the Franchise
5. CONSEQUENT: The party considering the purchase has the power to decide whether to purchase only the assets related to the operation of the Franchise or also purchase the other assets","Norm 1:
1. Norm type: Authorization
2. Subject: We
3. Object: the proposed Transfer
4. Antecedent: the proposed Transfer includes assets not related to the operation of the Franchise
5. Consequent: We may purchase only the assets related to the operation of the Franchise or may also purchase the other assets

Norm 2:
1. Norm type: Power
2. Subject: We
3. Object: the proposed Transfer
4. Antecedent: the proposed Transfer includes assets not related to the operation of the Franchise
5. Consequent: We may also purchase the other assets"
52,"If Parent enters an agreement to transfer the license granted to it under this Section 3.1 in connection with any sale or transfer of a Parent business, then SpinCo and members of the SpinCo Group shall be made third party beneficiaries under such transfer agreement to enforce breaches of the license","1. Norm type: Authorization
   - Clause: If Parent enters an agreement to transfer the license granted to it under this Section 3.1 in connection with any sale or transfer of a Parent business

2. Norm type: Commitment
   - Subject: Parent
   - Object: SpinCo and members of the SpinCo Group
   - Clause: shall be made third party beneficiaries under such transfer agreement

3. Norm type: Commitment
   - Subject: Parent
   - Object: SpinCo and members of the SpinCo Group
   - Clause: to enforce breaches of the license

4. Norm type: Commitment
   - Subject: SpinCo and members of the SpinCo Group
   - Object: Parent
   - Clause: to enforce breaches of the license

5. Norm type: Commitment
   - Subject: Parent
   - Object: SpinCo and members of the SpinCo Group
   - Antecedent: If Parent enters an agreement to transfer the license granted to it under this Section 3.1 in connection with any sale or transfer of a Parent business
   - Consequent: SpinCo and members of the SpinCo Group shall be made third party beneficiaries under such transfer agreement to enforce breaches of the license","Norm 1:
1. Norm type: Authorization
2. Subject: Parent
3. Object: SpinCo and members of the SpinCo Group
4. Antecedent: Parent enters an agreement to transfer the license granted to it under this Section 3.1 in connection with any sale or transfer of a Parent business
5. Consequent: SpinCo and members of the SpinCo Group shall be made third party beneficiaries under such transfer agreement to enforce breaches of the license

Norm 2:
1. Norm type: Commitment
2. Subject: Parent
3. Object: SpinCo and members of the SpinCo Group
4. Antecedent: Parent enters an agreement to transfer the license granted to it under this Section 3.1 in connection with any sale or transfer of a Parent business
5. Consequent: Parent commits to making SpinCo and members of the SpinCo Group third party beneficiaries under such transfer agreement to enforce breaches of the license","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Parent
3. OBJECT: SpinCo and members of the SpinCo Group
4. ANTECEDENT: Parent enters an agreement to transfer the license granted to it under this Section 3.1 in connection with any sale or transfer of a Parent business
5. CONSEQUENT: SpinCo and members of the SpinCo Group shall be made third party beneficiaries under such transfer agreement to enforce breaches of the license

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Parent
3. OBJECT: SpinCo and members of the SpinCo Group
4. ANTECEDENT: Parent enters an agreement to transfer the license granted to it under this Section 3.1 in connection with any sale or transfer of a Parent business
5. CONSEQUENT: Parent commits to ensuring that SpinCo and members of the SpinCo Group are made third party beneficiaries under such transfer agreement to enforce breaches of the license","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Parent
3. OBJECT: SpinCo and members of the SpinCo Group
4. ANTECEDENT: Parent enters an agreement to transfer the license granted to it under this Section 3.1 in connection with any sale or transfer of a Parent business
5. CONSEQUENT: SpinCo and members of the SpinCo Group shall be made third party beneficiaries under such transfer agreement to enforce breaches of the license

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: SpinCo and members of the SpinCo Group
3. OBJECT: Parent
4. ANTECEDENT: Parent enters an agreement to transfer the license granted to it under this Section 3.1 in connection with any sale or transfer of a Parent business
5. CONSEQUENT: SpinCo and members of the SpinCo Group shall be made third party beneficiaries under such transfer agreement to enforce breaches of the license","Norm 1:
1. Norm type: Authorization
2. Subject: Parent
3. Object: SpinCo and members of the SpinCo Group
4. Antecedent: Parent enters an agreement to transfer the license granted to it under this Section 3.1 in connection with any sale or transfer of a Parent business
5. Consequent: SpinCo and members of the SpinCo Group shall be made third party beneficiaries under such transfer agreement to enforce breaches of the license

Norm 2:
1. Norm type: Commitment
2. Subject: Parent
3. Object: SpinCo and members of the SpinCo Group
4. Antecedent: Parent enters an agreement to transfer the license granted to it under this Section 3.1 in connection with any sale or transfer of a Parent business
5. Consequent: SpinCo and members of the SpinCo Group shall be made third party beneficiaries under such transfer agreement to enforce breaches of the license"
53,"At all times during the Term, upon request from Bank of America and upon termination of this Agreement for any reason, Supplier shall provide immediately to Bank of America the then-current version of any Work Product in Supplier's possession.","1. Norm type: Commitment
   Subject: Supplier
   Object: Bank of America
   Antecedent: Request from Bank of America or termination of the Agreement
   Consequent: Supplier shall provide immediately to Bank of America the then-current version of any Work Product in Supplier's possession.

2. Norm type: Authorization
   Subject: Bank of America
   Object: Supplier
   Antecedent: None specified
   Consequent: Bank of America has the authority to request the then-current version of any Work Product from Supplier at any time during the Term or upon termination of the Agreement.

3. Norm type: Commitment
   Subject: Bank of America
   Object: None specified
   Antecedent: None specified
   Consequent: Bank of America commits to requesting the then-current version of any Work Product from Supplier at any time during the Term or upon termination of the Agreement.

4. Norm type: Commitment
   Subject: Supplier
   Object: None specified
   Antecedent: None specified
   Consequent: Supplier commits to providing immediately to Bank of America the then-current version of any Work Product in Supplier's possession upon request or termination of the Agreement.

5. Norm type: Commitment
   Subject: Supplier
   Object: Bank of America
   Antecedent: None specified
   Consequent: Supplier commits to providing immediately to Bank of America the then-current version of any Work Product in Supplier's possession upon request or termination of the Agreement.","Norm 1:
1. Norm type: Commitment
2. Subject: Supplier
3. Object: Bank of America
4. Antecedent: Request from Bank of America or termination of the Agreement
5. Consequent: Supplier shall provide immediately the then-current version of any Work Product in Supplier's possession. 

Norm 2:
1. Norm type: Authorization
2. Subject: Bank of America
3. Object: Supplier
4. Antecedent: Request from Bank of America or termination of the Agreement
5. Consequent: Bank of America is authorized to request the then-current version of any Work Product in Supplier's possession.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Supplier
3. OBJECT: Bank of America
4. ANTECEDENT: Request from Bank of America or termination of the Agreement
5. CONSEQUENT: Provide the then-current version of any Work Product in Supplier's possession

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Bank of America
3. OBJECT: Supplier
4. ANTECEDENT: N/A
5. CONSEQUENT: N/A","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Supplier
3. OBJECT: Bank of America
4. ANTECEDENT: Request from Bank of America or termination of the Agreement
5. CONSEQUENT: Supplier shall provide the then-current version of any Work Product in Supplier's possession immediately to Bank of America

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Bank of America
3. OBJECT: Supplier
4. ANTECEDENT: Request from Bank of America or termination of the Agreement
5. CONSEQUENT: Bank of America is authorized to request the then-current version of any Work Product in Supplier's possession immediately","Norm 1:
1. Norm type: Commitment
2. Subject: Supplier
3. Object: Bank of America
4. Antecedent: Request from Bank of America or termination of the Agreement
5. Consequent: Providing the then-current version of any Work Product in Supplier's possession immediately

Norm 2:
1. Norm type: Authorization
2. Subject: Bank of America
3. Object: Supplier
4. Antecedent: Request from Bank of America or termination of the Agreement
5. Consequent: Receiving the then-current version of any Work Product in Supplier's possession immediately"
54,"In addition to the foregoing, Sanofi shall use reasonable efforts with respect to those activities for which it is responsible hereunder to cooperate with RevMed to achieve an orderly transition of the Development, Manufacturing and Commercialization of Termination Products from Sanofi or its applicable Affiliate to RevMed.","Norm 1:
Norm type: Commitment
Subject: Sanofi
Object: RevMed
Antecedent: N/A
Consequent: Achieve an orderly transition of the Development, Manufacturing and Commercialization of Termination Products from Sanofi or its applicable Affiliate to RevMed.

Norm 2:
Norm type: Authorization
Subject: Sanofi
Object: N/A
Antecedent: N/A
Consequent: Use reasonable efforts with respect to those activities for which it is responsible hereunder to cooperate with RevMed.

Norm 3:
Norm type: Commitment
Subject: Sanofi
Object: N/A
Antecedent: N/A
Consequent: Use reasonable efforts with respect to those activities for which it is responsible hereunder to cooperate with RevMed.

Norm 4:
Norm type: Commitment
Subject: RevMed
Object: N/A
Antecedent: N/A
Consequent: Achieve an orderly transition of the Development, Manufacturing and Commercialization of Termination Products from Sanofi or its applicable Affiliate to RevMed.

Norm 5:
Norm type: Commitment
Subject: RevMed
Object: Sanofi
Antecedent: N/A
Consequent: Receive cooperation from Sanofi in achieving an orderly transition of the Development, Manufacturing and Commercialization of Termination Products.","Norm 1:
1. Norm type: Commitment
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: Sanofi is responsible for the activities mentioned in the contract.
5. Consequent: Sanofi shall use reasonable efforts to cooperate with RevMed for an orderly transition of the Development, Manufacturing, and Commercialization of Termination Products from Sanofi or its applicable Affiliate to RevMed.

Norm 2:
1. Norm type: Authorization
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: Sanofi is responsible for the activities mentioned in the contract.
5. Consequent: Sanofi is authorized to cooperate with RevMed for an orderly transition of the Development, Manufacturing, and Commercialization of Termination Products from Sanofi or its applicable Affiliate to RevMed.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: Sanofi being responsible for certain activities
5. CONSEQUENT: Cooperation with RevMed to achieve an orderly transition of Development, Manufacturing, and Commercialization of Termination Products

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: N/A
5. CONSEQUENT: Sanofi using reasonable efforts to cooperate with RevMed for the transition of Development, Manufacturing, and Commercialization of Termination Products","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: Sanofi being responsible for the activities
5. CONSEQUENT: Cooperation with RevMed to achieve an orderly transition of the Development, Manufacturing, and Commercialization of Termination Products

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: Sanofi using reasonable efforts to cooperate
5. CONSEQUENT: Achieving an orderly transition of the Development, Manufacturing, and Commercialization of Termination Products","Norm 1:
1. Norm type: Commitment
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: Sanofi being responsible for the activities
5. Consequent: Cooperation with RevMed for an orderly transition of Development, Manufacturing, and Commercialization of Termination Products from Sanofi or its applicable Affiliate to RevMed

Norm 2:
1. Norm type: Authorization
2. Subject: RevMed
3. Object: Sanofi
4. Antecedent: Cooperation from Sanofi
5. Consequent: Achieving an orderly transition of Development, Manufacturing, and Commercialization of Termination Products from Sanofi or its applicable Affiliate to RevMed"
55,"At RevMed's reasonable request, for a period not to exceed [***] following the effective date of termination, Sanofi shall provide RevMed with assistance up to a total of [***] with any inquiries and correspondence with Regulatory Authorities relating to any such Termination Product.","Norm 1:
Norm type: Authorization
Subject: Sanofi
Object: RevMed
Antecedent: RevMed's reasonable request
Consequent: Sanofi shall provide RevMed with assistance up to a total of [***] with any inquiries and correspondence with Regulatory Authorities relating to any such Termination Product.

Norm 2:
Norm type: Commitment
Subject: Sanofi
Object: RevMed
Antecedent: RevMed's reasonable request
Consequent: Sanofi shall provide assistance up to a total of [***] with any inquiries and correspondence with Regulatory Authorities relating to any such Termination Product.

Norm 3:
Norm type: Commitment
Subject: RevMed
Object: Sanofi
Antecedent: None
Consequent: RevMed shall make a reasonable request to Sanofi for assistance with any inquiries and correspondence with Regulatory Authorities relating to any such Termination Product.

Norm 4:
Norm type: Commitment
Subject: Sanofi
Object: Regulatory Authorities
Antecedent: RevMed's reasonable request
Consequent: Sanofi shall provide assistance up to a total of [***] with any inquiries and correspondence with Regulatory Authorities relating to any such Termination Product.

Norm 5:
Norm type: Commitment
Subject: RevMed
Object: Regulatory Authorities
Antecedent: Sanofi's assistance
Consequent: RevMed shall utilize Sanofi's assistance for any inquiries and correspondence with Regulatory Authorities relating to any such Termination Product.","Norm 1:
1. Norm type: Commitment
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: RevMed's reasonable request
5. Consequent: Sanofi shall provide RevMed with assistance up to a total of [***] with any inquiries and correspondence with Regulatory Authorities relating to any such Termination Product.

Norm 2:
1. Norm type: Authorization
2. Subject: RevMed
3. Object: Sanofi
4. Antecedent: RevMed's reasonable request
5. Consequent: Sanofi shall provide RevMed with assistance up to a total of [***] with any inquiries and correspondence with Regulatory Authorities relating to any such Termination Product.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: RevMed's reasonable request
5. CONSEQUENT: Sanofi shall provide RevMed with assistance up to a total of [***] with any inquiries and correspondence with Regulatory Authorities relating to any such Termination Product.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: N/A
5. CONSEQUENT: RevMed shall not exceed [***] following the effective date of termination in requesting assistance from Sanofi with any inquiries and correspondence with Regulatory Authorities relating to any such Termination Product.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: RevMed's reasonable request
5. CONSEQUENT: Sanofi shall provide RevMed with assistance up to a total of [***] with any inquiries and correspondence with Regulatory Authorities relating to any such Termination Product.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: RevMed's reasonable request
5. CONSEQUENT: Sanofi shall provide RevMed with assistance up to a total of [***] with any inquiries and correspondence with Regulatory Authorities relating to any such Termination Product.","Norm 1:
1. Norm type: Authorization
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: RevMed's reasonable request
5. Consequent: Sanofi shall provide assistance with inquiries and correspondence with Regulatory Authorities

Norm 2:
1. Norm type: Commitment
2. Subject: RevMed
3. Object: Sanofi
4. Antecedent: RevMed's reasonable request
5. Consequent: Sanofi shall provide assistance up to a total of [***] with any inquiries and correspondence with Regulatory Authorities"
56,"The insurance policies shall be under an occurrence form, but if only a claims-made form is available to a Party, then such Party shall continue to maintain such insurance after the expiration or termination of this Agreement for the longer of (a) a period of [***] following termination or expiration of this Agreement in its entirety, or (b) with respect to a particular Party, [***] by a Party.","Norm 1:
Norm type: Authorization
Subject: Party
Object: Insurance policies
Antecedent: Availability of claims-made form
Consequent: Party shall continue to maintain such insurance after the expiration or termination of this Agreement for the longer of (a) a period of [***] following termination or expiration of this Agreement in its entirety, or (b) with respect to a particular Party, [***] by a Party.

Norm 2:
Norm type: Commitment
Subject: Party
Object: Insurance policies
Antecedent: None
Consequent: Party shall continue to maintain such insurance after the expiration or termination of this Agreement for the longer of (a) a period of [***] following termination or expiration of this Agreement in its entirety, or (b) with respect to a particular Party, [***] by a Party.

Norm 3:
Norm type: Commitment
Subject: Party
Object: Insurance policies
Antecedent: None
Consequent: Party shall maintain such insurance after the expiration or termination of this Agreement for the longer of (a) a period of [***] following termination or expiration of this Agreement in its entirety, or (b) with respect to a particular Party, [***] by a Party.

Norm 4:
Norm type: Commitment
Subject: Party
Object: Insurance policies
Antecedent: None
Consequent: Party shall maintain such insurance after the expiration or termination of this Agreement for the longer of (a) a period of [***] following termination or expiration of this Agreement in its entirety, or (b) with respect to a particular Party, [***] by a Party.

Norm 5:
Norm type: Commitment
Subject: Party
Object: Insurance policies
Antecedent: None
Consequent: Party shall maintain such insurance after the expiration or termination of this Agreement for the longer of (a) a period of [***] following termination or expiration of this Agreement in its entirety, or (b) with respect to a particular Party, [***] by a Party.","1. Norm type: Commitment
2. Subject: Party 
3. Object: Party 
4. Antecedent: Claims-made form is the only available insurance form to a Party 
5. Consequent: Party shall continue to maintain such insurance after the expiration or termination of the Agreement for a specified period of time 

2. Norm type: Commitment
3. Subject: Party 
4. Object: Party 
5. Antecedent: Termination or expiration of the Agreement in its entirety 
6. Consequent: Party shall continue to maintain insurance for a specified period of time 

3. Norm type: Commitment
4. Subject: Party 
5. Object: Party 
6. Antecedent: Termination or expiration of the Agreement with respect to a particular Party 
7. Consequent: Party shall continue to maintain insurance for a specified period of time","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Party
3. OBJECT: Insurance policies
4. ANTECEDENT: Occurrence form not available
5. CONSEQUENT: Party shall continue to maintain insurance after expiration or termination of Agreement

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Party
3. OBJECT: Party
4. ANTECEDENT: Occurrence form not available
5. CONSEQUENT: Party authorized to maintain insurance for a specified period following termination or expiration of Agreement","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Party
3. OBJECT: Party
4. ANTECEDENT: Claims-made form is available to a Party
5. CONSEQUENT: Party shall continue to maintain insurance after the expiration or termination of the Agreement for a specified period.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Party
3. OBJECT: Party
4. ANTECEDENT: Claims-made form is available to a Party
5. CONSEQUENT: Party shall continue to maintain insurance after the expiration or termination of the Agreement for a specified period.","Norm 1:
1. Norm type: Commitment
2. Subject: Party
3. Object: Party
4. Antecedent: Claims-made form is available to a Party
5. Consequent: Party shall continue to maintain insurance after the expiration or termination of the Agreement for a specified period.

Norm 2:
1. Norm type: Authorization
2. Subject: Party
3. Object: Party
4. Antecedent: Claims-made form is available to a Party
5. Consequent: Party is authorized to maintain insurance after the expiration or termination of the Agreement for a specified period."
57,"In the event of termination or expiration of this Agreement             pursuant to Section 5.0 above, IBM shall have an option, which             shall expire [*] days after such termination or expiration, to             purchase from MSL, at a reasonable price agreeable to the Parties,             all assets used by MSL to perform the manufacturing and fulfillment             functions<omitted>outlined in Attachment 1: Statement of Work, to the extent owned or             transferable by MSL, and required by IBM to perform such functions.","1. Norm type: Authorization
Subject: IBM
Object: MSL
Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0 above
Consequent: IBM has the option to purchase assets from MSL

2. Norm type: Commitment
Subject: IBM
Object: MSL
Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0 above
Consequent: IBM commits to purchasing assets from MSL if the option is exercised

3. Norm type: Commitment
Subject: MSL
Object: IBM
Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0 above
Consequent: MSL commits to selling assets to IBM if the option is exercised

4. Norm type: Commitment
Subject: IBM
Object: MSL
Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0 above
Consequent: IBM commits to agreeing on a reasonable price for the assets with MSL

5. Norm type: Commitment
Subject: MSL
Object: IBM
Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0 above
Consequent: MSL commits to agreeing on a reasonable price for the assets with IBM","Norm 1:
1. Norm type: Power
2. Subject: IBM
3. Object: MSL
4. Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0
5. Consequent: IBM has the option to purchase all assets used by MSL to perform manufacturing and fulfillment functions outlined in Attachment 1: Statement of Work, to the extent owned or transferable by MSL, and required by IBM to perform such functions.

Norm 2:
1. Norm type: Commitment
2. Subject: MSL
3. Object: IBM
4. Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0
5. Consequent: MSL commits to offer IBM the option to purchase all assets used by MSL to perform manufacturing and fulfillment functions outlined in Attachment 1: Statement of Work, to the extent owned or transferable by MSL, and required by IBM to perform such functions at a reasonable price agreeable to the Parties.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: IBM
3. OBJECT: MSL
4. ANTECEDENT: Termination or expiration of the Agreement pursuant to Section 5.0
5. CONSEQUENT: IBM shall have an option to purchase assets from MSL

CLAUSE: IBM is authorized to purchase assets from MSL in the event of termination or expiration of the Agreement pursuant to Section 5.0.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: MSL
3. OBJECT: IBM
4. ANTECEDENT: Termination or expiration of the Agreement pursuant to Section 5.0
5. CONSEQUENT: MSL agrees to sell assets to IBM at a reasonable price agreeable to both parties

CLAUSE: MSL commits to selling assets to IBM at a reasonable price agreeable to both parties in the event of termination or expiration of the Agreement pursuant to Section 5.0.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: IBM
3. OBJECT: MSL
4. ANTECEDENT: Termination or expiration of the Agreement
5. CONSEQUENT: IBM has the option to purchase assets from MSL

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: MSL
3. OBJECT: IBM
4. ANTECEDENT: Termination or expiration of the Agreement
5. CONSEQUENT: MSL agrees to sell assets to IBM at a reasonable price","Norm 1:
1. Norm type: Authorization
2. Subject: IBM
3. Object: MSL
4. Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0
5. Consequent: IBM has the option to purchase assets used by MSL for manufacturing and fulfillment functions outlined in Attachment 1: Statement of Work.

Norm 2:
1. Norm type: Commitment
2. Subject: MSL
3. Object: IBM
4. Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0
5. Consequent: MSL commits to selling assets to IBM at a reasonable price agreeable to both parties."
58,"If AbbVie decides not to prepare, file, prosecute, or maintain a Product-Specific Patent or Joint Patent in a country or other jurisdiction in the Territory, AbbVie shall provide reasonable prior written notice to Harpoon of such intention (which notice shall, in any event, be given no later than [***] prior to the next deadline for any action that may be taken with respect to such Product-Specific Patent or Joint Patent in such country or other jurisdiction), and Harpoon shall thereupon have the option, in its sole discretion, to assume the control and direction of the preparation, filing, prosecution, and maintenance of such Product-Specific Patent or Joint Patent at its sole cost and expense in such country or other jurisdiction.","Norm 1:
Norm type: Commitment
Subject: AbbVie
Object: Harpoon
Antecedent: AbbVie decides not to prepare, file, prosecute, or maintain a Product-Specific Patent or Joint Patent in a country or other jurisdiction in the Territory
Consequent: AbbVie shall provide reasonable prior written notice to Harpoon of such intention (which notice shall, in any event, be given no later than [***] prior to the next deadline for any action that may be taken with respect to such Product-Specific Patent or Joint Patent in such country or other jurisdiction)

Norm 2:
Norm type: Authorization
Subject: AbbVie
Object: Harpoon
Antecedent: AbbVie decides not to prepare, file, prosecute, or maintain a Product-Specific Patent or Joint Patent in a country or other jurisdiction in the Territory
Consequent: Harpoon shall have the option, in its sole discretion, to assume the control and direction of the preparation, filing, prosecution, and maintenance of such Product-Specific Patent or Joint Patent at its sole cost and expense in such country or other jurisdiction.","Norm 1:
1. Norm type: Authorization
2. Subject: AbbVie
3. Object: Harpoon
4. Antecedent: AbbVie decides not to prepare, file, prosecute, or maintain a Product-Specific Patent or Joint Patent in a country or other jurisdiction in the Territory
5. Consequent: AbbVie shall provide reasonable prior written notice to Harpoon of such intention (which notice shall, in any event, be given no later than [***] prior to the next deadline for any action that may be taken with respect to such Product-Specific Patent or Joint Patent in such country or other jurisdiction), and Harpoon shall thereupon have the option, in its sole discretion, to assume the control and direction of the preparation, filing, prosecution, and maintenance of such Product-Specific Patent or Joint Patent at its sole cost and expense in such country or other jurisdiction.

Norm 2:
1. Norm type: Power
2. Subject: Harpoon
3. Object: AbbVie
4. Antecedent: AbbVie decides not to prepare, file, prosecute, or maintain a Product-Specific Patent or Joint Patent in a country or other jurisdiction in the Territory
5. Consequent: Harpoon shall have the option, in its sole discretion, to assume the control and direction of the preparation, filing, prosecution, and maintenance of such Product-Specific Patent or Joint Patent at its sole cost and expense in such country or other jurisdiction.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: AbbVie
3. OBJECT: Harpoon
4. ANTECEDENT: AbbVie decides not to prepare, file, prosecute, or maintain a Product-Specific Patent or Joint Patent in a country or other jurisdiction in the Territory
5. CONSEQUENT: AbbVie shall provide reasonable prior written notice to Harpoon of such intention

CLAUSE: AbbVie shall provide reasonable prior written notice to Harpoon of such intention (which notice shall, in any event, be given no later than [***] prior to the next deadline for any action that may be taken with respect to such Product-Specific Patent or Joint Patent in such country or other jurisdiction)

NORM 2:
1. NORM type: POWER
2. SUBJECT: Harpoon
3. OBJECT: AbbVie
4. ANTECEDENT: AbbVie decides not to prepare, file, prosecute, or maintain a Product-Specific Patent or Joint Patent in a country or other jurisdiction in the Territory
5. CONSEQUENT: Harpoon shall have the option, in its sole discretion, to assume the control and direction of the preparation, filing, prosecution, and maintenance of such Product-Specific Patent or Joint Patent at its sole cost and expense in such country or other jurisdiction

CLAUSE: Harpoon shall have the option, in its sole discretion, to assume the control and direction of the preparation, filing, prosecution, and maintenance of such Product-Specific Patent or Joint Patent at its sole cost and expense in such country or other jurisdiction.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: AbbVie
3. OBJECT: Harpoon
4. ANTECEDENT: AbbVie decides not to prepare, file, prosecute, or maintain a Product-Specific Patent or Joint Patent in a country or other jurisdiction in the Territory
5. CONSEQUENT: Harpoon has the option to assume control and direction of the preparation, filing, prosecution, and maintenance of such Patent at its sole cost and expense in such country or other jurisdiction.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: AbbVie
3. OBJECT: Harpoon
4. ANTECEDENT: AbbVie decides not to prepare, file, prosecute, or maintain a Product-Specific Patent or Joint Patent in a country or other jurisdiction in the Territory
5. CONSEQUENT: AbbVie shall provide reasonable prior written notice to Harpoon of such intention.","Norm 1:
1. Norm type: Authorization
2. Subject: AbbVie
3. Object: Harpoon
4. Antecedent: AbbVie decides not to prepare, file, prosecute, or maintain a Product-Specific Patent or Joint Patent in a country or other jurisdiction in the Territory
5. Consequent: Harpoon shall have the option to assume the control and direction of the preparation, filing, prosecution, and maintenance of such Patent at its sole cost and expense in such country or other jurisdiction.

Norm 2:
1. Norm type: Commitment
2. Subject: AbbVie
3. Object: Harpoon
4. Antecedent: AbbVie decides not to prepare, file, prosecute, or maintain a Product-Specific Patent or Joint Patent in a country or other jurisdiction in the Territory
5. Consequent: AbbVie shall provide reasonable prior written notice to Harpoon of such intention."
59,"ENERGOUS may, at any time after the third anniversary of the Effective Date, terminate this Agreement with or without cause upon not less than one hundred and eighty (180) days prior written notice to DIALOG.","1. Norm type: Authorization
Subject: ENERGOUS
Object: DIALOG
Antecedent: After the third anniversary of the Effective Date
Consequent: Termination of the Agreement

2. Norm type: Commitment
Subject: ENERGOUS
Object: DIALOG
Antecedent: None
Consequent: Providing one hundred and eighty (180) days prior written notice

3. Norm type: Commitment
Subject: DIALOG
Object: ENERGOUS
Antecedent: None
Consequent: Accepting the termination of the Agreement

4. Norm type: Prohibition
Subject: None
Object: ENERGOUS
Antecedent: None
Consequent: Not terminating the Agreement without one hundred and eighty (180) days prior written notice

5. Norm type: Prohibition
Subject: None
Object: DIALOG
Antecedent: None
Consequent: Not preventing or obstructing the termination of the Agreement upon receiving one hundred and eighty (180) days prior written notice.","Norm 1:
1. Norm type: Power
2. Subject: ENERGOUS
3. Object: DIALOG
4. Antecedent: After the third anniversary of the Effective Date
5. Consequent: Terminate the Agreement with or without cause upon not less than one hundred and eighty (180) days prior written notice","NORM 1:
1. NORM type: POWER
2. SUBJECT: ENERGOUS
3. OBJECT: DIALOG
4. ANTECEDENT: After the third anniversary of the Effective Date
5. CONSEQUENT: Terminate the Agreement with or without cause upon not less than one hundred and eighty (180) days prior written notice

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: ENERGOUS
3. OBJECT: DIALOG
4. ANTECEDENT: After the third anniversary of the Effective Date
5. CONSEQUENT: Provide one hundred and eighty (180) days prior written notice before terminating the Agreement","NORM 1:
1. NORM type: POWER
2. SUBJECT: ENERGOUS
3. OBJECT: DIALOG
4. ANTECEDENT: After the third anniversary of the Effective Date
5. CONSEQUENT: Terminate the Agreement with or without cause upon not less than one hundred and eighty (180) days prior written notice to DIALOG

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: ENERGOUS
3. OBJECT: DIALOG
4. ANTECEDENT: After the third anniversary of the Effective Date
5. CONSEQUENT: Provide one hundred and eighty (180) days prior written notice to DIALOG before terminating the Agreement","1. Norm type: commitment
2. Subject: ENERGOUS
3. Object: DIALOG
4. Antecedent: after the third anniversary of the Effective Date
5. Consequent: terminate this Agreement with or without cause upon not less than one hundred and eighty (180) days prior written notice"
60,"M&I may, at any time, withdraw any of the Services (other than the Core Services) upon providing ninety (90) days' prior written notice to Customer.","Norm 1:
1. Norm type: Authorization
2. Subject: M&I
3. Object: Customer
4. Antecedent: None mentioned
5. Consequent: M&I has the authority to withdraw any of the Services (other than the Core Services) from Customer by providing ninety (90) days' prior written notice.

Norm 2:
1. Norm type: Commitment
2. Subject: M&I
3. Object: Customer
4. Antecedent: None mentioned
5. Consequent: M&I commits to providing ninety (90) days' prior written notice to Customer before withdrawing any of the Services (other than the Core Services).

Norm 3:
1. Norm type: Prohibition
2. Subject: None mentioned
3. Object: None mentioned
4. Antecedent: None mentioned
5. Consequent: There are no prohibitions mentioned in this sentence.

Norm 4:
1. Norm type: Power
2. Subject: M&I
3. Object: None mentioned
4. Antecedent: None mentioned
5. Consequent: M&I has the power to withdraw any of the Services (other than the Core Services) from Customer.

Norm 5:
1. Norm type: Commitment
2. Subject: Customer
3. Object: M&I
4. Antecedent: None mentioned
5. Consequent: Customer commits to accepting the withdrawal of any of the Services (other than the Core Services) by M&I upon receiving ninety (90) days' prior written notice.","Norm 1:
1. Norm type: Power
2. Subject: M&I
3. Object: Customer
4. Antecedent: M&I providing ninety (90) days' prior written notice to Customer
5. Consequent: M&I may withdraw any of the Services (other than the Core Services) at any time","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: M&I
3. OBJECT: Customer
4. ANTECEDENT: M&I may, at any time, withdraw any of the Services (other than the Core Services)
5. CONSEQUENT: upon providing ninety (90) days' prior written notice to Customer

CLAUSE 1: M&I is authorized to withdraw any of the Services (other than the Core Services) upon providing ninety (90) days' prior written notice to Customer.","NORM 1:
1. NORM type: POWER
2. SUBJECT: M&I
3. OBJECT: Customer
4. ANTECEDENT: M&I providing ninety (90) days' prior written notice to Customer
5. CONSEQUENT: M&I withdrawing any of the Services (other than the Core Services)

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: M&I
3. OBJECT: Customer
4. ANTECEDENT: M&I providing ninety (90) days' prior written notice to Customer
5. CONSEQUENT: M&I ensuring the withdrawal of any of the Services (other than the Core Services)","1. Norm type: authorization
2. Subject: M&I
3. Object: Customer
4. Antecedent: M&I providing ninety (90) days' prior written notice to Customer
5. Consequent: M&I withdrawing any of the Services (other than the Core Services)"
61,"Bank of America may terminate this Agreement, an Order and/or any Customization Schedule(s) for its convenience, without cause, at any time without further charge or expense upon at least forty-five (45) calendar days prior written notice to Supplier.","Norm 1:
Norm type: Authorization
Subject: Bank of America
Object: Supplier
Antecedent: None
Consequent: Termination of the Agreement, Order, and/or any Customization Schedule(s) for the convenience of Bank of America without cause.

Norm 2:
Norm type: Commitment
Subject: Bank of America
Object: Supplier
Antecedent: None
Consequent: Providing at least forty-five (45) calendar days prior written notice to Supplier before terminating the Agreement, Order, and/or any Customization Schedule(s) for its convenience without cause.

Norm 3:
Norm type: Prohibition
Subject: None
Object: Bank of America
Antecedent: None
Consequent: Bank of America is prohibited from terminating the Agreement, Order, and/or any Customization Schedule(s) for its convenience without providing at least forty-five (45) calendar days prior written notice to Supplier.

Norm 4:
Norm type: Commitment
Subject: Supplier
Object: Bank of America
Antecedent: None
Consequent: Accepting the termination of the Agreement, Order, and/or any Customization Schedule(s) by Bank of America for its convenience without cause upon receiving at least forty-five (45) calendar days prior written notice.

Norm 5:
Norm type: Authorization
Subject: Supplier
Object: None
Antecedent: None
Consequent: Not charging or incurring any expenses upon the termination of the Agreement, Order, and/or any Customization Schedule(s) by Bank of America for its convenience without cause, provided that at least forty-five (45) calendar days prior written notice is given.","Norm 1:
1. Norm type: Power
2. Subject: Bank of America
3. Object: Supplier
4. Antecedent: Bank of America may terminate this Agreement, an Order and/or any Customization Schedule(s) for its convenience, without cause
5. Consequent: Termination of the Agreement, Order, or Customization Schedule(s) without further charge or expense upon at least forty-five (45) calendar days prior written notice to Supplier.

Norm 2:
1. Norm type: Commitment
2. Subject: Bank of America
3. Object: Supplier
4. Antecedent: Bank of America providing at least forty-five (45) calendar days prior written notice to Supplier
5. Consequent: Termination of the Agreement, Order, or Customization Schedule(s) without further charge or expense.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Bank of America
3. OBJECT: Supplier
4. ANTECEDENT: Bank of America may terminate this Agreement, an Order and/or any Customization Schedule(s) for its convenience, without cause, at any time
5. CONSEQUENT: without further charge or expense upon at least forty-five (45) calendar days prior written notice to Supplier

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Bank of America
3. OBJECT: Supplier
4. ANTECEDENT: Bank of America may terminate this Agreement, an Order and/or any Customization Schedule(s) for its convenience, without cause, at any time
5. CONSEQUENT: without further charge or expense upon at least forty-five (45) calendar days prior written notice to Supplier","NORM 1:
1. NORM type: POWER
2. SUBJECT: Bank of America
3. OBJECT: Supplier
4. ANTECEDENT: Bank of America may terminate this Agreement, an Order and/or any Customization Schedule(s) for its convenience, without cause, at any time
5. CONSEQUENT: termination without further charge or expense upon at least forty-five (45) calendar days prior written notice to Supplier

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Bank of America
3. OBJECT: Supplier
4. ANTECEDENT: Bank of America may terminate this Agreement, an Order and/or any Customization Schedule(s) for its convenience, without cause, at any time
5. CONSEQUENT: termination without further charge or expense upon at least forty-five (45) calendar days prior written notice to Supplier","Norm 1:
1. Norm type: Power
2. Subject: Bank of America
3. Object: Supplier
4. Antecedent: Bank of America may terminate this Agreement, an Order and/or any Customization Schedule(s) for its convenience, without cause
5. Consequent: termination of the Agreement, Order, or Customization Schedule(s) without further charge or expense

Norm 2:
1. Norm type: Commitment
2. Subject: Bank of America
3. Object: Supplier
4. Antecedent: at any time
5. Consequent: termination of the Agreement, Order, or Customization Schedule(s) upon at least forty-five (45) calendar days prior written notice"
62,"During the Term, if Exact desires to grant an exclusive commercial license to a Third Party solely to Promote or sell the Product in the OB/Gyn Field in the Territory (the ""OB/Gyn Commercial Rights""), Exact shall first notify Pfizer of such intent (a ""OB/Gyn Commercial Rights Transfer Notice"") and Pfizer shall have thirty (30) days thereafter to notify Exact of its desire to obtain the OB/Gyn Commercial Rights that are the subject of the OB/Gyn Commercial Rights Transfer Notice.","1. Norm type: Authorization
Subject: Exact
Object: Third Party
Antecedent: Exact desires to grant an exclusive commercial license to a Third Party solely to Promote or sell the Product in the OB/Gyn Field in the Territory
Consequent: Exact shall first notify Pfizer of such intent (a ""OB/Gyn Commercial Rights Transfer Notice"") and Pfizer shall have thirty (30) days thereafter to notify Exact of its desire to obtain the OB/Gyn Commercial Rights that are the subject of the OB/Gyn Commercial Rights Transfer Notice.

2. Norm type: Commitment
Subject: Pfizer
Object: Exact
Antecedent: Pfizer receives the OB/Gyn Commercial Rights Transfer Notice from Exact
Consequent: Pfizer shall have thirty (30) days thereafter to notify Exact of its desire to obtain the OB/Gyn Commercial Rights that are the subject of the OB/Gyn Commercial Rights Transfer Notice.

3. Norm type: Commitment
Subject: Exact
Object: Pfizer
Antecedent: Pfizer notifies Exact of its desire to obtain the OB/Gyn Commercial Rights
Consequent: Exact shall grant the OB/Gyn Commercial Rights to Pfizer.

4. Norm type: Prohibition
Subject: Exact
Object: Third Party
Antecedent: Exact desires to grant an exclusive commercial license to a Third Party solely to Promote or sell the Product in the OB/Gyn Field in the Territory
Consequent: Exact shall not grant the OB/Gyn Commercial Rights to the Third Party without first notifying Pfizer and giving Pfizer the opportunity to obtain the rights.

5. Norm type: Power
Subject: Pfizer
Object: Pfizer
Antecedent: Pfizer receives the OB/Gyn Commercial Rights Transfer Notice from Exact
Consequent: Pfizer has the power to obtain the OB/Gyn Commercial Rights that are the subject of the OB/Gyn Commercial Rights Transfer Notice.","Norm 1:
1. Norm type: Authorization
2. Subject: Exact
3. Object: Pfizer
4. Antecedent: Exact desires to grant an exclusive commercial license to a Third Party solely to Promote or sell the Product in the OB/Gyn Field in the Territory
5. Consequent: Exact shall first notify Pfizer of such intent

Norm 2:
1. Norm type: Commitment
2. Subject: Pfizer
3. Object: Exact
4. Antecedent: Exact notifies Pfizer of its intent to grant an exclusive commercial license to a Third Party in the OB/Gyn Field in the Territory
5. Consequent: Pfizer shall have thirty (30) days to notify Exact of its desire to obtain the OB/Gyn Commercial Rights that are the subject of the notice.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Exact
3. OBJECT: Pfizer
4. ANTECEDENT: Exact desires to grant an exclusive commercial license to a Third Party solely to Promote or sell the Product in the OB/Gyn Field in the Territory
5. CONSEQUENT: Exact shall first notify Pfizer of such intent

CLAUSE: Exact is authorized to notify Pfizer of its intent to grant an exclusive commercial license to a Third Party for the OB/Gyn Commercial Rights.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Pfizer
3. OBJECT: Exact
4. ANTECEDENT: Exact notifies Pfizer of its intent to grant an exclusive commercial license to a Third Party for the OB/Gyn Commercial Rights
5. CONSEQUENT: Pfizer shall have thirty (30) days to notify Exact of its desire to obtain the OB/Gyn Commercial Rights

CLAUSE: Pfizer commits to notifying Exact within thirty (30) days of its desire to obtain the OB/Gyn Commercial Rights after receiving the notification from Exact.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Exact
3. OBJECT: Pfizer
4. ANTECEDENT: Exact desires to grant an exclusive commercial license to a Third Party solely to Promote or sell the Product in the OB/Gyn Field in the Territory
5. CONSEQUENT: Exact shall first notify Pfizer of such intent

NORM 2:
1. NORM type: POWER
2. SUBJECT: Pfizer
3. OBJECT: Exact
4. ANTECEDENT: Pfizer desires to obtain the OB/Gyn Commercial Rights that are the subject of the OB/Gyn Commercial Rights Transfer Notice
5. CONSEQUENT: Pfizer shall have thirty (30) days thereafter to notify Exact of its desire to obtain the OB/Gyn Commercial Rights that are the subject of the OB/Gyn Commercial Rights Transfer Notice.","Norm 1:
1. Norm type: Authorization
2. Subject: Exact
3. Object: Pfizer
4. Antecedent: Exact desires to grant an exclusive commercial license to a Third Party solely to Promote or sell the Product in the OB/Gyn Field in the Territory
5. Consequent: Pfizer shall have thirty (30) days thereafter to notify Exact of its desire to obtain the OB/Gyn Commercial Rights that are the subject of the OB/Gyn Commercial Rights Transfer Notice.

Norm 2:
1. Norm type: Commitment
2. Subject: Pfizer
3. Object: Exact
4. Antecedent: Exact desires to grant an exclusive commercial license to a Third Party solely to Promote or sell the Product in the OB/Gyn Field in the Territory
5. Consequent: Pfizer shall first notify Exact of such intent."
63,"Notwithstanding the foregoing, either Party may, without consent of the other Party, assign this Agreement and its rights and obligations hereunder in whole or in part to an Affiliate of such Party, or in whole to its successor in interest in connection with the sale of all or substantially all of its stock or its assets to which this Agreement relates, or in connection with a merger, acquisition or similar transaction.","1. Norm type: Authorization
Subject: Either Party
Object: None specified
Antecedent: None specified
Consequent: The ability to assign the Agreement and its rights and obligations to an Affiliate, successor in interest, or in connection with a merger, acquisition, or similar transaction without the consent of the other Party.

2. Norm type: Commitment
Subject: None specified
Object: None specified
Antecedent: None specified
Consequent: The commitment to assign the Agreement and its rights and obligations to an Affiliate, successor in interest, or in connection with a merger, acquisition, or similar transaction without the consent of the other Party.

3. Norm type: Authorization
Subject: Either Party
Object: None specified
Antecedent: None specified
Consequent: The authority to assign the Agreement and its rights and obligations to an Affiliate, successor in interest, or in connection with a merger, acquisition, or similar transaction without the consent of the other Party.

4. Norm type: Authorization
Subject: Either Party
Object: None specified
Antecedent: None specified
Consequent: The authority to assign the Agreement and its rights and obligations to an Affiliate of such Party without the consent of the other Party.

5. Norm type: Authorization
Subject: Either Party
Object: None specified
Antecedent: None specified
Consequent: The authority to assign the Agreement and its rights and obligations to its successor in interest in connection with the sale of all or substantially all of its stock or its assets to which this Agreement relates without the consent of the other Party.","Norm 1:
1. Norm type: Power
2. Subject: Either Party
3. Object: Other Party
4. Antecedent: None specified
5. Consequent: Assign this Agreement and its rights and obligations hereunder in whole or in part to an Affiliate of such Party, or in whole to its successor in interest in connection with the sale of all or substantially all of its stock or its assets to which this Agreement relates, or in connection with a merger, acquisition or similar transaction.

Norm 2:
1. Norm type: Authorization
2. Subject: Either Party
3. Object: Other Party
4. Antecedent: None specified
5. Consequent: Assign this Agreement and its rights and obligations hereunder in whole or in part to an Affiliate of such Party, or in whole to its successor in interest in connection with the sale of all or substantially all of its stock or its assets to which this Agreement relates, or in connection with a merger, acquisition or similar transaction.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Either Party
3. OBJECT: Other Party
4. ANTECEDENT: None specified
5. CONSEQUENT: Either Party may assign this Agreement and its rights and obligations hereunder in whole or in part to an Affiliate of such Party, or in whole to its successor in interest in connection with the sale of all or substantially all of its stock or its assets to which this Agreement relates, or in connection with a merger, acquisition or similar transaction.

CLAUSE: Either Party may assign this Agreement and its rights and obligations hereunder in whole or in part to an Affiliate of such Party, or in whole to its successor in interest in connection with the sale of all or substantially all of its stock or its assets to which this Agreement relates, or in connection with a merger, acquisition or similar transaction.

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Other Party
3. OBJECT: Either Party
4. ANTECEDENT: None specified
5. CONSEQUENT: Other Party is prohibited from withholding consent for the assignment of this Agreement and its rights and obligations as described in NORM 1.

CLAUSE: Other Party is prohibited from withholding consent for the assignment of this Agreement and its rights and obligations as described in NORM 1.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Either Party
3. OBJECT: the other Party
4. ANTECEDENT: None specified
5. CONSEQUENT: Either Party may assign this Agreement and its rights and obligations hereunder in whole or in part to an Affiliate of such Party, or in whole to its successor in interest in connection with the sale of all or substantially all of its stock or its assets to which this Agreement relates, or in connection with a merger, acquisition or similar transaction.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Either Party
3. OBJECT: None specified
4. ANTECEDENT: None specified
5. CONSEQUENT: Either Party may assign this Agreement and its rights and obligations hereunder in whole or in part to an Affiliate of such Party, or in whole to its successor in interest in connection with the sale of all or substantially all of its stock or its assets to which this Agreement relates, or in connection with a merger, acquisition or similar transaction.","Norm 1:
1. Norm type: Authorization
2. Subject: Either Party
3. Object: the other Party
4. Antecedent: None specified
5. Consequent: Assigning the Agreement and its rights and obligations to an Affiliate, successor in interest, or in connection with a merger, acquisition, or similar transaction.

Norm 2:
1. Norm type: Power
2. Subject: Either Party
3. Object: None specified
4. Antecedent: None specified
5. Consequent: Assigning the Agreement and its rights and obligations to an Affiliate, successor in interest, or in connection with a merger, acquisition, or similar transaction."
64,"At any time between the Agreement Date and July 1, 2015, EKR shall have the right, exercisable upon sixty (60) days prior written  notice to PPI, to terminate the Lease Term and sell the Transferred Equipment back to PPI, subject to payment by PPI to EKR within  five (5) days of such notice of $[**] in cash, which if exercised shall result in (i) an offset against the unpaid balance of principal and  interest under the Promissory Note pursuant to Section 3.20(f) below; and (ii) the termination of the Step-in Right described in  Section 17.5.","Norm 1:
Norm type: Authorization
Subject: EKR
Object: PPI
Antecedent: Agreement Date and July 1, 2015
Consequent: EKR has the right to terminate the Lease Term and sell the Transferred Equipment back to PPI, subject to payment by PPI to EKR within five (5) days of such notice of $[**] in cash.

Norm 2:
Norm type: Commitment
Subject: PPI
Object: EKR
Antecedent: None mentioned
Consequent: PPI is committed to making the payment of $[**] in cash within five (5) days of the notice.

Norm 3:
Norm type: Commitment
Subject: EKR
Object: PPI
Antecedent: None mentioned
Consequent: EKR is committed to offsetting the unpaid balance of principal and interest under the Promissory Note pursuant to Section 3.20(f) below if the termination and sale are exercised.

Norm 4:
Norm type: Commitment
Subject: EKR
Object: PPI
Antecedent: None mentioned
Consequent: EKR is committed to the termination of the Step-in Right described in Section 17.5 if the termination and sale are exercised.","Norm 1:
1. Norm type: Power
2. Subject: EKR
3. Object: PPI
4. Antecedent: Between the Agreement Date and July 1, 2015
5. Consequent: EKR shall have the right to terminate the Lease Term and sell the Transferred Equipment back to PPI upon sixty (60) days prior written notice to PPI.

Clause: EKR has the power to terminate the Lease Term and sell the Transferred Equipment back to PPI with a sixty (60) days prior written notice.

Norm 2:
1. Norm type: Commitment
2. Subject: PPI
3. Object: EKR
4. Antecedent: Upon receiving the notice from EKR
5. Consequent: Payment by PPI to EKR within five (5) days of such notice of $[**] in cash

Clause: PPI commits to paying EKR $[**] in cash within five (5) days of receiving the notice for termination of the Lease Term and sale of Transferred Equipment.

Norm 3:
1. Norm type: Power
2. Subject: EKR
3. Object: PPI
4. Antecedent: If the right to terminate the Lease Term and sell the Transferred Equipment is exercised by EKR
5. Consequent: Offset against the unpaid balance of principal and interest under the Promissory Note pursuant to Section 3.20(f) and termination of the Step-in Right described in Section 17.5.

Clause: EKR has the power to offset the unpaid balance of principal and interest under the Promissory Note and terminate the Step-in Right if the right to terminate the Lease Term and sell the Transferred Equipment is exercised.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: EKR
3. OBJECT: PPI
4. ANTECEDENT: At any time between the Agreement Date and July 1, 2015
5. CONSEQUENT: EKR shall have the right to terminate the Lease Term and sell the Transferred Equipment back to PPI

CLAUSE:
- EKR has the right to terminate the Lease Term and sell the Transferred Equipment back to PPI between the Agreement Date and July 1, 2015.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: PPI
3. OBJECT: EKR
4. ANTECEDENT: EKR exercises the right to terminate the Lease Term and sell the Transferred Equipment back to PPI
5. CONSEQUENT: Payment by PPI to EKR within five (5) days of such notice of $[**] in cash

CLAUSE:
- PPI commits to paying EKR $[**] in cash within five (5) days of EKR exercising the right to terminate the Lease Term and sell the Transferred Equipment back to PPI. 

NORM 3:
1. NORM type: COMMITMENT
2. SUBJECT: PPI
3. OBJECT: EKR
4. ANTECEDENT: EKR exercises the right to terminate the Lease Term and sell the Transferred Equipment back to PPI
5. CONSEQUENT: Offset against the unpaid balance of principal and interest under the Promissory Note pursuant to Section 3.20(f) and termination of the Step-in Right described in Section 17.5

CLAUSE:
- PPI commits to offsetting the unpaid balance of principal and interest under the Promissory Note pursuant to Section 3.20(f) and terminating the Step-in Right described in Section 17.5 if EKR exercises the right to terminate the Lease Term and sell the Transferred Equipment back to PPI.","NORM 1:
1. NORM type: POWER
2. SUBJECT: EKR
3. OBJECT: PPI
4. ANTECEDENT: EKR provides sixty (60) days prior written notice to PPI
5. CONSEQUENT: EKR has the power to terminate the Lease Term and sell the Transferred Equipment back to PPI

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: PPI
3. OBJECT: EKR
4. ANTECEDENT: EKR exercises the right to terminate the Lease Term and sell the Transferred Equipment back to PPI
5. CONSEQUENT: PPI must make a payment of $[**] in cash to EKR within five (5) days of the notice

NORM 3:
1. NORM type: CONSEQUENT
2. SUBJECT: EKR
3. OBJECT: PPI
4. ANTECEDENT: PPI makes a payment of $[**] in cash to EKR within five (5) days of the notice
5. CONSEQUENT: EKR will offset the unpaid balance of principal and interest under the Promissory Note and terminate the Step-in Right described in Section 17.5.","Norm 1:
1. Norm type: Authorization
2. Subject: EKR
3. Object: PPI
4. Antecedent: Exercisable upon sixty (60) days prior written notice to PPI
5. Consequent: Termination of the Lease Term and sale of the Transferred Equipment back to PPI

Norm 2:
1. Norm type: Commitment
2. Subject: PPI
3. Object: EKR
4. Antecedent: Payment by PPI to EKR within five (5) days of such notice of $[**] in cash
5. Consequent: Offset against the unpaid balance of principal and interest under the Promissory Note pursuant to Section 3.20(f) and termination of the Step-in Right described in Section 17.5."
65,Microsoft may terminate this Agreement at any time without cause upon [*] ([*]) days prior written notice.,"Norm 1:
1. Norm type: Authorization
2. Subject: Microsoft
3. Object: This Agreement
4. Antecedent: None specified
5. Consequent: Termination of the Agreement

Norm 2:
1. Norm type: Commitment
2. Subject: Microsoft
3. Object: None specified
4. Antecedent: None specified
5. Consequent: Termination of the Agreement

Norm 3:
1. Norm type: Power
2. Subject: Microsoft
3. Object: None specified
4. Antecedent: None specified
5. Consequent: Termination of the Agreement

Norm 4:
1. Norm type: Prohibition
2. Subject: None specified
3. Object: None specified
4. Antecedent: None specified
5. Consequent: None specified

Norm 5:
1. Norm type: Commitment
2. Subject: Microsoft
3. Object: None specified
4. Antecedent: [*] ([*]) days prior written notice
5. Consequent: Termination of the Agreement","Norm 1:
1. Norm type: Power
2. Subject: Microsoft
3. Object: The Agreement
4. Antecedent: None specified
5. Consequent: Termination of the Agreement

Norm 2:
1. Norm type: Commitment
2. Subject: Microsoft
3. Object: The other party involved in the Agreement
4. Antecedent: None specified
5. Consequent: Termination of the Agreement","NORM 1:
1. NORM type: POWER
2. SUBJECT: Microsoft
3. OBJECT: the other party involved in the Agreement
4. ANTECEDENT: Microsoft deciding to terminate the Agreement
5. CONSEQUENT: termination of the Agreement

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Microsoft
3. OBJECT: the other party involved in the Agreement
4. ANTECEDENT: Microsoft providing [*] ([*]) days prior written notice
5. CONSEQUENT: termination of the Agreement","NORM 1:
1. NORM type: POWER
2. SUBJECT: Microsoft
3. OBJECT: Agreement
4. ANTECEDENT: Microsoft may terminate this Agreement at any time without cause
5. CONSEQUENT: termination of the Agreement

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Microsoft
3. OBJECT: Agreement
4. ANTECEDENT: [*] ([*]) days prior written notice
5. CONSEQUENT: termination of the Agreement","1. Norm type: power
2. Subject: Microsoft
3. Object: Agreement
4. Antecedent: [*] days prior written notice
5. Consequent: termination of the Agreement"
66,"If you or any of your Principal Owners wishes to Transfer any Interest, we will have a right of first refusal to purchase that Interest as follows.","1. Norm type: Authorization
Subject: Principal Owners
Object: We (the other party)
Antecedent: Principal Owners wishing to Transfer any Interest
Consequent: We will have a right of first refusal to purchase that Interest

2. Norm type: Commitment
Subject: We (the other party)
Object: Principal Owners
Antecedent: None
Consequent: We commit to exercising our right of first refusal to purchase the Interest if any of the Principal Owners wishes to Transfer it.

3. Norm type: Power
Subject: We (the other party)
Object: None
Antecedent: None
Consequent: We have the power to exercise our right of first refusal to purchase the Interest if any of the Principal Owners wishes to Transfer it.

4. Norm type: Commitment
Subject: Principal Owners
Object: None
Antecedent: None
Consequent: Principal Owners commit to offering us the opportunity to purchase the Interest before considering any other offers.

5. Norm type: Prohibition
Subject: None
Object: Principal Owners
Antecedent: None
Consequent: Principal Owners are prohibited from transferring the Interest to any other party without offering us the opportunity to purchase it first.","Norm 1:
1. Norm type: Authorization
2. Subject: Principal Owners
3. Object: Other party
4. Antecedent: Principal Owners wishing to Transfer any Interest
5. Consequent: Other party having a right of first refusal to purchase that Interest

Norm 2:
1. Norm type: Commitment
2. Subject: Other party
3. Object: Principal Owners
4. Antecedent: Principal Owners wishing to Transfer any Interest
5. Consequent: Other party committing to purchase that Interest if Principal Owners wish to Transfer","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Principal Owners
3. OBJECT: Other party
4. ANTECEDENT: Principal Owners wishes to Transfer any Interest
5. CONSEQUENT: Other party will have a right of first refusal to purchase that Interest

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Other party
3. OBJECT: Principal Owners
4. ANTECEDENT: Principal Owners wishes to Transfer any Interest
5. CONSEQUENT: Other party commits to purchase that Interest if the Principal Owners wish to Transfer it.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Principal Owners
3. OBJECT: we
4. ANTECEDENT: wishes to Transfer any Interest
5. CONSEQUENT: we will have a right of first refusal to purchase that Interest

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: we
3. OBJECT: Principal Owners
4. ANTECEDENT: Transfer any Interest
5. CONSEQUENT: will have a right of first refusal to purchase that Interest","Norm 1:
1. Norm type: Authorization
2. Subject: Principal Owners
3. Object: We
4. Antecedent: If Principal Owners wish to Transfer any Interest
5. Consequent: We will have a right of first refusal to purchase that Interest

Norm 2:
1. Norm type: Commitment
2. Subject: We
3. Object: Principal Owners
4. Antecedent: If Principal Owners wish to Transfer any Interest
5. Consequent: We commit to exercising our right of first refusal to purchase that Interest"
67,"Franchisee  further agrees that the purchase  price shall be further  reduced by ten percent (10%) per month for each subsequent  month  Franchisee  fails to act diligently to consummate this  transaction.  In the event that Franchisee cannot deliver clear title to all of the purchased assets as aforesaid, or in the event there are other unresolved  issues, at Pretzel Time's option,  the losing of the sale shall be accomplished through an escrow.","Norm 1:
Norm type: Commitment
Subject: Franchisee
Object: N/A
Antecedent: N/A
Consequent: The purchase price shall be further reduced by ten percent (10%) per month for each subsequent month Franchisee fails to act diligently to consummate this transaction.

Norm 2:
Norm type: Commitment
Subject: Franchisee
Object: N/A
Antecedent: N/A
Consequent: Franchisee cannot deliver clear title to all of the purchased assets as aforesaid, or there are other unresolved issues
(Note: This norm is conditional and depends on the antecedent)

Norm 3:
Norm type: Authorization
Subject: Pretzel Time
Object: N/A
Antecedent: N/A
Consequent: The losing of the sale shall be accomplished through an escrow.

Note: The given sentence does not contain any norms related to 'power' or 'prohibition' norm types.","Norm 1:
1. Norm type: Commitment
2. Subject: Franchisee
3. Object: Pretzel Time
4. Antecedent: Franchisee fails to act diligently to consummate the transaction
5. Consequent: Purchase price shall be reduced by ten percent (10%) per month for each subsequent month

Norm 2:
1. Norm type: Authorization
2. Subject: Pretzel Time
3. Object: Franchisee
4. Antecedent: Franchisee cannot deliver clear title to all purchased assets or there are other unresolved issues
5. Consequent: Losing of the sale shall be accomplished through an escrow

Norm 3:
1. Norm type: Power
2. Subject: Pretzel Time
3. Object: Franchisee
4. Antecedent: Franchisee cannot deliver clear title to all purchased assets or there are other unresolved issues
5. Consequent: Losing of the sale shall be accomplished through an escrow","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Franchisee
3. OBJECT: Pretzel Time
4. ANTECEDENT: Franchisee fails to act diligently to consummate the transaction
5. CONSEQUENT: Purchase price shall be reduced by ten percent (10%) per month for each subsequent month

CLAUSE: Franchisee commits to reducing the purchase price by ten percent (10%) per month for each subsequent month if Franchisee fails to act diligently to consummate the transaction.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Pretzel Time
3. OBJECT: Franchisee
4. ANTECEDENT: Franchisee cannot deliver clear title to all purchased assets or there are other unresolved issues
5. CONSEQUENT: Losing of the sale shall be accomplished through an escrow

CLAUSE: Pretzel Time authorizes the losing of the sale to be accomplished through an escrow if Franchisee cannot deliver clear title to all purchased assets or there are other unresolved issues.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Franchisee
3. OBJECT: Pretzel Time
4. ANTECEDENT: Franchisee fails to act diligently to consummate the transaction
5. CONSEQUENT: Purchase price shall be reduced by ten percent (10%) per month for each subsequent month

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Pretzel Time
3. OBJECT: Franchisee
4. ANTECEDENT: Franchisee cannot deliver clear title to all purchased assets or there are other unresolved issues
5. CONSEQUENT: Losing of the sale shall be accomplished through an escrow.","Norm 1:
1. Norm type: Commitment
2. Subject: Franchisee
3. Object: Pretzel Time
4. Antecedent: Franchisee fails to act diligently to consummate the transaction
5. Consequent: Purchase price shall be reduced by ten percent (10%) per month for each subsequent month

Norm 2:
1. Norm type: Authorization
2. Subject: Pretzel Time
3. Object: Franchisee
4. Antecedent: Franchisee cannot deliver clear title to all purchased assets or there are other unresolved issues
5. Consequent: Losing of the sale shall be accomplished through an escrow."
68,"Upon termination of this Agreement for whatever reason whatsoever, the Parties shall have the  following rights and obligations:<omitted>(b) Aura shall have the right but not the obligation to purchase any or all Products then in Aura's possession at the invoiced price(s). In the  event that Aura does not elect to purchase said Products, Aura, at its cost, shall return all such non-purchased Products to Zanotti.","1. Norm type: Authorization
Subject: Aura
Object: Aura
Antecedent: Termination of the Agreement
Consequent: Aura has the right to purchase any or all Products in its possession at the invoiced price(s).

2. Norm type: Commitment
Subject: Aura
Object: Zanotti
Antecedent: Termination of the Agreement
Consequent: Aura is obligated to return all non-purchased Products to Zanotti at its own cost.","Norm 1:
1. Norm type: Authorization
2. Subject: Aura
3. Object: Zanotti
4. Antecedent: Termination of the Agreement
5. Consequent: Aura has the right to purchase any or all Products then in Aura's possession at the invoiced price(s).

Norm 2:
1. Norm type: Commitment
2. Subject: Aura
3. Object: Zanotti
4. Antecedent: Termination of the Agreement and Aura not electing to purchase said Products
5. Consequent: Aura commits to returning all non-purchased Products to Zanotti at its cost.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Aura
3. OBJECT: Zanotti
4. ANTECEDENT: Upon termination of the Agreement
5. CONSEQUENT: Aura has the right to purchase any or all Products then in Aura's possession at the invoiced price(s).

CLAUSE: Aura has the right to purchase any or all Products then in Aura's possession at the invoiced price(s).

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Aura
3. OBJECT: Zanotti
4. ANTECEDENT: Upon termination of the Agreement
5. CONSEQUENT: Aura, at its cost, shall return all such non-purchased Products to Zanotti.

CLAUSE: Aura, at its cost, shall return all such non-purchased Products to Zanotti.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Zanotti
3. OBJECT: Aura
4. ANTECEDENT: Upon termination of the Agreement
5. CONSEQUENT: Zanotti authorizes Aura to purchase any or all Products then in Aura's possession at the invoiced price(s).

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Aura
3. OBJECT: Zanotti
4. ANTECEDENT: Aura does not elect to purchase said Products
5. CONSEQUENT: Aura commits to returning all such non-purchased Products to Zanotti at its cost.","1. Norm type: authorization
2. Subject: Aura
3. Object: Zanotti
4. Antecedent: Upon termination of the Agreement
5. Consequent: Aura has the right to purchase any or all Products at the invoiced price(s)"
69,"If at the time of such termination, Sanofi or its Affiliates are Commercializing a particular Termination Product, then, at RevMed's request, the Parties shall negotiate in good faith a transition services agreement to cover detailing and promotion of such Termination Product (in the same manner and no more extensive than the then-current detailing and promotional efforts of Sanofi) by Sanofi or its Affiliate or contract sales force pursuant to a transition plan agreed by the Parties for a period not to exceed [***], and RevMed shall pay Sanofi a commercially reasonable amount to conduct such activities (which amount would include a commercially reasonable per-detail rate).","Norm 1:
Norm type: Commitment
Subject: Sanofi or its Affiliates
Object: RevMed
Antecedent: Termination of the contract
Consequent: Negotiation of a transition services agreement for detailing and promotion of the Termination Product by Sanofi or its Affiliate or contract sales force, for a period not to exceed [***], with RevMed paying a commercially reasonable amount to Sanofi for conducting such activities.

Norm 2:
Norm type: Commitment
Subject: RevMed
Object: Sanofi
Antecedent: Termination of the contract
Consequent: RevMed shall pay Sanofi a commercially reasonable amount to conduct the detailing and promotional activities for the Termination Product, which would include a commercially reasonable per-detail rate.

Norm 3:
Norm type: Commitment
Subject: Parties
Object: Transition services agreement
Antecedent: Termination of the contract
Consequent: The Parties shall negotiate in good faith a transition services agreement to cover detailing and promotion of the Termination Product, in the same manner and no more extensive than the then-current detailing and promotional efforts of Sanofi, for a period not to exceed [***].

Norm 4:
Norm type: Authorization
Subject: Sanofi or its Affiliates
Object: Transition services agreement
Antecedent: Termination of the contract
Consequent: Sanofi or its Affiliates are authorized to perform detailing and promotion of the Termination Product as per the transition services agreement.

Norm 5:
Norm type: Prohibition
Subject: Parties
Object: Transition services agreement
Antecedent: None mentioned
Consequent: The transition services agreement should not be more extensive than the then-current detailing and promotional efforts of Sanofi.","Norm 1:
1. Norm type: Commitment
2. Subject: Sanofi or its Affiliates
3. Object: RevMed
4. Antecedent: Termination of the contract
5. Consequent: Negotiate in good faith a transition services agreement to cover detailing and promotion of the Termination Product
6. Clause: ""at RevMed's request, the Parties shall negotiate in good faith a transition services agreement to cover detailing and promotion of such Termination Product""

Norm 2:
1. Norm type: Commitment
2. Subject: RevMed
3. Object: Sanofi or its Affiliates
4. Antecedent: Termination of the contract
5. Consequent: Pay Sanofi a commercially reasonable amount to conduct detailing and promotional activities
6. Clause: ""RevMed shall pay Sanofi a commercially reasonable amount to conduct such activities (which amount would include a commercially reasonable per-detail rate)""","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi or its Affiliates
3. OBJECT: RevMed
4. ANTECEDENT: Termination of the contract
5. CONSEQUENT: Negotiate in good faith a transition services agreement to cover detailing and promotion of the Termination Product
CLAUSE: ""at RevMed's request, the Parties shall negotiate in good faith a transition services agreement to cover detailing and promotion of such Termination Product""

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: RevMed
3. OBJECT: Sanofi or its Affiliates
4. ANTECEDENT: Termination of the contract
5. CONSEQUENT: Pay Sanofi a commercially reasonable amount to conduct detailing and promotional activities
CLAUSE: ""RevMed shall pay Sanofi a commercially reasonable amount to conduct such activities""","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi or its Affiliates
3. OBJECT: RevMed
4. ANTECEDENT: Termination of the contract
5. CONSEQUENT: Negotiate in good faith a transition services agreement for detailing and promotion of the Termination Product

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: RevMed
3. OBJECT: Sanofi or its Affiliate or contract sales force
4. ANTECEDENT: Termination of the contract
5. CONSEQUENT: Pay Sanofi a commercially reasonable amount to conduct detailing and promotional activities for the Termination Product","1. Norm type: authorization
2. Subject: RevMed
3. Object: Sanofi or its Affiliates
4. Antecedent: Termination of the contract
5. Consequent: Negotiation of a transition services agreement for detailing and promotion of the Termination Product by Sanofi or its Affiliate or contract sales force for a specified period with payment to Sanofi. 

2. Norm type: commitment
2. Subject: Sanofi or its Affiliates
3. Object: RevMed
4. Antecedent: Termination of the contract
5. Consequent: Negotiation of a transition services agreement for detailing and promotion of the Termination Product by Sanofi or its Affiliate or contract sales force for a specified period with payment from RevMed."
70,"Upon the termination or expiration of the Franchise, we will have the option, but not the obligation, exercisable for thirty (30) days upon written notice to you, to purchase at fair market value all of the assets of the Franchise, including all approved equipment, fixtures, furniture and signs and all supplies, materials, and other items imprinted with any Mark, and to take an assignment of the lease for the Premises and any other lease or concession agreement necessary for the operation of the Franchise","1. Norm type: Authorization
Subject: We
Object: You
Antecedent: Termination or expiration of the Franchise
Consequent: We have the option to purchase all assets of the Franchise, including equipment, fixtures, furniture, signs, supplies, materials, and other items imprinted with any Mark, and to take an assignment of the lease for the Premises and any other lease or concession agreement necessary for the operation of the Franchise.

2. Norm type: Commitment
Subject: We
Object: You
Antecedent: Termination or expiration of the Franchise
Consequent: We commit to providing written notice to you within thirty (30) days to exercise the option to purchase the assets of the Franchise at fair market value.

3. Norm type: Commitment
Subject: You
Object: We
Antecedent: Termination or expiration of the Franchise
Consequent: You commit to providing us with written notice to exercise the option to purchase the assets of the Franchise at fair market value.

4. Norm type: Authorization
Subject: We
Object: You
Antecedent: Termination or expiration of the Franchise
Consequent: We have the authority to purchase all assets of the Franchise at fair market value, including equipment, fixtures, furniture, signs, supplies, materials, and other items imprinted with any Mark, and to take an assignment of the lease for the Premises and any other lease or concession agreement necessary for the operation of the Franchise.

5. Norm type: Prohibition
Subject: We
Object: None specified
Antecedent: None specified
Consequent: We are not obligated to exercise the option to purchase the assets of the Franchise.","Norm 1:
1. Norm type: Power
2. Subject: We
3. Object: You
4. Antecedent: Termination or expiration of the Franchise
5. Consequent: Option to purchase all assets of the Franchise, including equipment, fixtures, furniture, signs, supplies, materials, and other items imprinted with any Mark, and to take an assignment of the lease for the Premises and any other lease or concession agreement necessary for the operation of the Franchise.

Norm 2:
1. Norm type: Commitment
2. Subject: We
3. Object: You
4. Antecedent: Termination or expiration of the Franchise
5. Consequent: Purchase all assets of the Franchise, including equipment, fixtures, furniture, signs, supplies, materials, and other items imprinted with any Mark, and take an assignment of the lease for the Premises and any other lease or concession agreement necessary for the operation of the Franchise.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: We
3. OBJECT: you
4. ANTECEDENT: Upon the termination or expiration of the Franchise
5. CONSEQUENT: We will have the option to purchase at fair market value all assets of the Franchise, including equipment, fixtures, furniture, signs, supplies, materials, and other items imprinted with any Mark, and to take an assignment of the lease for the Premises and any other lease or concession agreement necessary for the operation of the Franchise.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: We
3. OBJECT: you
4. ANTECEDENT: Upon the termination or expiration of the Franchise
5. CONSEQUENT: We will have the option to purchase at fair market value all assets of the Franchise, including equipment, fixtures, furniture, signs, supplies, materials, and other items imprinted with any Mark, and to take an assignment of the lease for the Premises and any other lease or concession agreement necessary for the operation of the Franchise, exercisable for thirty (30) days upon written notice to you.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: we
3. OBJECT: you
4. ANTECEDENT: termination or expiration of the Franchise
5. CONSEQUENT: purchase at fair market value all assets of the Franchise, including equipment, fixtures, furniture, signs, supplies, materials, and other items imprinted with any Mark, and take an assignment of the lease for the Premises and any other lease or concession agreement necessary for the operation of the Franchise

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: you
3. OBJECT: we
4. ANTECEDENT: termination or expiration of the Franchise
5. CONSEQUENT: allow us the option, but not the obligation, exercisable for thirty (30) days upon written notice, to purchase at fair market value all assets of the Franchise, including equipment, fixtures, furniture, signs, supplies, materials, and other items imprinted with any Mark, and to take an assignment of the lease for the Premises and any other lease or concession agreement necessary for the operation of the Franchise","Norm 1:
1. Norm type: Authorization
2. Subject: We
3. Object: you
4. Antecedent: Termination or expiration of the Franchise
5. Consequent: Purchase all assets of the Franchise, including equipment, fixtures, furniture, signs, supplies, materials, and other items imprinted with any Mark, and take an assignment of the lease for the Premises and any other lease or concession agreement necessary for the operation of the Franchise

Norm 2:
1. Norm type: Power
2. Subject: We
3. Object: you
4. Antecedent: Termination or expiration of the Franchise
5. Consequent: Purchase all assets of the Franchise, including equipment, fixtures, furniture, signs, supplies, materials, and other items imprinted with any Mark, and take an assignment of the lease for the Premises and any other lease or concession agreement necessary for the operation of the Franchise (causing a change in existing norms)"
71,"Upon termination of this Agreement for any reason except as set forth in Section 17.4 below (and, if applicable, in respect of that country in  respect of which termination occurs):<omitted>(b) the following provisions of this Agreement shall continue in full force and effect: Article 1 (""Definitions""), Section 3.20(k),  Section 3.20(l), Article 9 (""Representations and Warranties""), Article 10 (""Liability, Insurance and Indemnities"") (excluding  Section 10.6 (""Insurance"")), Article 11 (""Confidentiality, Press Releases and Publications""), Article 13 (""Infringement of  Third Party Rights""), Section 16.4 (""Effect of Termination""), Article 17 (""Consequences of Termination""), Article 18 (""Force  Majeure""), Article 19 (""Notices""), Article 20 (""Assignment and Change of Control"") and Article 21 (""General Provisions"");     (c) EKR shall return to PPI all PPI IP in its possession;     (d) EKR shall assign to PPI free of charge any domain name registrations it has registered pursuant to Section 8.5; and

  (e) Except in the event of termination of this Agreement by EKR pursuant to Section 16.1(a), EKR shall promptly transfer to PPI  or its nominee, each and every Marketing Authorization (to the extent not held by PPI) relating to the Product, together  with all communications with the relevant Regulatory Authorities, and all notes and record thereof.","Norm 1:
Norm type: Commitment
Subject: EKR
Object: PPI
Antecedent: Termination of this Agreement for any reason except as set forth in Section 17.4 below
Consequent: EKR shall return to PPI all PPI IP in its possession

Norm 2:
Norm type: Commitment
Subject: EKR
Object: PPI
Antecedent: Termination of this Agreement for any reason except as set forth in Section 17.4 below
Consequent: EKR shall assign to PPI free of charge any domain name registrations it has registered pursuant to Section 8.5

Norm 3:
Norm type: Commitment
Subject: EKR
Object: PPI or its nominee
Antecedent: Termination of this Agreement by EKR pursuant to Section 16.1(a)
Consequent: EKR shall promptly transfer to PPI or its nominee, each and every Marketing Authorization (to the extent not held by PPI) relating to the Product, together with all communications with the relevant Regulatory Authorities, and all notes and record thereof.","Norm 1:
1. Norm type: Commitment
2. Subject: EKR
3. Object: PPI
4. Antecedent: Termination of the Agreement for any reason except as set forth in Section 17.4
5. Consequent: EKR shall return to PPI all PPI IP in its possession; EKR shall assign to PPI free of charge any domain name registrations it has registered pursuant to Section 8.5; EKR shall promptly transfer to PPI or its nominee, each and every Marketing Authorization (to the extent not held by PPI) relating to the Product, together with all communications with the relevant Regulatory Authorities, and all notes and record thereof.

Norm 2:
1. Norm type: Authorization
2. Subject: EKR
3. Object: PPI
4. Antecedent: Termination of the Agreement by EKR pursuant to Section 16.1(a)
5. Consequent: EKR shall promptly transfer to PPI or its nominee, each and every Marketing Authorization (to the extent not held by PPI) relating to the Product, together with all communications with the relevant Regulatory Authorities, and all notes and record thereof.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: EKR
3. OBJECT: PPI
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Transfer of Marketing Authorization relating to the Product to PPI or its nominee

CLAUSE: EKR shall promptly transfer to PPI or its nominee, each and every Marketing Authorization (to the extent not held by PPI) relating to the Product, together with all communications with the relevant Regulatory Authorities, and all notes and record thereof.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: EKR
3. OBJECT: PPI
4. ANTECEDENT: Termination of the Agreement by EKR pursuant to Section 16.1(a)
5. CONSEQUENT: Not applicable

CLAUSE: Not applicable

NORM 3:
1. NORM type: COMMITMENT
2. SUBJECT: EKR
3. OBJECT: PPI
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Return of PPI IP in possession

CLAUSE: EKR shall return to PPI all PPI IP in its possession. 

NORM 4:
1. NORM type: COMMITMENT
2. SUBJECT: EKR
3. OBJECT: PPI
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Assignment of domain name registrations pursuant to Section 8.5 to PPI free of charge

CLAUSE: EKR shall assign to PPI free of charge any domain name registrations it has registered pursuant to Section 8.5.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: EKR
3. OBJECT: PPI
4. ANTECEDENT: Termination of the Agreement by EKR pursuant to Section 16.1(a)
5. CONSEQUENT: EKR shall transfer each Marketing Authorization relating to the Product to PPI or its nominee, along with all relevant communications and records.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: EKR
3. OBJECT: PPI
4. ANTECEDENT: Termination of the Agreement for any reason except as set forth in Section 17.4
5. CONSEQUENT: EKR shall return all PPI IP in its possession and assign domain name registrations to PPI as specified in the contract.","1. Norm type: Authorization
2. Subject: EKR
3. Object: PPI
4. Antecedent: Termination of the Agreement by EKR pursuant to Section 16.1(a)
5. Consequent: Prompt transfer of Marketing Authorization relating to the Product, communications with Regulatory Authorities, and all related notes and records. 

1. Norm type: Commitment
2. Subject: EKR
3. Object: PPI
4. Antecedent: Termination of the Agreement for any reason except as set forth in Section 17.4
5. Consequent: Return of all PPI IP in EKR's possession and assignment of domain name registrations to PPI."
72,"During the Term, if Exact (i) enters a formal process authorized or directed by its board of directors or CEO to seek and enter into an arrangement or (ii) intends to agree to a term sheet or seeks to sign a letter of intent or similar arrangement to grant an exclusive commercial license to a Third Party solely to promote or sell the Product outside the Territory (""Ex-US Commercial Rights""), Exact shall first notify Pfizer of such intent (a ""Ex-US Commercial Rights Transfer Notice"") and Pfizer shall have thirty (30) days thereafter to notify Exact of its desire to obtain the Ex-US Commercial Rights that are the subject of the Ex-US Commercial Rights Transfer Notice.","Norm 1:
Norm type: Authorization
Subject: Exact
Object: Third Party
Antecedent: Exact enters a formal process authorized or directed by its board of directors or CEO to seek and enter into an arrangement
Consequent: Exact is authorized to grant an exclusive commercial license to a Third Party solely to promote or sell the Product outside the Territory (""Ex-US Commercial Rights"")

Norm 2:
Norm type: Commitment
Subject: Exact
Object: Pfizer
Antecedent: Exact intends to agree to a term sheet or seeks to sign a letter of intent or similar arrangement
Consequent: Exact shall first notify Pfizer of such intent (a ""Ex-US Commercial Rights Transfer Notice"")

Norm 3:
Norm type: Commitment
Subject: Pfizer
Object: Exact
Antecedent: Pfizer receives the Ex-US Commercial Rights Transfer Notice
Consequent: Pfizer shall have thirty (30) days thereafter to notify Exact of its desire to obtain the Ex-US Commercial Rights that are the subject of the Ex-US Commercial Rights Transfer Notice.","Norm 1:
1. Norm type: Authorization
2. Subject: Exact
3. Object: Pfizer
4. Antecedent: Exact enters a formal process authorized or directed by its board of directors or CEO to seek and enter into an arrangement
5. Consequent: Exact shall first notify Pfizer of such intent

Clause: Exact is authorized to notify Pfizer if it enters a formal process authorized or directed by its board of directors or CEO to seek and enter into an arrangement.

Norm 2:
1. Norm type: Authorization
2. Subject: Exact
3. Object: Pfizer
4. Antecedent: Exact intends to agree to a term sheet or seeks to sign a letter of intent or similar arrangement to grant an exclusive commercial license to a Third Party solely to promote or sell the Product outside the Territory
5. Consequent: Exact shall first notify Pfizer of such intent

Clause: Exact is authorized to notify Pfizer if it intends to agree to a term sheet or seeks to sign a letter of intent or similar arrangement to grant an exclusive commercial license to a Third Party solely to promote or sell the Product outside the Territory.

Norm 3:
1. Norm type: Commitment
2. Subject: Pfizer
3. Object: Exact
4. Antecedent: Exact notifies Pfizer of its intent to transfer Ex-US Commercial Rights
5. Consequent: Pfizer shall have thirty (30) days to notify Exact of its desire to obtain the Ex-US Commercial Rights

Clause: Pfizer commits to notifying Exact within thirty (30) days of receiving the Ex-US Commercial Rights Transfer Notice if it desires to obtain the Ex-US Commercial Rights.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Exact
3. OBJECT: Pfizer
4. ANTECEDENT: Exact enters a formal process authorized or directed by its board of directors or CEO to seek and enter into an arrangement or intends to agree to a term sheet or seeks to sign a letter of intent or similar arrangement to grant an exclusive commercial license to a Third Party solely to promote or sell the Product outside the Territory
5. CONSEQUENT: Exact shall first notify Pfizer of such intent (a ""Ex-US Commercial Rights Transfer Notice"") and Pfizer shall have thirty (30) days thereafter to notify Exact of its desire to obtain the Ex-US Commercial Rights that are the subject of the Ex-US Commercial Rights Transfer Notice.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Pfizer
3. OBJECT: Exact
4. ANTECEDENT: Exact enters a formal process authorized or directed by its board of directors or CEO to seek and enter into an arrangement or intends to agree to a term sheet or seeks to sign a letter of intent or similar arrangement to grant an exclusive commercial license to a Third Party solely to promote or sell the Product outside the Territory
5. CONSEQUENT: Pfizer shall have thirty (30) days thereafter to notify Exact of its desire to obtain the Ex-US Commercial Rights that are the subject of the Ex-US Commercial Rights Transfer Notice.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Exact
3. OBJECT: Pfizer
4. ANTECEDENT: Exact enters a formal process authorized or directed by its board of directors or CEO to seek and enter into an arrangement
5. CONSEQUENT: Exact shall first notify Pfizer of such intent

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Pfizer
3. OBJECT: Exact
4. ANTECEDENT: Pfizer receives the Ex-US Commercial Rights Transfer Notice
5. CONSEQUENT: Pfizer shall have thirty (30) days to notify Exact of its desire to obtain the Ex-US Commercial Rights","1. Norm type: authorization
2. Subject: Exact
3. Object: Pfizer
4. Antecedent: Exact enters a formal process authorized or directed by its board of directors or CEO to seek and enter into an arrangement or intends to agree to a term sheet or seeks to sign a letter of intent or similar arrangement to grant an exclusive commercial license to a Third Party solely to promote or sell the Product outside the Territory
5. Consequent: Exact shall first notify Pfizer of such intent (a ""Ex-US Commercial Rights Transfer Notice"") and Pfizer shall have thirty (30) days thereafter to notify Exact of its desire to obtain the Ex-US Commercial Rights that are the subject of the Ex-US Commercial Rights Transfer Notice."
73,"In addition, Metavante agrees to provide to Customer, at Customer's expense, all necessary assistance to facilitate the orderly transition of Services to Customer or its designee (""Termination Assistance""). As part of the Termination Assistance, Metavante shall assist Customer to develop a plan for the transition of all Services then being performed by Metavante under this Agreement, from Metavante to Customer or Customer's designee, on a reasonable schedule developed jointly by Metavante and Customer.","1. Norm type: Commitment
Subject: Metavante
Object: Customer
Antecedent: None mentioned
Consequent: Metavante agrees to provide necessary assistance to facilitate the orderly transition of Services to Customer or its designee.

2. Norm type: Authorization
Subject: Metavante
Object: Customer
Antecedent: None mentioned
Consequent: Metavante agrees to provide necessary assistance to facilitate the orderly transition of Services to Customer or its designee.

3. Norm type: Commitment
Subject: Metavante
Object: Customer
Antecedent: None mentioned
Consequent: Metavante shall assist Customer to develop a plan for the transition of all Services then being performed by Metavante under this Agreement, from Metavante to Customer or Customer's designee.

4. Norm type: Commitment
Subject: Metavante
Object: Customer
Antecedent: None mentioned
Consequent: The plan for the transition of all Services will be developed on a reasonable schedule jointly by Metavante and Customer.

5. Norm type: Commitment
Subject: Metavante
Object: Customer
Antecedent: None mentioned
Consequent: The transition of all Services from Metavante to Customer or Customer's designee will be performed on a reasonable schedule developed jointly by Metavante and Customer.","Norm 1:
1. Norm type: Commitment
2. Subject: Metavante
3. Object: Customer
4. Antecedent: Termination of the Agreement
5. Consequent: Providing necessary assistance for the orderly transition of Services to Customer or its designee

Norm 2:
1. Norm type: Authorization
2. Subject: Metavante
3. Object: Customer
4. Antecedent: Termination of the Agreement
5. Consequent: Assisting Customer to develop a transition plan for all Services being performed by Metavante, on a reasonable schedule jointly developed by both parties.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Metavante
3. OBJECT: Customer
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Providing necessary assistance for the orderly transition of Services to Customer or its designee

CLAUSE: Metavante agrees to provide to Customer, at Customer's expense, all necessary assistance to facilitate the orderly transition of Services to Customer or its designee (""Termination Assistance"").

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Metavante
3. OBJECT: Customer
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Assisting Customer in developing a plan for the transition of all Services from Metavante to Customer or Customer's designee on a reasonable schedule

CLAUSE: As part of the Termination Assistance, Metavante shall assist Customer to develop a plan for the transition of all Services then being performed by Metavante under this Agreement, from Metavante to Customer or Customer's designee, on a reasonable schedule developed jointly by Metavante and Customer.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Metavante
3. OBJECT: Customer
4. ANTECEDENT: Termination Assistance is required
5. CONSEQUENT: Metavante agrees to provide necessary assistance for the transition of Services to Customer or its designee

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Customer
3. OBJECT: Metavante
4. ANTECEDENT: Termination Assistance is required
5. CONSEQUENT: Customer is authorized to develop a transition plan for the Services with assistance from Metavante.","Norm 1:
1. Norm type: Commitment
2. Subject: Metavante
3. Object: Customer
4. Antecedent: Termination Assistance is required
5. Consequent: Metavante agrees to provide all necessary assistance to facilitate the orderly transition of Services to Customer or its designee

Norm 2:
1. Norm type: Authorization
2. Subject: Metavante
3. Object: Customer
4. Antecedent: Termination Assistance is required
5. Consequent: Metavante shall assist Customer to develop a plan for the transition of all Services then being performed by Metavante under this Agreement, from Metavante to Customer or Customer's designee, on a reasonable schedule developed jointly by Metavante and Customer."
74,"DIALOG will have the right to terminate this Agreement immediately upon the issuance of written notice to ENERGOUS (A) if ENERGOUS undergoes a Change of Control involving a competitor of DIALOG, or (B) if ENERGOUS acquires, whether directly through a sale of assets or through a Change of Control transaction, any competitor of DIALOG (as reasonably determined by DIALOG). ENERGOUS will provide DIALOG with notice of any such Change of Control or acquisition within [***] after the closing thereof and DIALOG's right to terminate the Agreement will expire [***] after receipt of such notice.","Norm 1:
Norm type: Authorization
Subject: DIALOG
Object: ENERGOUS
Antecedent: ENERGOUS undergoes a Change of Control involving a competitor of DIALOG
Consequent: DIALOG will have the right to terminate this Agreement immediately upon the issuance of written notice to ENERGOUS

Norm 2:
Norm type: Authorization
Subject: DIALOG
Object: ENERGOUS
Antecedent: ENERGOUS acquires, whether directly through a sale of assets or through a Change of Control transaction, any competitor of DIALOG (as reasonably determined by DIALOG)
Consequent: DIALOG will have the right to terminate this Agreement immediately upon the issuance of written notice to ENERGOUS

Norm 3:
Norm type: Commitment
Subject: ENERGOUS
Object: DIALOG
Antecedent: ENERGOUS undergoes a Change of Control involving a competitor of DIALOG or acquires any competitor of DIALOG
Consequent: ENERGOUS will provide DIALOG with notice of any such Change of Control or acquisition within [***] after the closing thereof

Norm 4:
Norm type: Commitment
Subject: ENERGOUS
Object: DIALOG
Antecedent: ENERGOUS undergoes a Change of Control involving a competitor of DIALOG or acquires any competitor of DIALOG
Consequent: DIALOG's right to terminate the Agreement will expire [***] after receipt of such notice.","Norm 1:
1. Norm type: Power
2. Subject: DIALOG
3. Object: ENERGOUS
4. Antecedent: ENERGOUS undergoes a Change of Control involving a competitor of DIALOG
5. Consequent: DIALOG will have the right to terminate this Agreement immediately upon the issuance of written notice to ENERGOUS

Norm 2:
1. Norm type: Power
2. Subject: DIALOG
3. Object: ENERGOUS
4. Antecedent: ENERGOUS acquires, whether directly through a sale of assets or through a Change of Control transaction, any competitor of DIALOG (as reasonably determined by DIALOG)
5. Consequent: DIALOG will have the right to terminate this Agreement immediately upon the issuance of written notice to ENERGOUS

Norm 3:
1. Norm type: Commitment
2. Subject: ENERGOUS
3. Object: DIALOG
4. Antecedent: ENERGOUS undergoes a Change of Control involving a competitor of DIALOG or acquires any competitor of DIALOG
5. Consequent: ENERGOUS will provide DIALOG with notice of any such Change of Control or acquisition within [***] after the closing thereof and DIALOG's right to terminate the Agreement will expire [***] after receipt of such notice.","1. NORM type: AUTHORIZATION
2. SUBJECT: DIALOG
3. OBJECT: ENERGOUS
4. ANTECEDENT: ENERGOUS undergoes a Change of Control involving a competitor of DIALOG or acquires any competitor of DIALOG
5. CONSEQUENT: DIALOG will have the right to terminate the Agreement immediately upon the issuance of written notice to ENERGOUS

6. NORM type: COMMITMENT
7. SUBJECT: ENERGOUS
8. OBJECT: DIALOG
9. ANTECEDENT: N/A
10. CONSEQUENT: ENERGOUS will provide DIALOG with notice of any Change of Control or acquisition involving a competitor of DIALOG within [***] after the closing thereof and DIALOG's right to terminate the Agreement will expire [***] after receipt of such notice.","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: ENERGOUS
3. OBJECT: DIALOG
4. ANTECEDENT: ENERGOUS undergoes a Change of Control involving a competitor of DIALOG
5. CONSEQUENT: DIALOG will have the right to terminate the Agreement immediately upon the issuance of written notice to ENERGOUS

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: ENERGOUS
3. OBJECT: DIALOG
4. ANTECEDENT: ENERGOUS acquires, whether directly through a sale of assets or through a Change of Control transaction, any competitor of DIALOG (as reasonably determined by DIALOG)
5. CONSEQUENT: DIALOG will have the right to terminate the Agreement immediately upon the issuance of written notice to ENERGOUS","1. Norm type: 
- Authorization: DIALOG authorizes ENERGOUS to terminate the Agreement immediately upon the issuance of written notice.
- Prohibition: ENERGOUS is prohibited by DIALOG from undergoing a Change of Control involving a competitor of DIALOG or acquiring any competitor of DIALOG.

2. Subject:
- Authorization: ENERGOUS
- Prohibition: ENERGOUS

3. Object:
- Authorization: DIALOG
- Prohibition: DIALOG

4. Antecedent:
- Authorization: Undergoes a Change of Control involving a competitor of DIALOG or acquires a competitor of DIALOG.
- Prohibition: Undergoes a Change of Control involving a competitor of DIALOG or acquires a competitor of DIALOG.

5. Consequent:
- Authorization: Termination of the Agreement immediately upon the issuance of written notice.
- Prohibition: ENERGOUS is prohibited from undergoing a Change of Control involving a competitor of DIALOG or acquiring any competitor of DIALOG."
75,"In the case of a termination of this Agreement, Sanofi (with respect to the Termination Products in the Licensed Territory), shall be entitled, for a period of [***] after termination, to (i) complete Manufacture of work-in-progress, and (ii) continue conducting Commercialization activities being conducted by Sanofi hereunder as of such termination (if applicable, with respect to the terminated country(ies)), to the extent related to such Termination Product in Sanofi's inventory as of such termination (or added to such inventory as a result of the completion described in clause (i)), provided that Sanofi fulfills its payment obligations under this Agreement in connection with such inventory sell-off, provided further that the sharing of Net Profits and Net Losses under the Profit/Loss Share Agreement shall continue to apply during the sell-off period.","Norm 1:
Norm type: Authorization
Subject: Sanofi
Object: Termination Products in the Licensed Territory
Antecedent: Termination of this Agreement
Consequent: Sanofi shall be entitled to complete Manufacture of work-in-progress and continue conducting Commercialization activities related to the Termination Product in Sanofi's inventory.

Norm 2:
Norm type: Commitment
Subject: Sanofi
Object: Termination Products in the Licensed Territory
Antecedent: Termination of this Agreement
Consequent: Sanofi shall fulfill its payment obligations under this Agreement in connection with the inventory sell-off.

Norm 3:
Norm type: Authorization
Subject: Sanofi
Object: Termination Products in the Licensed Territory
Antecedent: Termination of this Agreement
Consequent: Sanofi shall be entitled to add the completed Manufacture to its inventory.

Norm 4:
Norm type: Commitment
Subject: Sanofi
Object: Termination Products in the Licensed Territory
Antecedent: Termination of this Agreement
Consequent: The sharing of Net Profits and Net Losses under the Profit/Loss Share Agreement shall continue to apply during the sell-off period.

Norm 5:
Norm type: Commitment
Subject: Sanofi
Object: Termination Products in the Licensed Territory
Antecedent: Termination of this Agreement
Consequent: Sanofi shall fulfill its payment obligations under this Agreement in connection with the inventory sell-off.","Norm 1:
1. Norm type: Authorization
2. Subject: Sanofi
3. Object: Termination Products in the Licensed Territory
4. Antecedent: Termination of the Agreement
5. Consequent: Sanofi shall be entitled to complete Manufacture of work-in-progress and continue conducting Commercialization activities related to the Termination Product in Sanofi's inventory as of termination, provided Sanofi fulfills its payment obligations under the Agreement in connection with such inventory sell-off.

Norm 2:
1. Norm type: Commitment
2. Subject: Sanofi
3. Object: Payment obligations under the Agreement
4. Antecedent: Termination of the Agreement
5. Consequent: Sanofi shall fulfill its payment obligations under the Agreement in connection with the inventory sell-off of the Termination Product. 

Norm 3:
1. Norm type: Authorization
2. Subject: Sanofi
3. Object: Profit/Loss Share Agreement
4. Antecedent: Termination of the Agreement
5. Consequent: The sharing of Net Profits and Net Losses under the Profit/Loss Share Agreement shall continue to apply during the sell-off period.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Sanofi
3. OBJECT: Termination Products in the Licensed Territory
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Sanofi shall be entitled to complete Manufacture of work-in-progress and continue conducting Commercialization activities related to the Termination Product in Sanofi's inventory as of termination.

CLAUSE: Sanofi is authorized to complete Manufacture of work-in-progress and continue conducting Commercialization activities related to the Termination Product in Sanofi's inventory as of termination.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Sanofi
3. OBJECT: Termination Products in the Licensed Territory
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Sanofi shall be entitled to continue conducting Commercialization activities being conducted by Sanofi hereunder as of termination, with respect to the terminated country(ies), to the extent related to such Termination Product in Sanofi's inventory as of termination (or added to such inventory as a result of the completion described in clause (i)).

CLAUSE: Sanofi is authorized to continue conducting Commercialization activities with respect to the terminated country(ies) related to the Termination Product in Sanofi's inventory as of termination.

NORM 3:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: Payment obligations under the Agreement
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Sanofi shall fulfill its payment obligations under the Agreement in connection with the inventory sell-off during the specified period.

CLAUSE: Sanofi commits to fulfilling its payment obligations under the Agreement in connection with the inventory sell-off during the specified period.

NORM 4:
1. NORM type: AUTHORIZATION
2. SUBJECT: Sanofi
3. OBJECT: Profit/Loss Share Agreement
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: The sharing of Net Profits and Net Losses under the Profit/Loss Share Agreement shall continue to apply during the sell-off period.

CLAUSE: Sanofi is authorized to continue the sharing of Net Profits and Net Losses under the Profit/Loss Share Agreement during the sell-off period.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Sanofi
3. OBJECT: Termination Products in the Licensed Territory
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Sanofi shall be entitled to complete Manufacture of work-in-progress and continue conducting Commercialization activities related to the Termination Product in Sanofi's inventory

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: Payment obligations under the Agreement
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Sanofi shall fulfill its payment obligations in connection with the inventory sell-off

NORM 3:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: Sharing of Net Profits and Net Losses under the Profit/Loss Share Agreement
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Sharing of Net Profits and Net Losses shall continue to apply during the sell-off period.","Norm 1:
1. Norm type: Authorization
2. Subject: Sanofi
3. Object: Termination Products in the Licensed Territory
4. Antecedent: Termination of the Agreement
5. Consequent: Sanofi shall be entitled to complete Manufacture of work-in-progress and continue conducting Commercialization activities related to the Termination Product in Sanofi's inventory.

Norm 2:
1. Norm type: Commitment
2. Subject: Sanofi
3. Object: Payment obligations under the Agreement
4. Antecedent: Inventory sell-off
5. Consequent: Sanofi must fulfill its payment obligations under the Agreement in connection with the inventory sell-off."
76,Licensee shall notify Bioeq in writing within [***] ([***]) days after entry by Licensee into a definitive agreement which would result in a Competitor Change of Control.,"1. Norm type: Commitment
2. Subject: Licensee
3. Object: Bioeq
4. Antecedent: Entry by Licensee into a definitive agreement which would result in a Competitor Change of Control
5. Consequent: Licensee shall notify Bioeq in writing within [***] ([***]) days","Norm 1:
1. Norm type: Commitment
2. Subject: Licensee
3. Object: Bioeq
4. Antecedent: Entry by Licensee into a definitive agreement
5. Consequent: Competitor Change of Control

Norm 2:
1. Norm type: Authorization
2. Subject: Licensee
3. Object: Bioeq
4. Antecedent: Entry by Licensee into a definitive agreement
5. Consequent: Notify Bioeq in writing within [***] ([***]) days","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Licensee
3. OBJECT: Bioeq
4. ANTECEDENT: Licensee entering into a definitive agreement resulting in a Competitor Change of Control
5. CONSEQUENT: Licensee shall notify Bioeq in writing within [***] ([***]) days

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Bioeq
3. OBJECT: Licensee
4. ANTECEDENT: Licensee entering into a definitive agreement resulting in a Competitor Change of Control
5. CONSEQUENT: Bioeq authorizes Licensee to notify them in writing within [***] ([***]) days","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Licensee
3. OBJECT: Bioeq
4. ANTECEDENT: Licensee entering into a definitive agreement resulting in a Competitor Change of Control
5. CONSEQUENT: Licensee notifying Bioeq in writing within [***] ([***]) days

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Licensee
3. OBJECT: Bioeq
4. ANTECEDENT: Licensee entering into a definitive agreement resulting in a Competitor Change of Control
5. CONSEQUENT: Licensee not bringing about the Competitor Change of Control without notifying Bioeq","Norm 1:
1. Norm type: Commitment
2. Subject: Licensee
3. Object: Bioeq
4. Antecedent: Entry by Licensee into a definitive agreement
5. Consequent: Competitor Change of Control

Norm 2:
1. Norm type: Authorization
2. Subject: Bioeq
3. Object: Licensee
4. Antecedent: Licensee notifying Bioeq in writing within [***] ([***]) days
5. Consequent: Competitor Change of Control"
77,"During the term of this Agreement, if MSL decides to sell a substantial       portion of its assets or operations outside the ordinary course of its       business, or to merge or transfer ownership of MSL to a third Party, MSL       will immediately notify IBM.","Norm 1:
Norm type: Authorization
Subject: MSL
Object: IBM
Antecedent: MSL decides to sell a substantial portion of its assets or operations outside the ordinary course of its business, or to merge or transfer ownership of MSL to a third Party
Consequent: MSL will immediately notify IBM

Norm 2:
Norm type: Commitment
Subject: MSL
Object: N/A
Antecedent: N/A
Consequent: MSL commits to notifying IBM if it decides to sell a substantial portion of its assets or operations outside the ordinary course of its business, or to merge or transfer ownership of MSL to a third Party

Norm 3:
Norm type: Commitment
Subject: IBM
Object: N/A
Antecedent: N/A
Consequent: IBM expects to be immediately notified by MSL if MSL decides to sell a substantial portion of its assets or operations outside the ordinary course of its business, or to merge or transfer ownership of MSL to a third Party

Norm 4:
Norm type: Prohibition
Subject: N/A
Object: MSL
Antecedent: N/A
Consequent: MSL is prohibited from failing to notify IBM if it decides to sell a substantial portion of its assets or operations outside the ordinary course of its business, or to merge or transfer ownership of MSL to a third Party

Norm 5:
Norm type: Prohibition
Subject: N/A
Object: N/A
Antecedent: N/A
Consequent: No party is allowed to sell a substantial portion of MSL's assets or operations outside the ordinary course of its business, or to merge or transfer ownership of MSL to a third Party without immediately notifying IBM.","Norm 1:
1. Norm type: Commitment
2. Subject: MSL
3. Object: IBM
4. Antecedent: MSL decides to sell a substantial portion of its assets or operations outside the ordinary course of its business, or to merge or transfer ownership of MSL to a third party
5. Consequent: MSL will immediately notify IBM

Norm 2:
1. Norm type: Authorization
2. Subject: MSL
3. Object: IBM
4. Antecedent: MSL decides to sell a substantial portion of its assets or operations outside the ordinary course of its business, or to merge or transfer ownership of MSL to a third party
5. Consequent: MSL is authorized to sell a substantial portion of its assets or operations outside the ordinary course of its business, or to merge or transfer ownership of MSL to a third party","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: MSL
3. OBJECT: IBM
4. ANTECEDENT: MSL decides to sell a substantial portion of its assets or operations outside the ordinary course of its business, or to merge or transfer ownership of MSL to a third Party
5. CONSEQUENT: MSL will immediately notify IBM

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: MSL
3. OBJECT: IBM
4. ANTECEDENT: None
5. CONSEQUENT: MSL will notify IBM during the term of this Agreement if the conditions specified in the contract are met.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: MSL
3. OBJECT: IBM
4. ANTECEDENT: MSL decides to sell a substantial portion of its assets or operations outside the ordinary course of its business, or to merge or transfer ownership of MSL to a third Party
5. CONSEQUENT: MSL will immediately notify IBM

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: MSL
3. OBJECT: IBM
4. ANTECEDENT: MSL decides to sell a substantial portion of its assets or operations outside the ordinary course of its business, or to merge or transfer ownership of MSL to a third Party
5. CONSEQUENT: MSL will immediately notify IBM","Norm 1:
1. Norm type: Commitment
2. Subject: MSL
3. Object: IBM
4. Antecedent: MSL decides to sell a substantial portion of its assets or operations outside the ordinary course of its business, or to merge or transfer ownership of MSL to a third Party
5. Consequent: MSL will immediately notify IBM

Norm 2:
1. Norm type: Authorization
2. Subject: MSL
3. Object: IBM
4. Antecedent: MSL decides to sell a substantial portion of its assets or operations outside the ordinary course of its business, or to merge or transfer ownership of MSL to a third Party
5. Consequent: MSL will immediately notify IBM"
78,"Subject to subsections (i)-(iii) of this Section 5.1(a), each Party agrees that prior to the date that is six (6) months after the Effective Time (""Delivery Date""), it will deliver possession of any Tangible/Intangible Information of the other Party that is in its possession or control to the other Party, without retaining any copies.","1. Norm type: Commitment
2. Subject: Each Party
3. Object: The other Party
4. Antecedent: Prior to the date that is six (6) months after the Effective Time (""Delivery Date"")
5. Consequent: Deliver possession of any Tangible/Intangible Information of the other Party that is in its possession or control to the other Party, without retaining any copies.","Norm 1:
1. Norm type: Commitment
2. Subject: Each Party
3. Object: Other Party
4. Antecedent: Prior to the date that is six (6) months after the Effective Time (""Delivery Date"")
5. Consequent: Deliver possession of any Tangible/Intangible Information of the other Party that is in its possession or control to the other Party, without retaining any copies.

Norm 2:
1. Norm type: Prohibition
2. Subject: Each Party
3. Object: Other Party
4. Antecedent: Prior to the date that is six (6) months after the Effective Time (""Delivery Date"")
5. Consequent: Retaining any copies of Tangible/Intangible Information of the other Party that is in its possession or control.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Each Party
3. OBJECT: the other Party
4. ANTECEDENT: prior to the date that is six (6) months after the Effective Time (""Delivery Date"")
5. CONSEQUENT: deliver possession of any Tangible/Intangible Information of the other Party that is in its possession or control to the other Party, without retaining any copies

CLAUSE: Each Party agrees to deliver possession of any Tangible/Intangible Information of the other Party that is in its possession or control to the other Party, without retaining any copies, prior to the date that is six (6) months after the Effective Time (""Delivery Date"").

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Each Party
3. OBJECT: the other Party
4. ANTECEDENT: N/A
5. CONSEQUENT: retain any copies of Tangible/Intangible Information of the other Party that is in its possession or control

CLAUSE: Each Party is prohibited from retaining any copies of Tangible/Intangible Information of the other Party that is in its possession or control.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Each Party
3. OBJECT: the other Party
4. ANTECEDENT: prior to the date that is six (6) months after the Effective Time (""Delivery Date"")
5. CONSEQUENT: deliver possession of any Tangible/Intangible Information of the other Party that is in its possession or control to the other Party, without retaining any copies

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Each Party
3. OBJECT: the other Party
4. ANTECEDENT: prior to the date that is six (6) months after the Effective Time (""Delivery Date"")
5. CONSEQUENT: retain any copies of Tangible/Intangible Information of the other Party that is in its possession or control","Norm 1:
1. Norm type: Commitment
2. Subject: Each Party
3. Object: the other Party
4. Antecedent: prior to the date that is six (6) months after the Effective Time (""Delivery Date"")
5. Consequent: deliver possession of any Tangible/Intangible Information of the other Party that is in its possession or control to the other Party, without retaining any copies

Norm 2:
1. Norm type: Prohibition
2. Subject: Each Party
3. Object: the other Party
4. Antecedent: prior to the date that is six (6) months after the Effective Time (""Delivery Date"")
5. Consequent: retaining any copies of Tangible/Intangible Information of the other Party that is in its possession or control"
79,RevMed shall pay Sanofi such royalties until the earlier of (x) expiration of the Post-Termination Royalty Term therefor and (y) a Change of Control of Sanofi.,"Norm 1:
Norm type: Commitment
Subject: RevMed
Object: Sanofi
Antecedent: Expiration of the Post-Termination Royalty Term or a Change of Control of Sanofi
Consequent: RevMed shall pay royalties to Sanofi

Norm 2:
Norm type: Commitment
Subject: RevMed
Object: Sanofi
Antecedent: Expiration of the Post-Termination Royalty Term
Consequent: RevMed shall pay royalties to Sanofi

Norm 3:
Norm type: Commitment
Subject: RevMed
Object: Sanofi
Antecedent: A Change of Control of Sanofi
Consequent: RevMed shall pay royalties to Sanofi

Norm 4:
Norm type: Commitment
Subject: Sanofi
Object: RevMed
Antecedent: Expiration of the Post-Termination Royalty Term or a Change of Control of Sanofi
Consequent: Sanofi shall receive royalties from RevMed

Norm 5:
Norm type: Commitment
Subject: Sanofi
Object: RevMed
Antecedent: Expiration of the Post-Termination Royalty Term
Consequent: Sanofi shall receive royalties from RevMed","Norm 1:
1. Norm type: Commitment
2. Subject: RevMed
3. Object: Sanofi
4. Antecedent: Expiration of the Post-Termination Royalty Term or a Change of Control of Sanofi
5. Consequent: Payment of royalties by RevMed to Sanofi

Norm 2:
1. Norm type: Power
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: Expiration of the Post-Termination Royalty Term or a Change of Control of Sanofi
5. Consequent: Ability for Sanofi to cease receiving royalties from RevMed","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: expiration of the Post-Termination Royalty Term
5. CONSEQUENT: payment of royalties

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: Change of Control of Sanofi
5. CONSEQUENT: payment of royalties","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: expiration of the Post-Termination Royalty Term
5. CONSEQUENT: payment of royalties

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: RevMed
3. OBJECT: Sanofi
4. ANTECEDENT: Change of Control of Sanofi
5. CONSEQUENT: payment of royalties","Norm 1:
1. Norm type: Commitment
2. Subject: RevMed
3. Object: Sanofi
4. Antecedent: Expiration of the Post-Termination Royalty Term or a Change of Control of Sanofi
5. Consequent: Payment of royalties by RevMed to Sanofi

Norm 2:
1. Norm type: Authorization
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: Expiration of the Post-Termination Royalty Term or a Change of Control of Sanofi
5. Consequent: Receipt of royalties by Sanofi from RevMed"
80,"If AbbVie provides the License Option Exercise Notice during the License Option Period, upon AbbVie's request, the Parties shall work together in good faith to conduct an analysis of whether any filings or notifications are or may be required to be filed under the HSR Act (the ""HSR Filing"") or any similar applicable foreign law or regulation in connection with AbbVie's exercise of the License Option.","1. Norm type: Commitment
Subject: Parties
Object: AbbVie
Antecedent: AbbVie providing the License Option Exercise Notice during the License Option Period
Consequent: Parties shall work together in good faith to conduct an analysis of whether any filings or notifications are or may be required to be filed under the HSR Act (the ""HSR Filing"") or any similar applicable foreign law or regulation in connection with AbbVie's exercise of the License Option.

2. Norm type: Authorization
Subject: AbbVie
Object: Parties
Antecedent: None specified
Consequent: AbbVie has the authority to request the Parties to work together in good faith to conduct an analysis.

3. Norm type: Commitment
Subject: Parties
Object: None specified
Antecedent: AbbVie providing the License Option Exercise Notice during the License Option Period
Consequent: Parties shall work together in good faith to conduct an analysis.

4. Norm type: Commitment
Subject: Parties
Object: None specified
Antecedent: None specified
Consequent: Parties shall work together in good faith to conduct an analysis of whether any filings or notifications are or may be required to be filed under the HSR Act (the ""HSR Filing"") or any similar applicable foreign law or regulation.

5. Norm type: Commitment
Subject: Parties
Object: None specified
Antecedent: AbbVie's exercise of the License Option
Consequent: Parties shall work together in good faith to conduct an analysis of whether any filings or notifications are or may be required to be filed under the HSR Act (the ""HSR Filing"") or any similar applicable foreign law or regulation.","Norm 1:
1. Norm type: Commitment
2. Subject: AbbVie
3. Object: Other Party
4. Antecedent: AbbVie provides the License Option Exercise Notice during the License Option Period
5. Consequent: Parties shall work together in good faith to conduct an analysis of whether any filings or notifications are or may be required to be filed under the HSR Act or any similar applicable foreign law or regulation in connection with AbbVie's exercise of the License Option.

Norm 2:
1. Norm type: Authorization
2. Subject: Other Party
3. Object: AbbVie
4. Antecedent: AbbVie provides the License Option Exercise Notice during the License Option Period
5. Consequent: Parties shall work together in good faith to conduct an analysis of whether any filings or notifications are or may be required to be filed under the HSR Act or any similar applicable foreign law or regulation in connection with AbbVie's exercise of the License Option.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: AbbVie
3. OBJECT: Parties
4. ANTECEDENT: AbbVie provides the License Option Exercise Notice during the License Option Period
5. CONSEQUENT: Parties shall work together in good faith to conduct an analysis of whether any filings or notifications are or may be required to be filed under the HSR Act (the ""HSR Filing"") or any similar applicable foreign law or regulation in connection with AbbVie's exercise of the License Option.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Parties
3. OBJECT: AbbVie
4. ANTECEDENT: AbbVie's request
5. CONSEQUENT: Parties shall work together in good faith to conduct an analysis of whether any filings or notifications are or may be required to be filed under the HSR Act (the ""HSR Filing"") or any similar applicable foreign law or regulation in connection with AbbVie's exercise of the License Option.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: AbbVie
3. OBJECT: Parties
4. ANTECEDENT: AbbVie provides the License Option Exercise Notice during the License Option Period
5. CONSEQUENT: Parties shall work together in good faith to conduct an analysis of whether any filings or notifications are or may be required to be filed under the HSR Act (the ""HSR Filing"") or any similar applicable foreign law or regulation in connection with AbbVie's exercise of the License Option.

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Parties
3. OBJECT: AbbVie
4. ANTECEDENT: AbbVie's exercise of the License Option
5. CONSEQUENT: Parties shall work together in good faith to conduct an analysis of whether any filings or notifications are or may be required to be filed under the HSR Act (the ""HSR Filing"") or any similar applicable foreign law or regulation in connection with AbbVie's exercise of the License Option.","Norm 1:
1. Norm type: Commitment
2. Subject: AbbVie
3. Object: Parties
4. Antecedent: AbbVie provides the License Option Exercise Notice during the License Option Period
5. Consequent: Parties shall work together in good faith to conduct an analysis of whether any filings or notifications are or may be required to be filed under the HSR Act or any similar applicable foreign law or regulation in connection with AbbVie's exercise of the License Option.

Norm 2:
1. Norm type: Authorization
2. Subject: Parties
3. Object: AbbVie
4. Antecedent: AbbVie's request
5. Consequent: Parties shall work together in good faith to conduct an analysis of whether any filings or notifications are or may be required to be filed under the HSR Act or any similar applicable foreign law or regulation in connection with AbbVie's exercise of the License Option."
81,Such insurance shall be with a reputable insurance company and where  reasonably possible (taking into account the availability of such insurance) shall be maintained for not less than [**] ([**]) years following  the expiry or termination of this Agreement.,"Norm 1:
- Norm type: Authorization
- Subject: The party entering into the contract
- Object: The party affected by the outcome of the actions (not explicitly mentioned)
- Antecedent: The availability of insurance
- Consequent: The insurance shall be maintained for not less than [**] ([**]) years following the expiry or termination of the Agreement.

Norm 2:
- Norm type: Commitment
- Subject: The party entering into the contract
- Object: The party affected by the outcome of the actions (not explicitly mentioned)
- Antecedent: None
- Consequent: The insurance shall be maintained for not less than [**] ([**]) years following the expiry or termination of the Agreement.

Norm 3:
- Norm type: Prohibition
- Subject: The party entering into the contract
- Object: The party affected by the outcome of the actions (not explicitly mentioned)
- Antecedent: None
- Consequent: The insurance shall not be maintained for less than [**] ([**]) years following the expiry or termination of the Agreement.

Note: The norms and clauses extracted are based on the given sentence, and the object (party affected) is not explicitly mentioned.","Norm 1:
1. Norm type: Commitment
2. Subject: Party responsible for maintaining insurance
3. Object: Other party to the contract
4. Antecedent: The expiry or termination of the Agreement
5. Consequent: Maintenance of insurance for not less than [**] ([**]) years

Norm 2:
1. Norm type: Authorization
2. Subject: Party responsible for maintaining insurance
3. Object: Other party to the contract
4. Antecedent: The expiry or termination of the Agreement
5. Consequent: Obtaining insurance from a reputable insurance company

Norm 3:
1. Norm type: Power
2. Subject: Party responsible for maintaining insurance
3. Object: Other party to the contract
4. Antecedent: The expiry or termination of the Agreement
5. Consequent: Ability to choose a reputable insurance company for maintaining insurance","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Party responsible for obtaining insurance
3. OBJECT: Other party in the contract
4. ANTECEDENT: Expiry or termination of the Agreement
5. CONSEQUENT: Insurance shall be maintained for not less than [**] ([**]) years

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Party responsible for obtaining insurance
3. OBJECT: Other party in the contract
4. ANTECEDENT: Availability of insurance
5. CONSEQUENT: Insurance shall be with a reputable insurance company","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Party obtaining insurance
3. OBJECT: Other party in the contract
4. ANTECEDENT: Insurance shall be with a reputable insurance company
5. CONSEQUENT: Insurance shall be maintained for not less than [**] ([**]) years following the expiry or termination of the Agreement

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Party obtaining insurance
3. OBJECT: Other party in the contract
4. ANTECEDENT: Insurance shall be maintained for not less than [**] ([**]) years following the expiry or termination of the Agreement
5. CONSEQUENT: Party obtaining insurance is authorized to maintain insurance for the specified period.","1. Norm type: commitment
2. Subject: the party obtaining the insurance
3. Object: the party requiring the insurance to be maintained
4. Antecedent: the expiry or termination of the Agreement
5. Consequent: the insurance to be maintained for a specified number of years"
82,"If AbbVie notifies Harpoon in writing within [***] after receipt of such copy that AbbVie wishes to receive a license or sublicense (as applicable) under, and be subject to the rights and obligations of, the Proposed Future In-Licensed Rights as they apply to AbbVie and this Agreement, then the Proposed Future In-Licensed Rights shall automatically be included in the Harpoon Patents and/or Harpoon Know-How (as applicable) hereunder and AbbVie agrees to abide by all applicable terms and conditions of such license, sublicense or other agreement, as it relates to AbbVie and this Agreement, including payment of any financial obligations based upon AbbVie's practice of such intellectual property rights.","Norm 1:
Norm type: Authorization
Subject: AbbVie
Object: Harpoon
Antecedent: AbbVie notifies Harpoon in writing within [***] after receipt of such copy
Consequent: Proposed Future In-Licensed Rights shall automatically be included in the Harpoon Patents and/or Harpoon Know-How (as applicable) hereunder and AbbVie agrees to abide by all applicable terms and conditions of such license, sublicense or other agreement, as it relates to AbbVie and this Agreement, including payment of any financial obligations based upon AbbVie's practice of such intellectual property rights.

Norm 2:
Norm type: Commitment
Subject: AbbVie
Object: Harpoon
Antecedent: AbbVie notifies Harpoon in writing within [***] after receipt of such copy
Consequent: AbbVie agrees to abide by all applicable terms and conditions of such license, sublicense or other agreement, as it relates to AbbVie and this Agreement, including payment of any financial obligations based upon AbbVie's practice of such intellectual property rights.","Norm 1:
1. Norm type: Authorization
2. Subject: AbbVie
3. Object: Harpoon
4. Antecedent: AbbVie notifies Harpoon in writing within [***] after receipt of such copy that AbbVie wishes to receive a license or sublicense under the Proposed Future In-Licensed Rights
5. Consequent: Proposed Future In-Licensed Rights shall automatically be included in the Harpoon Patents and/or Harpoon Know-How hereunder and AbbVie agrees to abide by all applicable terms and conditions of such license, sublicense or other agreement, as it relates to AbbVie and this Agreement, including payment of any financial obligations based upon AbbVie's practice of such intellectual property rights.

Norm 2:
1. Norm type: Commitment
2. Subject: AbbVie
3. Object: Harpoon
4. Antecedent: AbbVie notifies Harpoon in writing within [***] after receipt of such copy that AbbVie wishes to receive a license or sublicense under the Proposed Future In-Licensed Rights
5. Consequent: AbbVie agrees to abide by all applicable terms and conditions of such license, sublicense or other agreement, as it relates to AbbVie and this Agreement, including payment of any financial obligations based upon AbbVie's practice of such intellectual property rights.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: AbbVie
3. OBJECT: Harpoon
4. ANTECEDENT: AbbVie notifies Harpoon in writing within [***] after receipt of such copy that AbbVie wishes to receive a license or sublicense under the Proposed Future In-Licensed Rights
5. CONSEQUENT: Proposed Future In-Licensed Rights shall automatically be included in the Harpoon Patents and/or Harpoon Know-How hereunder and AbbVie agrees to abide by all applicable terms and conditions of such license, sublicense or other agreement, as it relates to AbbVie and this Agreement, including payment of any financial obligations based upon AbbVie's practice of such intellectual property rights.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: AbbVie
3. OBJECT: Harpoon
4. ANTECEDENT: AbbVie notifies Harpoon in writing within [***] after receipt of such copy that AbbVie wishes to receive a license or sublicense under the Proposed Future In-Licensed Rights
5. CONSEQUENT: AbbVie agrees to abide by all applicable terms and conditions of such license, sublicense or other agreement, as it relates to AbbVie and this Agreement, including payment of any financial obligations based upon AbbVie's practice of such intellectual property rights.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: AbbVie
3. OBJECT: Harpoon
4. ANTECEDENT: AbbVie notifies Harpoon in writing within [***] after receipt of such copy that AbbVie wishes to receive a license or sublicense under the Proposed Future In-Licensed Rights
5. CONSEQUENT: Proposed Future In-Licensed Rights shall automatically be included in the Harpoon Patents and/or Harpoon Know-How hereunder and AbbVie agrees to abide by all applicable terms and conditions of such license, sublicense or other agreement, including payment of any financial obligations based upon AbbVie's practice of such intellectual property rights.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: AbbVie
3. OBJECT: Harpoon
4. ANTECEDENT: AbbVie notifies Harpoon in writing within [***] after receipt of such copy that AbbVie wishes to receive a license or sublicense under the Proposed Future In-Licensed Rights
5. CONSEQUENT: AbbVie agrees to abide by all applicable terms and conditions of such license, sublicense or other agreement, as it relates to AbbVie and this Agreement, including payment of any financial obligations based upon AbbVie's practice of such intellectual property rights.","Norm 1:
1. Norm type: Commitment
2. Subject: AbbVie
3. Object: Harpoon
4. Antecedent: AbbVie notifies Harpoon in writing within [***] after receipt of such copy
5. Consequent: AbbVie wishes to receive a license or sublicense under the Proposed Future In-Licensed Rights and be subject to the rights and obligations of the Proposed Future In-Licensed Rights as they apply to AbbVie and this Agreement

Norm 2:
1. Norm type: Authorization
2. Subject: Harpoon
3. Object: AbbVie
4. Antecedent: AbbVie notifies Harpoon in writing within [***] after receipt of such copy
5. Consequent: Proposed Future In-Licensed Rights shall automatically be included in the Harpoon Patents and/or Harpoon Know-How hereunder and AbbVie agrees to abide by all applicable terms and conditions of such license, sublicense or other agreement, as it relates to AbbVie and this Agreement, including payment of any financial obligations based upon AbbVie's practice of such intellectual property rights."
83,"You may not permit the Franchised Business to be operated, managed, directed, or controlled by any other person without our prior written consent.","Norm 1:
1. Norm type: Prohibition
2. Subject: You
3. Object: Franchised Business
4. Antecedent: None
5. Consequent: Franchised Business cannot be operated, managed, directed, or controlled by any other person without prior written consent from the party issuing the contract.

Norm 2:
1. Norm type: Authorization
2. Subject: The party issuing the contract (not explicitly mentioned in the sentence)
3. Object: You (the party being addressed in the sentence)
4. Antecedent: None
5. Consequent: The party issuing the contract has the authority to give or withhold consent for the Franchised Business to be operated, managed, directed, or controlled by any other person.

Norm 3:
1. Norm type: Commitment
2. Subject: The party issuing the contract (not explicitly mentioned in the sentence)
3. Object: None
4. Antecedent: None
5. Consequent: The party issuing the contract is committed to providing prior written consent for the Franchised Business to be operated, managed, directed, or controlled by any other person.

Norm 4:
1. Norm type: Prohibition
2. Subject: None
3. Object: Any other person
4. Antecedent: None
5. Consequent: Any other person is prohibited from operating, managing, directing, or controlling the Franchised Business without prior written consent.

Norm 5:
1. Norm type: Authorization
2. Subject: The party issuing the contract (not explicitly mentioned in the sentence)
3. Object: Any other person
4. Antecedent: None
5. Consequent: The party issuing the contract has the authority to give or withhold consent for any other person to operate, manage, direct, or control the Franchised Business.","Norm 1:
1. Norm type: Prohibition
2. Subject: You (party receiving the consent)
3. Object: Us (party giving the consent)
4. Antecedent: Permitting the Franchised Business to be operated, managed, directed, or controlled by any other person
5. Consequent: Without our prior written consent

Norm 2:
1. Norm type: Authorization
2. Subject: Us (party giving the consent)
3. Object: You (party receiving the consent)
4. Antecedent: Prior written consent
5. Consequent: Permitting the Franchised Business to be operated, managed, directed, or controlled by any other person","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: You
3. OBJECT: Franchised Business
4. ANTECEDENT: Permitting the Franchised Business to be operated, managed, directed, or controlled by any other person
5. CONSEQUENT: Without prior written consent

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: You
3. OBJECT: Franchised Business
4. ANTECEDENT: Obtaining prior written consent
5. CONSEQUENT: Permitting the Franchised Business to be operated, managed, directed, or controlled by any other person","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: You
3. OBJECT: Franchised Business
4. ANTECEDENT: being operated, managed, directed, or controlled by any other person
5. CONSEQUENT: without prior written consent

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: You
3. OBJECT: Franchised Business
4. ANTECEDENT: our prior written consent
5. CONSEQUENT: permitting the Franchised Business to be operated, managed, directed, or controlled by any other person","Norm 1:
1. Norm type: Prohibition
2. Subject: You
3. Object: Franchised Business
4. Antecedent: Permitting the Franchised Business to be operated, managed, directed, or controlled by any other person
5. Consequent: Without prior written consent from the other party

Norm 2:
1. Norm type: Authorization
2. Subject: Other person
3. Object: You
4. Antecedent: Operating, managing, directing, or controlling the Franchised Business
5. Consequent: With prior written consent from the other party"
84,"Both parties shall have the right to terminate this Agreement at any time, for any or for no reason, upon one hundred twenty (120) days written notice to the other party.","1. Norm type: Authorization
   Clause: Both parties shall have the right to terminate this Agreement at any time, for any or for no reason, upon one hundred twenty (120) days written notice to the other party.

2. Subject: Both parties
3. Object: Agreement
4. Antecedent: None specified
5. Consequent: Termination of the Agreement","Norm 1:
1. Norm type: Power
2. Subject: Both parties
3. Object: Each other
4. Antecedent: None specified
5. Consequent: Termination of the Agreement

Norm 2:
1. Norm type: Commitment
2. Subject: Both parties
3. Object: Each other
4. Antecedent: One hundred twenty (120) days written notice
5. Consequent: Termination of the Agreement","NORM 1:
1. NORM type: POWER
2. SUBJECT: Both parties
3. OBJECT: Each other
4. ANTECEDENT: None specified
5. CONSEQUENT: Terminate the Agreement

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Both parties
3. OBJECT: Each other
4. ANTECEDENT: Providing one hundred twenty (120) days written notice
5. CONSEQUENT: Terminate the Agreement","NORM 1:
1. NORM type: POWER
2. SUBJECT: Both parties
3. OBJECT: Each other
4. ANTECEDENT: Termination of the Agreement
5. CONSEQUENT: Termination of the Agreement

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Both parties
3. OBJECT: Each other
4. ANTECEDENT: Giving one hundred twenty (120) days written notice
5. CONSEQUENT: Termination of the Agreement","1. Norm type: authorization
2. Subject: Both parties
3. Object: Each other
4. Antecedent: One hundred twenty (120) days written notice
5. Consequent: Termination of the Agreement"
85,You must immediately notify us of any changes in the terms of an offer.,"Norm 1:
1. Norm type: Commitment
2. Subject: You
3. Object: Us
4. Antecedent: Changes in the terms of an offer
5. Consequent: Immediate notification to us

Norm 2:
1. Norm type: Prohibition
2. Subject: You
3. Object: None specified
4. Antecedent: None specified
5. Consequent: None specified","Norm 1:
1. Norm type: Commitment
2. Subject: You
3. Object: Us
4. Antecedent: Changes in the terms of an offer
5. Consequent: Immediate notification

Norm 2:
1. Norm type: Authorization
2. Subject: You
3. Object: Us
4. Antecedent: Changes in the terms of an offer
5. Consequent: Immediate notification","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: You
3. OBJECT: us
4. ANTECEDENT: any changes in the terms of an offer
5. CONSEQUENT: must immediately notify us

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: You
3. OBJECT: us
4. ANTECEDENT: any changes in the terms of an offer
5. CONSEQUENT: notify us","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: You
3. OBJECT: us
4. ANTECEDENT: any changes in the terms of an offer
5. CONSEQUENT: must immediately notify us

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: You
3. OBJECT: us
4. ANTECEDENT: any changes in the terms of an offer
5. CONSEQUENT: must not delay in notifying us","Norm 1:
1. Norm type: Commitment
2. Subject: You
3. Object: us
4. Antecedent: any changes in the terms of an offer
5. Consequent: immediate notification

Norm 2:
1. Norm type: Authorization
2. Subject: us
3. Object: You
4. Antecedent: any changes in the terms of an offer
5. Consequent: notification"
86,"Distributor agrees not to use in any manner whatsoever the marks, logos, images and copy of Vendor following the expiration or termination of this Agreement, except as may be needed to sell any Products remaining in Distributor's inventory.","1. Norm type: Prohibition
2. Subject: Distributor
3. Object: Vendor
4. Antecedent: Expiration or termination of this Agreement
5. Consequent: Distributor agrees not to use the marks, logos, images, and copy of Vendor, except as may be needed to sell any Products remaining in Distributor's inventory.","Norm 1:
1. Norm type: Prohibition
2. Subject: Distributor
3. Object: Vendor
4. Antecedent: Expiration or termination of the Agreement
5. Consequent: Not to use the marks, logos, images, and copy of Vendor
6. Clause: Distributor agrees not to use in any manner whatsoever the marks, logos, images, and copy of Vendor following the expiration or termination of this Agreement.

Norm 2:
1. Norm type: Authorization
2. Subject: Distributor
3. Object: Vendor
4. Antecedent: Expiration or termination of the Agreement
5. Consequent: Use the marks, logos, images, and copy of Vendor as needed to sell any Products remaining in Distributor's inventory
6. Clause: except as may be needed to sell any Products remaining in Distributor's inventory.","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: Distributor
3. OBJECT: Vendor
4. ANTECEDENT: expiration or termination of this Agreement
5. CONSEQUENT: not to use the marks, logos, images, and copy of Vendor

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Vendor
3. OBJECT: Distributor
4. ANTECEDENT: expiration or termination of this Agreement
5. CONSEQUENT: may be needed to sell any Products remaining in Distributor's inventory.","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: Distributor
3. OBJECT: Vendor
4. ANTECEDENT: expiration or termination of the Agreement
5. CONSEQUENT: not to use the marks, logos, images, and copy of Vendor

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Vendor
3. OBJECT: Distributor
4. ANTECEDENT: expiration or termination of the Agreement
5. CONSEQUENT: may be needed to sell any Products remaining in Distributor's inventory.","Norm 1:
1. Norm type: Prohibition
2. Subject: Distributor
3. Object: Vendor
4. Antecedent: expiration or termination of this Agreement
5. Consequent: not to use the marks, logos, images, and copy of Vendor

Norm 2:
1. Norm type: Authorization
2. Subject: Vendor
3. Object: Distributor
4. Antecedent: expiration or termination of this Agreement
5. Consequent: may be needed to sell any Products remaining in Distributor's inventory."
87,"of the data then in RevMed's Control regarding the relevant SHP1-SHP2 Dual Inhibitor. Sanofi shall notify RevMed in writing (a ""Notice of Interest""), within [***] after Sanofi's receipt of such notice, if Sanofi desires to enter into negotiations with RevMed of the terms under which Sanofi would obtain SHP1-SHP2 Dual Inhibitor License Rights.","1. Norm type: Authorization
   Subject: Sanofi
   Object: RevMed
   Antecedent: Sanofi's receipt of the notice
   Consequent: Sanofi's desire to enter into negotiations with RevMed for the terms of obtaining SHP1-SHP2 Dual Inhibitor License Rights.

2. Norm type: Commitment
   Subject: Sanofi
   Object: RevMed
   Antecedent: None mentioned
   Consequent: Sanofi shall notify RevMed in writing (a ""Notice of Interest"") within [***] after Sanofi's receipt of such notice.

3. Norm type: Commitment
   Subject: Sanofi
   Object: RevMed
   Antecedent: None mentioned
   Consequent: Sanofi desires to enter into negotiations with RevMed of the terms under which Sanofi would obtain SHP1-SHP2 Dual Inhibitor License Rights.

Note: The given sentence does not contain any clauses related to 'power' or 'prohibition' norms.","Norm 1:
1. Norm type: Authorization
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: Sanofi desires to enter into negotiations with RevMed of the terms under which Sanofi would obtain SHP1-SHP2 Dual Inhibitor License Rights
5. Consequent: Sanofi shall notify RevMed in writing (a ""Notice of Interest""), within [***] after Sanofi's receipt of such notice

Norm 2:
1. Norm type: Commitment
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: Sanofi desires to enter into negotiations with RevMed of the terms under which Sanofi would obtain SHP1-SHP2 Dual Inhibitor License Rights
5. Consequent: Sanofi would obtain SHP1-SHP2 Dual Inhibitor License Rights","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: Sanofi desires to enter into negotiations with RevMed of the terms under which Sanofi would obtain SHP1-SHP2 Dual Inhibitor License Rights
5. CONSEQUENT: Sanofi is authorized to enter into negotiations with RevMed for obtaining SHP1-SHP2 Dual Inhibitor License Rights

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: Sanofi desires to enter into negotiations with RevMed of the terms under which Sanofi would obtain SHP1-SHP2 Dual Inhibitor License Rights
5. CONSEQUENT: Sanofi commits to notify RevMed in writing (a ""Notice of Interest"") within [***] after Sanofi's receipt of such notice if Sanofi desires to enter into negotiations with RevMed of the terms under which Sanofi would obtain SHP1-SHP2 Dual Inhibitor License Rights.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: Sanofi desires to enter into negotiations with RevMed of the terms under which Sanofi would obtain SHP1-SHP2 Dual Inhibitor License Rights
5. CONSEQUENT: Sanofi is authorized to enter into negotiations with RevMed for obtaining SHP1-SHP2 Dual Inhibitor License Rights

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Sanofi
3. OBJECT: RevMed
4. ANTECEDENT: Sanofi desires to enter into negotiations with RevMed of the terms under which Sanofi would obtain SHP1-SHP2 Dual Inhibitor License Rights
5. CONSEQUENT: Sanofi commits to notifying RevMed in writing within [***] after Sanofi's receipt of the Notice of Interest if they desire to enter into negotiations for SHP1-SHP2 Dual Inhibitor License Rights.","Norm 1:
1. Norm type: Authorization
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: Sanofi desires to enter into negotiations with RevMed of the terms under which Sanofi would obtain SHP1-SHP2 Dual Inhibitor License Rights
5. Consequent: Sanofi would obtain SHP1-SHP2 Dual Inhibitor License Rights

Norm 2:
1. Norm type: Commitment
2. Subject: Sanofi
3. Object: RevMed
4. Antecedent: Sanofi's receipt of the Notice of Interest
5. Consequent: Sanofi shall notify RevMed in writing (a ""Notice of Interest"") within [***] after Sanofi's receipt of such notice"
88,"Upon the occurrence of any of the following, WGT may      terminate the Term by giving Distributor written notice of such termination      for:<omitted>WGT giving Distributor ninety (90) days' advance written notice of      termination at any time after the expiration of the Initial Term.","Norm 1:
- Norm type: Authorization
- Subject: WGT
- Object: Distributor
- Antecedent: Occurrence of any of the following
- Consequent: Termination of the Term by giving Distributor written notice of such termination

Norm 2:
- Norm type: Commitment
- Subject: WGT
- Object: Distributor
- Antecedent: None
- Consequent: WGT giving Distributor ninety (90) days' advance written notice of termination

Norm 3:
- Norm type: Commitment
- Subject: Distributor
- Object: WGT
- Antecedent: None
- Consequent: Distributor receiving ninety (90) days' advance written notice of termination

Norm 4:
- Norm type: Commitment
- Subject: Distributor
- Object: None
- Antecedent: None
- Consequent: Distributor fulfilling the obligations during the Initial Term

Norm 5:
- Norm type: Commitment
- Subject: WGT
- Object: None
- Antecedent: None
- Consequent: WGT terminating the Term after the expiration of the Initial Term.","Norm 1:
1. Norm type: Power
2. Subject: WGT
3. Object: Distributor
4. Antecedent: Occurrence of any of the specified events
5. Consequent: Termination of the Term by giving Distributor written notice

Norm 2:
1. Norm type: Commitment
2. Subject: WGT
3. Object: Distributor
4. Antecedent: Expiration of the Initial Term
5. Consequent: Giving Distributor ninety (90) days' advance written notice of termination","NORM 1:
1. NORM type: POWER
2. SUBJECT: WGT
3. OBJECT: Distributor
4. ANTECEDENT: Occurrence of any of the following
5. CONSEQUENT: Termination of the Term by giving Distributor written notice

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: WGT
3. OBJECT: Distributor
4. ANTECEDENT: Giving Distributor ninety (90) days' advance written notice of termination
5. CONSEQUENT: Termination of the Term after the expiration of the Initial Term","1. NORM type: COMMITMENT
2. SUBJECT: WGT
3. OBJECT: Distributor
4. ANTECEDENT: Occurrence of any of the specified events
5. CONSEQUENT: Termination of the Term by giving Distributor written notice of termination","1. Norm type: authorization
2. Subject: WGT
3. Object: Distributor
4. Antecedent: Upon the occurrence of any of the following
5. Consequent: WGT may terminate the Term by giving Distributor written notice of such termination"
89,"If DIALOG is acquired by a third party, DIALOG's acquirer will have the right, for a period of [***] following closing of such acquisition, to terminate this Agreement upon written notice to ENERGOUS.","1. Norm type: Authorization
Subject: DIALOG's acquirer
Object: ENERGOUS
Antecedent: DIALOG being acquired by a third party
Consequent: The right to terminate the Agreement upon written notice to ENERGOUS

2. Norm type: Commitment
Subject: DIALOG's acquirer
Object: ENERGOUS
Antecedent: DIALOG being acquired by a third party
Consequent: The commitment to provide a written notice to ENERGOUS for termination of the Agreement within a specified period following the closing of the acquisition.

Note: In this sentence, there is only one norm identified, which can be categorized as both 'authorization' and 'commitment' norm types.","Norm 1:
1. Norm type: Power
2. Subject: DIALOG's acquirer
3. Object: ENERGOUS
4. Antecedent: DIALOG is acquired by a third party
5. Consequent: DIALOG's acquirer will have the right to terminate the Agreement upon written notice to ENERGOUS.

Norm 2:
1. Norm type: Commitment
2. Subject: DIALOG's acquirer
3. Object: ENERGOUS
4. Antecedent: DIALOG is acquired by a third party
5. Consequent: DIALOG's acquirer commits to terminating the Agreement upon written notice to ENERGOUS.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: DIALOG's acquirer
3. OBJECT: ENERGOUS
4. ANTECEDENT: DIALOG is acquired by a third party
5. CONSEQUENT: DIALOG's acquirer will have the right to terminate the Agreement upon written notice to ENERGOUS.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: DIALOG's acquirer
3. OBJECT: ENERGOUS
4. ANTECEDENT: DIALOG is acquired by a third party
5. CONSEQUENT: DIALOG's acquirer commits to terminating the Agreement upon written notice to ENERGOUS.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: DIALOG's acquirer
3. OBJECT: ENERGOUS
4. ANTECEDENT: DIALOG is acquired by a third party
5. CONSEQUENT: DIALOG's acquirer will have the right to terminate the Agreement upon written notice to ENERGOUS

NORM 2:
1. NORM type: POWER
2. SUBJECT: DIALOG's acquirer
3. OBJECT: ENERGOUS
4. ANTECEDENT: DIALOG is acquired by a third party
5. CONSEQUENT: DIALOG's acquirer can terminate the Agreement upon written notice to ENERGOUS, even if it causes a change in existing NORMS.","Norm 1:
1. Norm type: Authorization
2. Subject: DIALOG's acquirer
3. Object: ENERGOUS
4. Antecedent: DIALOG is acquired by a third party
5. Consequent: DIALOG's acquirer will have the right to terminate the Agreement upon written notice to ENERGOUS.

Norm 2:
1. Norm type: Commitment
2. Subject: DIALOG's acquirer
3. Object: ENERGOUS
4. Antecedent: DIALOG is acquired by a third party
5. Consequent: DIALOG's acquirer commits to terminating the Agreement upon written notice to ENERGOUS."
90,"On any termination of this Agreement under Section 5.l (a), (b), or (c) all outstanding stock options granted to the Consultant shall be exercisable in accordance with the terms of the option agreements covering such grants","Norm 1:
- Norm type: Authorization
- Subject: Consultant
- Object: Consultant
- Antecedent: Termination of Agreement under Section 5.l (a), (b), or (c)
- Consequent: All outstanding stock options granted to the Consultant shall be exercisable in accordance with the terms of the option agreements covering such grants.

Norm 2:
- Norm type: Commitment
- Subject: Parties involved in the Agreement
- Object: Consultant
- Antecedent: None specified
- Consequent: The parties involved in the Agreement commit to granting stock options to the Consultant.

Norm 3:
- Norm type: Commitment
- Subject: Parties involved in the Agreement
- Object: Consultant
- Antecedent: None specified
- Consequent: The parties involved in the Agreement commit to allowing the Consultant to exercise the stock options.

Norm 4:
- Norm type: Commitment
- Subject: Parties involved in the Agreement
- Object: Consultant
- Antecedent: None specified
- Consequent: The parties involved in the Agreement commit to following the terms of the option agreements covering the granted stock options.

Norm 5:
- Norm type: Commitment
- Subject: Parties involved in the Agreement
- Object: Consultant
- Antecedent: None specified
- Consequent: The parties involved in the Agreement commit to ensuring that the Consultant's exercisability of stock options aligns with the terms of the option agreements.","Norm 1:
1. Norm type: Commitment
2. Subject: Consultant
3. Object: Other party (not specified in the sentence)
4. Antecedent: Termination of the Agreement under Section 5.1 (a), (b), or (c)
5. Consequent: All outstanding stock options granted to the Consultant shall be exercisable in accordance with the terms of the option agreements covering such grants

Norm 2:
1. Norm type: Authorization
2. Subject: Consultant
3. Object: Other party (not specified in the sentence)
4. Antecedent: Termination of the Agreement under Section 5.1 (a), (b), or (c)
5. Consequent: All outstanding stock options granted to the Consultant shall be exercisable in accordance with the terms of the option agreements covering such grants","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Consultant
3. OBJECT: Company
4. ANTECEDENT: Termination of the Agreement under Section 5.l (a), (b), or (c)
5. CONSEQUENT: All outstanding stock options granted to the Consultant shall be exercisable in accordance with the terms of the option agreements covering such grants

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Company
3. OBJECT: Consultant
4. ANTECEDENT: Termination of the Agreement under Section 5.l (a), (b), or (c)
5. CONSEQUENT: All outstanding stock options granted to the Consultant shall be exercisable in accordance with the terms of the option agreements covering such grants","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Consultant
3. OBJECT: Stock options
4. ANTECEDENT: Termination of the Agreement under Section 5.1 (a), (b), or (c)
5. CONSEQUENT: Stock options granted to the Consultant shall be exercisable in accordance with the terms of the option agreements covering such grants

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Consultant
3. OBJECT: Stock options
4. ANTECEDENT: Termination of the Agreement under Section 5.1 (a), (b), or (c)
5. CONSEQUENT: Consultant is authorized to exercise the stock options in accordance with the terms of the option agreements covering such grants.","Norm 1:
1. Norm type: Commitment
2. Subject: Consultant
3. Object: N/A
4. Antecedent: Termination of the Agreement under Section 5.1 (a), (b), or (c)
5. Consequent: All outstanding stock options granted to the Consultant shall be exercisable in accordance with the terms of the option agreements covering such grants

Norm 2:
1. Norm type: Authorization
2. Subject: Consultant
3. Object: N/A
4. Antecedent: Termination of the Agreement under Section 5.1 (a), (b), or (c)
5. Consequent: All outstanding stock options granted to the Consultant shall be exercisable in accordance with the terms of the option agreements covering such grants"
91,"Bioeq may terminate this Agreement immediately upon written notice to Licensee, if Licensee conducts any clinical development of, markets, sells or distributes any Competitive Product in the Territory, whether directly or indirectly through the intermediary of a Third Party or its Affiliates (Restricted Activities); provided, that in the event that Restricted Activities are being or would be deemed to be conducted by Licensee solely in connection with a Competitor Change of Control, Bioeq may not terminate this Agreement in accordance with this Section 15.2.2 and instead may terminate this Agreement in accordance with Section 15.2.9.","Norm 1:
- Norm type: Prohibition
- Subject: Bioeq
- Object: Licensee
- Antecedent: Licensee conducts any clinical development of, markets, sells or distributes any Competitive Product in the Territory, whether directly or indirectly through the intermediary of a Third Party or its Affiliates (Restricted Activities)
- Consequent: Bioeq may terminate this Agreement immediately upon written notice to Licensee

Norm 2:
- Norm type: Authorization
- Subject: Bioeq
- Object: Licensee
- Antecedent: Restricted Activities are being or would be deemed to be conducted by Licensee solely in connection with a Competitor Change of Control
- Consequent: Bioeq may not terminate this Agreement in accordance with this Section 15.2.2 and instead may terminate this Agreement in accordance with Section 15.2.9.","Norm 1:
1. Norm type: Power
2. Subject: Bioeq
3. Object: Licensee
4. Antecedent: Licensee conducts any clinical development of, markets, sells or distributes any Competitive Product in the Territory, whether directly or indirectly through the intermediary of a Third Party or its Affiliates (Restricted Activities)
5. Consequent: Bioeq may terminate this Agreement immediately upon written notice to Licensee

Norm 2:
1. Norm type: Prohibition
2. Subject: Bioeq
3. Object: Licensee
4. Antecedent: Restricted Activities are being or would be deemed to be conducted by Licensee solely in connection with a Competitor Change of Control
5. Consequent: Bioeq may not terminate this Agreement in accordance with Section 15.2.2 and instead may terminate this Agreement in accordance with Section 15.2.9.","1. NORM type: PROHIBITION
2. SUBJECT: Licensee
3. OBJECT: Bioeq
4. ANTECEDENT: Licensee conducts any clinical development of, markets, sells or distributes any Competitive Product in the Territory, whether directly or indirectly through the intermediary of a Third Party or its Affiliates (Restricted Activities)
5. CONSEQUENT: Bioeq may terminate this Agreement immediately upon written notice to Licensee

2. NORM type: AUTHORIZATION
3. SUBJECT: Bioeq
4. ANTECEDENT: Restricted Activities are being or would be deemed to be conducted by Licensee solely in connection with a Competitor Change of Control
5. CONSEQUENT: Bioeq may not terminate this Agreement in accordance with Section 15.2.2 and instead may terminate this Agreement in accordance with Section 15.2.9.","NORM 1:
1. NORM type: PROHIBITION
2. SUBJECT: Licensee
3. OBJECT: Bioeq
4. ANTECEDENT: Licensee conducts any clinical development of, markets, sells or distributes any Competitive Product in the Territory, whether directly or indirectly through the intermediary of a Third Party or its Affiliates (Restricted Activities)
5. CONSEQUENT: Bioeq may terminate this Agreement immediately upon written notice to Licensee

NORM 2:
1. NORM type: AUTHORIZATION
2. SUBJECT: Bioeq
3. OBJECT: Licensee
4. ANTECEDENT: Restricted Activities are being or would be deemed to be conducted by Licensee solely in connection with a Competitor Change of Control
5. CONSEQUENT: Bioeq may not terminate this Agreement in accordance with Section 15.2.2 and instead may terminate this Agreement in accordance with Section 15.2.9.","Norm 1:
1. Norm type: Prohibition
2. Subject: Licensee
3. Object: Bioeq
4. Antecedent: Licensee conducts any clinical development of, markets, sells or distributes any Competitive Product in the Territory, whether directly or indirectly through the intermediary of a Third Party or its Affiliates (Restricted Activities)
5. Consequent: Bioeq may terminate this Agreement immediately upon written notice to Licensee

Norm 2:
1. Norm type: Authorization
2. Subject: Bioeq
3. Object: Licensee
4. Antecedent: Restricted Activities are being or would be deemed to be conducted by Licensee solely in connection with a Competitor Change of Control
5. Consequent: Bioeq may not terminate this Agreement in accordance with Section 15.2.2 and instead may terminate this Agreement in accordance with Section 15.2.9."
92,"In the event of termination or expiration of this Agreement             pursuant to Section 5.0 above, IBM shall have an option, which             shall expire [*] days after such termination or expiration, to             purchase from MSL, at a reasonable price agreeable to the Parties,             all assets used by MSL to perform the manufacturing and fulfillment             functions<omitted>outlined in Attachment 1: Statement of Work, to the extent owned or             transferable by MSL, and required by IBM to perform such functions.","1. Norm type: Authorization
Subject: IBM
Object: MSL
Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0
Consequent: IBM has the option to purchase assets from MSL

2. Norm type: Commitment
Subject: IBM
Object: MSL
Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0
Consequent: IBM commits to purchasing assets from MSL if the option is exercised

3. Norm type: Commitment
Subject: MSL
Object: IBM
Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0
Consequent: MSL commits to selling assets to IBM if the option is exercised

4. Norm type: Commitment
Subject: IBM
Object: MSL
Antecedent: None specified
Consequent: IBM commits to purchasing assets at a reasonable price agreeable to the Parties

5. Norm type: Commitment
Subject: MSL
Object: IBM
Antecedent: None specified
Consequent: MSL commits to selling assets at a reasonable price agreeable to the Parties","Norm 1:
1. Norm type: Power
2. Subject: IBM
3. Object: MSL
4. Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0
5. Consequent: IBM has the option to purchase all assets used by MSL to perform manufacturing and fulfillment functions outlined in Attachment 1: Statement of Work, to the extent owned or transferable by MSL, and required by IBM to perform such functions.

Norm 2:
1. Norm type: Commitment
2. Subject: MSL
3. Object: IBM
4. Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0
5. Consequent: MSL commits to offer IBM the option to purchase all assets used by MSL to perform manufacturing and fulfillment functions outlined in Attachment 1: Statement of Work, to the extent owned or transferable by MSL, and required by IBM to perform such functions at a reasonable price agreeable to the Parties.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: IBM
3. OBJECT: MSL
4. ANTECEDENT: Termination or expiration of the Agreement
5. CONSEQUENT: IBM has the option to purchase assets from MSL

CLAUSE: IBM has the authorization to purchase assets from MSL in the event of termination or expiration of the Agreement.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: IBM
3. OBJECT: MSL
4. ANTECEDENT: Termination or expiration of the Agreement
5. CONSEQUENT: IBM commits to purchasing assets at a reasonable price agreeable to both parties

CLAUSE: IBM commits to purchasing assets from MSL at a reasonable price agreeable to both parties in the event of termination or expiration of the Agreement.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: IBM
3. OBJECT: MSL
4. ANTECEDENT: Termination or expiration of the Agreement
5. CONSEQUENT: IBM has the option to purchase assets from MSL

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: MSL
3. OBJECT: IBM
4. ANTECEDENT: Termination or expiration of the Agreement
5. CONSEQUENT: MSL agrees to sell assets to IBM at a reasonable price","1. Norm type: authorization
2. Subject: IBM
3. Object: MSL
4. Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0
5. Consequent: IBM has the option to purchase assets from MSL at a reasonable price. 

2. Norm type: commitment
2. Subject: MSL
3. Object: IBM
4. Antecedent: Termination or expiration of the Agreement pursuant to Section 5.0
5. Consequent: MSL commits to selling assets to IBM if IBM chooses to exercise its option."
93,"If a Change in Control occurs with respect to Customer, Metavante agrees to continue to provide Services under this Agreement; provided that (a) Metavante's obligation to provide Services shall be limited to the Entities comprising the Customer prior to such Change in Control and (b) Metavante's obligation to provide Services shall be limited in any and all circumstances to the number of accounts processed in the three (3) -month period prior to such Change in Control occurring, plus twenty-five percent (25%).","1. Norm type: Commitment
Subject: Metavante
Object: Customer
Antecedent: Change in Control occurs with respect to Customer
Consequent: Metavante agrees to continue to provide Services under this Agreement

2. Norm type: Commitment
Subject: Metavante
Object: Entities comprising the Customer prior to Change in Control
Antecedent: Change in Control occurs with respect to Customer
Consequent: Metavante's obligation to provide Services shall be limited to the Entities comprising the Customer prior to such Change in Control

3. Norm type: Commitment
Subject: Metavante
Object: Services
Antecedent: Change in Control occurs with respect to Customer
Consequent: Metavante's obligation to provide Services shall be limited in any and all circumstances to the number of accounts processed in the three (3)-month period prior to such Change in Control occurring, plus twenty-five percent (25%)

Note: The given sentence does not contain any norms of 'authorization,' 'power,' or 'prohibition' types.","Norm 1:
1. Norm type: Commitment
2. Subject: Metavante
3. Object: Customer
4. Antecedent: Change in Control occurs with respect to Customer
5. Consequent: Metavante agrees to continue to provide Services under this Agreement

Clause:
- Metavante agrees to continue to provide Services under this Agreement if a Change in Control occurs with respect to Customer.

Norm 2:
1. Norm type: Commitment
2. Subject: Metavante
3. Object: Customer
4. Antecedent: Change in Control occurs with respect to Customer
5. Consequent: Metavante's obligation to provide Services shall be limited to the Entities comprising the Customer prior to such Change in Control

Clause:
- Metavante's obligation to provide Services shall be limited to the Entities comprising the Customer prior to such Change in Control if a Change in Control occurs with respect to Customer.

Norm 3:
1. Norm type: Commitment
2. Subject: Metavante
3. Object: Customer
4. Antecedent: Change in Control occurs with respect to Customer
5. Consequent: Metavante's obligation to provide Services shall be limited in any and all circumstances to the number of accounts processed in the three (3)-month period prior to such Change in Control occurring, plus twenty-five percent (25%)

Clause:
- Metavante's obligation to provide Services shall be limited in any and all circumstances to the number of accounts processed in the three (3)-month period prior to such Change in Control occurring, plus twenty-five percent (25%) if a Change in Control occurs with respect to Customer.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Metavante
3. OBJECT: Customer
4. ANTECEDENT: Change in Control occurs with respect to Customer
5. CONSEQUENT: Metavante agrees to continue to provide Services under this Agreement

CLAUSE: Metavante agrees to continue to provide Services under this Agreement if a Change in Control occurs with respect to Customer.

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Metavante
3. OBJECT: Customer
4. ANTECEDENT: Change in Control occurs with respect to Customer
5. CONSEQUENT: Metavante's obligation to provide Services shall be limited to the Entities comprising the Customer prior to such Change in Control

CLAUSE: Metavante's obligation to provide Services shall be limited to the Entities comprising the Customer prior to such Change in Control if a Change in Control occurs with respect to Customer.

NORM 3:
1. NORM type: PROHIBITION
2. SUBJECT: Metavante
3. OBJECT: Customer
4. ANTECEDENT: Change in Control occurs with respect to Customer
5. CONSEQUENT: Metavante's obligation to provide Services shall be limited in any and all circumstances to the number of accounts processed in the three (3)-month period prior to such Change in Control occurring, plus twenty-five percent (25%)

CLAUSE: Metavante's obligation to provide Services shall be limited in any and all circumstances to the number of accounts processed in the three (3)-month period prior to such Change in Control occurring, plus twenty-five percent (25%) if a Change in Control occurs with respect to Customer.","1. NORM type: COMMITMENT
2. SUBJECT: Metavante
3. OBJECT: Customer
4. ANTECEDENT: Change in Control occurs with respect to Customer
5. CONSEQUENT: Metavante agrees to continue to provide Services under this Agreement

1. NORM type: COMMITMENT
2. SUBJECT: Metavante
3. OBJECT: Entities comprising the Customer prior to Change in Control
4. ANTECEDENT: Change in Control occurs with respect to Customer
5. CONSEQUENT: Metavante's obligation to provide Services shall be limited to the Entities comprising the Customer prior to such Change in Control

1. NORM type: COMMITMENT
2. SUBJECT: Metavante
3. OBJECT: Number of accounts processed in the three (3)-month period prior to Change in Control
4. ANTECEDENT: Change in Control occurs with respect to Customer
5. CONSEQUENT: Metavante's obligation to provide Services shall be limited to the number of accounts processed in the three (3)-month period prior to such Change in Control occurring, plus twenty-five percent (25%)","Norm 1:
1. Norm type: Commitment
2. Subject: Metavante
3. Object: Customer
4. Antecedent: Change in Control occurs with respect to Customer
5. Consequent: Metavante agrees to continue to provide Services under this Agreement

Norm 2:
1. Norm type: Authorization
2. Subject: Customer
3. Object: Metavante
4. Antecedent: Change in Control occurs with respect to Customer
5. Consequent: Metavante's obligation to provide Services shall be limited to the Entities comprising the Customer prior to such Change in Control

Norm 3:
1. Norm type: Authorization
2. Subject: Customer
3. Object: Metavante
4. Antecedent: Change in Control occurs with respect to Customer
5. Consequent: Metavante's obligation to provide Services shall be limited in any and all circumstances to the number of accounts processed in the three (3) -month period prior to such Change in Control occurring, plus twenty-five percent (25%)"
94,"The parties acknowledge and agree that a ""Release Condition"" for purposes of the Escrow Agreement shall be deemed to mean any one or more of the following listed events (in addition to any other event specified as a release condition under the Escrow Agreement):<omitted>(vi) Ehave undergoes a change of control or is a party to a merger or amalgamation;","1. Norm type: Authorization
Subject: Ehave
Object: -
Antecedent: Change of control or being a party to a merger or amalgamation
Consequent: Being deemed as a ""Release Condition"" for purposes of the Escrow Agreement

2. Norm type: Commitment
Subject: The parties
Object: -
Antecedent: -
Consequent: Acknowledging and agreeing that a ""Release Condition"" shall be deemed to mean any one or more of the listed events (including change of control or being a party to a merger or amalgamation) for purposes of the Escrow Agreement

Note: The given sentence does not explicitly mention the creditor or beneficiary.","Norm 1:
1. Norm type: Authorization
2. Subject: Ehave
3. Object: Parties
4. Antecedent: Ehave undergoes a change of control or is a party to a merger or amalgamation
5. Consequent: Ehave is authorized to be released from the Escrow Agreement

Norm 2:
1. Norm type: Commitment
2. Subject: Parties
3. Object: Ehave
4. Antecedent: Ehave undergoes a change of control or is a party to a merger or amalgamation
5. Consequent: Parties commit to releasing Ehave from the Escrow Agreement","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Ehave
3. OBJECT: Escrow Agreement
4. ANTECEDENT: Ehave undergoes a change of control or is a party to a merger or amalgamation
5. CONSEQUENT: Release Condition is deemed to be met

NORM 2:
1. NORM type: POWER
2. SUBJECT: Escrow Agreement
3. OBJECT: Ehave
4. ANTECEDENT: Ehave undergoes a change of control or is a party to a merger or amalgamation
5. CONSEQUENT: Allows Escrow Agreement to release funds or take action even if it causes a change in existing norms.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Ehave
3. OBJECT: parties to the contract
4. ANTECEDENT: Ehave undergoes a change of control or is a party to a merger or amalgamation
5. CONSEQUENT: Release Condition for purposes of the Escrow Agreement is deemed to mean the event specified

NORM 2:
1. NORM type: POWER
2. SUBJECT: parties to the contract
3. OBJECT: Ehave
4. ANTECEDENT: Ehave undergoes a change of control or is a party to a merger or amalgamation
5. CONSEQUENT: Parties to the contract are empowered to enforce the Release Condition for purposes of the Escrow Agreement.","1. Norm type: authorization
2. Subject: Ehave
3. Object: parties
4. Antecedent: Ehave undergoes a change of control or is a party to a merger or amalgamation
5. Consequent: Release Condition is deemed to mean any one or more of the listed events"
95,"Within [***] after receipt of such cessation request, Distributor shall provide Zogenix an estimate of the quantity and shelf life of all Product remaining in Distributor's or its Affiliates' or Sub-distributors' inventory, and Zogenix shall have the right to purchase any such quantities of Product from Distributor at a price mutually agreed by the Parties.","1. Norm type: Authorization
Subject: Distributor
Object: Zogenix
Antecedent: Receipt of cessation request
Consequent: Distributor shall provide Zogenix an estimate of the quantity and shelf life of all Product remaining in Distributor's or its Affiliates' or Sub-distributors' inventory, and Zogenix shall have the right to purchase any such quantities of Product from Distributor at a price mutually agreed by the Parties.

2. Norm type: Commitment
Subject: Distributor
Object: Zogenix
Antecedent: None mentioned
Consequent: Distributor shall provide Zogenix an estimate of the quantity and shelf life of all Product remaining in Distributor's or its Affiliates' or Sub-distributors' inventory

3. Norm type: Authorization
Subject: Zogenix
Object: Distributor
Antecedent: None mentioned
Consequent: Zogenix shall have the right to purchase any such quantities of Product from Distributor at a price mutually agreed by the Parties.

Note: The given sentence does not contain any clauses related to power or prohibition norms.","Norm 1:
1. Norm type: Authorization
2. Subject: Distributor
3. Object: Zogenix
4. Antecedent: Distributor receives a cessation request
5. Consequent: Distributor shall provide Zogenix an estimate of the quantity and shelf life of all Product remaining in Distributor's or its Affiliates' or Sub-distributors' inventory, and Zogenix shall have the right to purchase any such quantities of Product from Distributor at a price mutually agreed by the Parties.

Norm 2:
1. Norm type: Commitment
2. Subject: Zogenix
3. Object: Distributor
4. Antecedent: Distributor provides Zogenix with an estimate of the quantity and shelf life of all Product remaining in Distributor's or its Affiliates' or Sub-distributors' inventory
5. Consequent: Zogenix shall have the right to purchase any such quantities of Product from Distributor at a price mutually agreed by the Parties.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Distributor
3. OBJECT: Zogenix
4. ANTECEDENT: Distributor providing an estimate of the quantity and shelf life of all Product remaining in inventory
5. CONSEQUENT: Zogenix having the right to purchase any such quantities of Product from Distributor at a price mutually agreed by the Parties

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Zogenix
3. OBJECT: Distributor
4. ANTECEDENT: Distributor providing an estimate of the quantity and shelf life of all Product remaining in inventory
5. CONSEQUENT: Zogenix committing to purchase any such quantities of Product from Distributor at a price mutually agreed by the Parties","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: Distributor
3. OBJECT: Zogenix
4. ANTECEDENT: Distributor providing an estimate of the quantity and shelf life of all Product remaining in inventory
5. CONSEQUENT: Zogenix having the right to purchase any such quantities of Product from Distributor at a price mutually agreed by the Parties

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: Zogenix
3. OBJECT: Distributor
4. ANTECEDENT: Distributor providing an estimate of the quantity and shelf life of all Product remaining in inventory
5. CONSEQUENT: Distributor ensuring that Zogenix has the right to purchase any such quantities of Product at a price mutually agreed by the Parties","Norm 1:
1. Norm type: Authorization
2. Subject: Distributor
3. Object: Zogenix
4. Antecedent: Distributor providing an estimate of the quantity and shelf life of all Product remaining in inventory
5. Consequent: Zogenix having the right to purchase any such quantities of Product from Distributor at a price mutually agreed by the Parties

Norm 2:
1. Norm type: Commitment
2. Subject: Zogenix
3. Object: Distributor
4. Antecedent: Distributor providing an estimate of the quantity and shelf life of all Product remaining in inventory
5. Consequent: Zogenix committing to purchase any such quantities of Product from Distributor at a price mutually agreed by the Parties"
96,"Except as otherwise provided in Subsection 3(b) below, within [*]     calendar days after termination or expiration of the Agreement (or this     Attachment 6, in the event of termination in part) for any reason,     MSL shall return to IBM all MS Software Image(s) master media and all MS     Software Image documentation which has not been placed in a Product package     prior to such termination or expiration, and MSL shall provide written     notice to IBM signed by a representative certifying that MSL has fulfilled     such requirements.","1. Norm type: Commitment
Subject: MSL
Object: IBM
Antecedent: Termination or expiration of the Agreement (or this Attachment 6, in the event of termination in part) for any reason
Consequent: MSL shall return to IBM all MS Software Image(s) master media and all MS Software Image documentation which has not been placed in a Product package prior to such termination or expiration, and MSL shall provide written notice to IBM signed by a representative certifying that MSL has fulfilled such requirements.

2. Norm type: Prohibition
Subject: MSL
Object: None specified
Antecedent: None specified
Consequent: None specified

3. Norm type: Authorization
Subject: MSL
Object: IBM
Antecedent: None specified
Consequent: MSL is authorized to return to IBM all MS Software Image(s) master media and all MS Software Image documentation which has not been placed in a Product package prior to such termination or expiration.

4. Norm type: Commitment
Subject: IBM
Object: MSL
Antecedent: Termination or expiration of the Agreement (or this Attachment 6, in the event of termination in part) for any reason
Consequent: IBM expects MSL to fulfill the requirement of returning all MS Software Image(s) master media and all MS Software Image documentation which has not been placed in a Product package prior to such termination or expiration, and provide written notice to IBM signed by a representative certifying that MSL has fulfilled such requirements.

5. Norm type: Commitment
Subject: MSL
Object: None specified
Antecedent: None specified
Consequent: MSL is committed to providing written notice to IBM signed by a representative certifying that MSL has fulfilled the requirements of returning all MS Software Image(s) master media and all MS Software Image documentation which has not been placed in a Product package prior to termination or expiration of the Agreement.","Norm 1:
1. Norm type: Commitment
2. Subject: MSL
3. Object: IBM
4. Antecedent: Termination or expiration of the Agreement (or this Attachment 6, in the event of termination in part) for any reason
5. Consequent: MSL shall return to IBM all MS Software Image(s) master media and all MS Software Image documentation which has not been placed in a Product package prior to such termination or expiration, and MSL shall provide written notice to IBM signed by a representative certifying that MSL has fulfilled such requirements.

Norm 2:
1. Norm type: Authorization
2. Subject: MSL
3. Object: IBM
4. Antecedent: Termination or expiration of the Agreement (or this Attachment 6, in the event of termination in part) for any reason
5. Consequent: MSL shall provide written notice to IBM signed by a representative certifying that MSL has fulfilled such requirements.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: MSL
3. OBJECT: IBM
4. ANTECEDENT: Termination or expiration of the Agreement (or this Attachment 6, in the event of termination in part) for any reason
5. CONSEQUENT: MSL shall return to IBM all MS Software Image(s) master media and all MS Software Image documentation which has not been placed in a Product package prior to such termination or expiration, and MSL shall provide written notice to IBM signed by a representative certifying that MSL has fulfilled such requirements.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: MSL
3. OBJECT: IBM
4. ANTECEDENT: Termination or expiration of the Agreement (or this Attachment 6, in the event of termination in part) for any reason
5. CONSEQUENT: MSL shall provide written notice to IBM signed by a representative certifying that MSL has fulfilled the requirement of returning all MS Software Image(s) master media and all MS Software Image documentation which has not been placed in a Product package prior to such termination or expiration.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: MSL
3. OBJECT: IBM
4. ANTECEDENT: Termination or expiration of the Agreement (or Attachment 6)
5. CONSEQUENT: MSL shall return all MS Software Image(s) master media and documentation to IBM within [*] calendar days and provide written notice certifying fulfillment of requirements.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: MSL
3. OBJECT: IBM
4. ANTECEDENT: Termination or expiration of the Agreement (or Attachment 6)
5. CONSEQUENT: MSL shall return all MS Software Image(s) master media and documentation to IBM within [*] calendar days and provide written notice certifying fulfillment of requirements.","1. Norm type: commitment
2. Subject: MSL
3. Object: IBM
4. Antecedent: termination or expiration of the Agreement
5. Consequent: return all MS Software Image(s) master media and documentation, provide written notice signed by a representative certifying fulfillment of requirements. 

2. Norm type: prohibition
2. Subject: MSL
3. Object: IBM
4. Antecedent: termination in part
5. Consequent: not to place MS Software Image documentation in a Product package prior to termination in part."
97,"ExxonMobil may terminate this Agreement upon fifteen (15) days written notice, without penalty, payment or prejudice to claims and obligations then accrued, if FCE undergoes a Change in Control.","1. Norm type: Authorization
Subject: ExxonMobil
Object: This Agreement
Antecedent: FCE undergoes a Change in Control
Consequent: Termination of the Agreement upon fifteen (15) days written notice, without penalty, payment or prejudice to claims and obligations then accrued

2. Norm type: Commitment
Subject: FCE
Object: N/A
Antecedent: N/A
Consequent: Undergo a Change in Control

3. Norm type: Commitment
Subject: ExxonMobil
Object: N/A
Antecedent: N/A
Consequent: Provide fifteen (15) days written notice for termination of the Agreement

4. Norm type: Commitment
Subject: ExxonMobil
Object: N/A
Antecedent: N/A
Consequent: Terminate the Agreement without penalty, payment or prejudice to claims and obligations then accrued

5. Norm type: Prohibition
Subject: N/A
Object: N/A
Antecedent: N/A
Consequent: No penalty, payment or prejudice to claims and obligations then accrued upon termination of the Agreement.","Norm 1:
1. Norm type: Power
2. Subject: ExxonMobil
3. Object: FCE
4. Antecedent: FCE undergoes a Change in Control
5. Consequent: ExxonMobil may terminate this Agreement upon fifteen (15) days written notice, without penalty, payment or prejudice to claims and obligations then accrued. 

Norm 2:
1. Norm type: Commitment
2. Subject: ExxonMobil
3. Object: FCE
4. Antecedent: None specified
5. Consequent: ExxonMobil commits to terminate this Agreement upon fifteen (15) days written notice, without penalty, payment or prejudice to claims and obligations then accrued, if FCE undergoes a Change in Control.","NORM 1:
1. NORM type: POWER
2. SUBJECT: ExxonMobil
3. OBJECT: FCE
4. ANTECEDENT: FCE undergoes a Change in Control
5. CONSEQUENT: ExxonMobil may terminate this Agreement upon fifteen (15) days written notice, without penalty, payment or prejudice to claims and obligations then accrued

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: FCE
3. OBJECT: ExxonMobil
4. ANTECEDENT: FCE undergoes a Change in Control
5. CONSEQUENT: FCE commits to not penalize, make payment, or prejudice claims and obligations then accrued if ExxonMobil terminates the Agreement upon fifteen (15) days written notice.","NORM 1:
1. NORM type: POWER
2. SUBJECT: ExxonMobil
3. OBJECT: FCE
4. ANTECEDENT: FCE undergoes a Change in Control
5. CONSEQUENT: ExxonMobil may terminate the Agreement upon fifteen (15) days written notice, without penalty, payment, or prejudice to claims and obligations then accrued.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: FCE
3. OBJECT: ExxonMobil
4. ANTECEDENT: FCE undergoes a Change in Control
5. CONSEQUENT: FCE commits to not penalize, demand payment, or prejudice claims and obligations then accrued if ExxonMobil terminates the Agreement upon fifteen (15) days written notice.","1. Norm type: commitment
2. Subject: ExxonMobil
3. Object: FCE
4. Antecedent: FCE undergoes a Change in Control
5. Consequent: ExxonMobil may terminate the Agreement upon fifteen (15) days written notice, without penalty, payment, or prejudice to claims and obligations then accrued."
98,"In the event that MSL owns the tooling and has received a bona fide             third party offer to purchase any or all of the tooling, before MSL             may accept such offer, MSL shall notify IBM in writing, and IBM             shall have [*] Days after such notice to agree to purchase such             tooling on the same terms and conditions as such third party offer.","1. Norm type: Authorization
Subject: MSL
Object: IBM
Antecedent: MSL owning the tooling and receiving a bona fide third party offer to purchase any or all of the tooling
Consequent: IBM has [*] Days after receiving notice to agree to purchase such tooling on the same terms and conditions as the third party offer.

2. Norm type: Commitment
Subject: MSL
Object: IBM
Antecedent: None
Consequent: MSL shall notify IBM in writing before accepting any third party offer to purchase the tooling.

3. Norm type: Commitment
Subject: IBM
Object: None
Antecedent: None
Consequent: IBM shall have [*] Days after receiving notice to agree to purchase the tooling on the same terms and conditions as the third party offer.

4. Norm type: Prohibition
Subject: MSL
Object: None
Antecedent: None
Consequent: MSL is prohibited from accepting any third party offer to purchase the tooling without notifying IBM in writing.

5. Norm type: Power
Subject: IBM
Object: None
Antecedent: None
Consequent: IBM has the power to agree to purchase the tooling on the same terms and conditions as the third party offer within [*] Days after receiving notice.","Norm 1:
1. Norm type: Authorization
2. Subject: MSL
3. Object: IBM
4. Antecedent: MSL owns the tooling and has received a bona fide third party offer to purchase any or all of the tooling
5. Consequent: IBM shall have [*] Days after such notice to agree to purchase such tooling on the same terms and conditions as such third party offer.

Norm 2:
1. Norm type: Commitment
2. Subject: MSL
3. Object: IBM
4. Antecedent: MSL owns the tooling and has received a bona fide third party offer to purchase any or all of the tooling
5. Consequent: MSL shall notify IBM in writing before accepting such offer.","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: MSL
3. OBJECT: IBM
4. ANTECEDENT: MSL owns the tooling and has received a bona fide third party offer to purchase any or all of the tooling
5. CONSEQUENT: IBM shall have [*] Days after such notice to agree to purchase such tooling on the same terms and conditions as such third party offer

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: MSL
3. OBJECT: IBM
4. ANTECEDENT: MSL owns the tooling and has received a bona fide third party offer to purchase any or all of the tooling
5. CONSEQUENT: MSL shall notify IBM in writing before accepting such offer","NORM 1:
1. NORM type: AUTHORIZATION
2. SUBJECT: MSL
3. OBJECT: IBM
4. ANTECEDENT: MSL owns the tooling and has received a bona fide third party offer to purchase any or all of the tooling
5. CONSEQUENT: IBM shall have [*] Days after such notice to agree to purchase such tooling on the same terms and conditions as such third party offer.

NORM 2:
1. NORM type: COMMITMENT
2. SUBJECT: IBM
3. OBJECT: MSL
4. ANTECEDENT: MSL notifies IBM in writing
5. CONSEQUENT: IBM agrees to purchase such tooling on the same terms and conditions as the third party offer.","Norm 1:
1. Norm type: Authorization
2. Subject: MSL
3. Object: IBM
4. Antecedent: MSL owning the tooling and receiving a bona fide third party offer to purchase any or all of the tooling
5. Consequent: IBM agreeing to purchase such tooling on the same terms and conditions as the third party offer

Norm 2:
1. Norm type: Commitment
2. Subject: MSL
3. Object: IBM
4. Antecedent: MSL owning the tooling and receiving a bona fide third party offer to purchase any or all of the tooling
5. Consequent: MSL notifying IBM in writing before accepting such offer

Norm 3:
1. Norm type: Power
2. Subject: IBM
3. Object: MSL
4. Antecedent: MSL notifying IBM in writing before accepting the third party offer
5. Consequent: IBM having [*] Days after such notice to agree to purchase the tooling on the same terms and conditions as the third party offer."
99,"A Termination Event shall have occurred if:<omitted>(c) Supplier either: (i) merges with another entity, (ii) suffers a transfer involving fifty (50%) percent or more of any class of its voting securities or (iii) transfers all, or substantially all, of its assets;","1. Norm type: Commitment
Subject: Supplier
Object: N/A
Antecedent: N/A
Consequent: Termination Event shall have occurred

2. Norm type: Prohibition
Subject: Supplier
Object: N/A
Antecedent: N/A
Consequent: N/A

3. Norm type: Commitment
Subject: Supplier
Object: N/A
Antecedent: N/A
Consequent: N/A

4. Norm type: Commitment
Subject: Supplier
Object: N/A
Antecedent: N/A
Consequent: N/A

5. Norm type: Commitment
Subject: Supplier
Object: N/A
Antecedent: N/A
Consequent: N/A","Norm 1:
1. Norm type: Commitment
2. Subject: Supplier
3. Object: Other party in the contract
4. Antecedent: Supplier either merges with another entity, suffers a transfer involving fifty (50%) percent or more of any class of its voting securities, or transfers all, or substantially all, of its assets
5. Consequent: Termination Event shall have occurred

Norm 2:
1. Norm type: Power
2. Subject: Other party in the contract
3. Object: Supplier
4. Antecedent: Termination Event occurs as per the conditions mentioned in Norm 1
5. Consequent: Other party has the power to terminate the contract.","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Supplier
3. OBJECT: Other party
4. ANTECEDENT: Supplier merges with another entity, suffers a transfer involving fifty (50%) percent or more of any class of its voting securities, or transfers all, or substantially all, of its assets
5. CONSEQUENT: Termination Event shall have occurred

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Supplier
3. OBJECT: Other party
4. ANTECEDENT: None specified
5. CONSEQUENT: None specified

NORM 3:
1. NORM type: PROHIBITION
2. SUBJECT: Supplier
3. OBJECT: Other party
4. ANTECEDENT: Supplier merges with another entity, suffers a transfer involving fifty (50%) percent or more of any class of its voting securities, or transfers all, or substantially all, of its assets
5. CONSEQUENT: None specified","NORM 1:
1. NORM type: COMMITMENT
2. SUBJECT: Supplier
3. OBJECT: Other party in the contract
4. ANTECEDENT: Supplier merges with another entity, suffers a transfer involving fifty (50%) percent or more of any class of its voting securities, or transfers all, or substantially all, of its assets
5. CONSEQUENT: Termination Event shall have occurred

NORM 2:
1. NORM type: PROHIBITION
2. SUBJECT: Supplier
3. OBJECT: Other party in the contract
4. ANTECEDENT: None
5. CONSEQUENT: None","1. Norm type: commitment
2. Subject: Supplier
3. Object: Not specified
4. Antecedent: Supplier either merges with another entity, suffers a transfer involving fifty (50%) percent or more of any class of its voting securities, or transfers all, or substantially all, of its assets
5. Consequent: A Termination Event shall have occurred"
